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ABSTRACT 
Competence induction in Streptococcus pneumoniae (pneumococcus) is initiated by the 
binding of the 17-amino acid competence stimulating peptide (CSP) to its membrane-associated 
histidine sensor kinase ComD. ComD autophosphorylates and subsequently phosphorylates and 
activates its cognate response regulator ComE. CSP-ComDE triggers the expression of 24 “early” 
competence genes and approximately 80 “late” competence genes. Some late competence 
genes encode effectors for genetic transformation. In recent years, the competence regulon of S. 
pneumoniae has been shown to cross regulate virulence. For example, Lau et al reported that 
the loss of function in ComB, an accessory protein to the ComA ABC transporter required for the 
export of CSP, as well as loss of function in the ComD, attenuate the ability of S. pneumoniae to 
cause pneumonia and bacteremia in mice. Because these studies suggest that competence 
regulon is not only essential for genetic transformation, but also for virulence, I sought a strategy 
to suppress pneumococcal competence development as a mean to reduce horizontal gene 
transfer as well as virulence. Of all the steps required for the development of competence for 
genetic transformation, the only one that occurs extracellularlly is the interaction between CSP 
and ComD. I hypothesized that blocking CSP-ComD interaction could effectively inhibit the 
induction of competence system. Previous studies have shown that the variable central region of 
CSP determines its receptor specificity. However, the roles of the conserved amino acid residues 
on both the N- and C-termini are unknown. I examined if amino acid substitution or deletion of 
these conserved residues could generate analogs that inhibit competence induction by wild-type 
CSP. I demonstrate that one of the CSP analogs, CSP1-E1A, competitively inhibits the ability of 
CSP1 to induce genetic transformation in a concentration dependent manner. I also demonstrate 
that CSP1-E1A successfully attenuates the expression of two virulence factors, CbpD and LytA 
during competence induction in a concentration-dependent manner. Inhibition of LytA and CbpD 
by CSP1-E1A reveals the possibility of using this peptide analog to attenuate pneumococcal 
infection. I examined whether CSP1-E1A could attenuate the virulence of S. pneumoniae D39 
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using a mouse model of acute pneumonia. CSP1-E1A significantly reduced the mortality rate as 
well as the kinetic of death infected mice. These results suggest that CSP1-E1A is able to 
attenuate virulence mechanisms of pneumococcus regulated by the competence regulon.  
One important feature of pneumococcal DNA uptake during competence is the degradation 
of one strand of donor DNA by the pneumococcal membrane nuclease EndA. EndA-mediated 
DNA degradation and small DNA fragment release were used as indicators of competence 
development. Interestingly, EndA has been identified as a virulence factor, most probably by 
degrading the neutrophil extracellular traps (NETs) and facilitate pneumococcal dissemination. I 
hypothesized that the nucleolytic activity of EndA during competence development is important 
for virulence. Contrary to my expectations, my experimental results demonstrate that EndA-
mediated degradation of extracellular DNA is independent of the competence state of 
pneumococcus. S. pneumoniae mutants with deletion in genes essential for competence 
induction and regulation have extracellular nuclease activity comparable to their parental wild-
type. In addition, nuclease activity of EndA is independent of LytA-mediated partial cell lysis, which 
may release the endonuclease into DNA-rich environments. Based on these results, I have 
proposed the existence of two distinct physiological states of EndA: the “competent state” and the 
“constitutive state”. During the competent state, a portion of EndA molecules is recruited by the 
competent apparatus to degrade one strand of the DNA, allowing the uptake of the remaining 
single stranded DNA for integration. During the “constitutive state”, EndA degrades extracellular 
DNA randomly. This portion of EndA activity is primarily responsible for the degradation of (NETs, 
virulence and bacterial dissemination. In addition, my data demonstrate that EndA molecules are 
secreted into the environment, and secreted EndA contributes substantially to “constitutive state” 
nucleolytic activity. Finally, the nuclease inhibitor aurintricarboxylic acid attenuates EndA-
mediated genetic transformation as well as degradation of NETs. Since EndA is essential for both 
virulence and genetic transformation, it may serve as an interesting drug target to attenuate 
pneumococcal infection and inhibit horizontal gene transfer. 
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 A key event of competence development in S. pneumoniae is the expression of pneumococcal 
alternative sigma factor ComX. ComX initiates the expression of 80 “late” competence genes in 
pneumococcal cells competent for genetic transformation. I hypothesized that the expression of 
ComX-regulated genes is beneficial to the fitness of S. pneumoniae during host infection. In this 
study, I conducted a systematic deletion study on the contribution ComX-regulated late genes to 
mouse infection. I showed that 13 mutants with deletions of ComX-regulated genes are 
attenuated in at least one model of mouse infection. For some late competence genes, their 
specific expression during competence contributes to bacterial fitness. While for some other 
ComX regulated genes, their constitutive baseline expression is important for bacterial fitness. 
Finally, inactivating dprA, a gene essential for competence shut off, severely attenuates the 
virulence of pneumococcus, indicating competence needs to be properly regulated during host 
infection. Collectively, these experimental data suggest that the competence regulon of S. 
pneumoniae plays crucial rules in both genetic transformation as well as fitness and survival in 
the hosts. 
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CHAPTER 1: GENERAL INTRODUCTION 
Streptococcus pneumoniae (pneumococcus) is an alpha-hemolytic, aerotolerant anaerobic 
Gram-positive bacterial pathogen. In most cases, S. pneumoniae inhabits the nasopharynx of 
humans asymptomatically. S. pneumoniae is more likely to cause invasive diseases in individuals 
with immature or compromised immune system such as children less than five years old and 
elderly individuals more than sixty five years old (Scott, 2007). Apart from pneumonia, invasive 
pneumococcal diseases also include otitis media (Block et al., 1995, Xu et al., 2009), meningitis 
(Bhattacharya, 1996, Paris et al., 1995), bacteremia (Plouffe et al., 1996), sinusitis (Nelson et al., 
1994), endocarditis (Clark et al., 1989, Sands et al., 1987), and brain abscess (Grigoriadis and 
Gold, 1997). Pneumococcal infection is a major cause of infant mortality in developing countries, 
where it causes more than 1.2 million infant deaths per year (Denny and Loda, 1986, Berkley et 
al., 2005). 
 
1.1 Genome Organization 
The genome size of S. pneumoniae is approximately 2 million base pairs. The GC content of 
the pneumococcal genome is approximately 39.7% (Tettelin et al., 2001). One characteristic of 
the S. pneumoniae genome is the presence of large numbers of repeated sequences called the 
BOX elements (Martin et al., 1992a). BOX elements facilitate genomic recombination and 
contribute to genome plasticity (Tettelin et al., 2001). Multi-genome analyses have shown that 
there are 1553 to 1666 genes in the core genome of S. pneumoniae (Donati et al., 2010). S. 
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pneumoniae is genetically highly related to S. mitis (Kilian et al., 2008). Aside from genes 
encoding certain choline binding protein genes, very few genes seem to be unique to S. 
pneumoniae. The detailed mechanism of why S. mitis is a not pathogen is still unclear. 
 
1.2 Cell surface structures 
S. pneumoniae cell wall consists of teichoic acids (TA) and multiple layers of peptdidoclycan 
(PG). Lipoteichoic acid (LTA) and TA are chemically identical except for the fact that LTA have a 
lipid moiety that anchors them to the cytoplasmic membrane (Fischer et al., 1993), while TA are 
attached to the PG. S. pneumoniae surface proteins could be divided into three groups, 
depending on their modes of anchoring. The three groups are the choline binding proteins, the 
peptidoglycan-bound proteins and the lipoproteins (Bergmann and Hammerschmidt, 2006). 
Choline binding proteins bind to the bacterial surface by associating with choline moieties on TA 
and LTA. These proteins have choline binding domains that attach specifically to choline moieties. 
S. pneumoniae express 13 to 16 choline binding proteins, including the cell wall hydrolases LytA, 
LytB, LytC and CbpD as well as the surface proteins PspA and PspC. PG-bound proteins 
possess unique LPxTG motives that could be recognized by sortases. Sortases catalyze the 
covalent attachment of these proteins to the cell wall PG (Navarre and Schneewind, 1999). 
Pneumococcal hyaluronidase, the neuraminidase NanA, the IgA1 protease and the zinc 
metalloprotease ZmpC are examples of PG-bound proteins (Oggioni et al., 2003). Lipoproteins 
are the most abundant pneumococcal surface proteins. There are 47 and 42 lipoproteins in 
pneumococcal strains TIGR4 and R6 respectively (Bergmann and Hammerschmidt, 2006). 
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Pneumococcal lipoproteins have been shown to contribute to substrate transport and bacterial 
fitness. Pneumococcal surface protein A (PsaA) is the substrate-binding lipoprotein of a 
manganese-transport system (Dintilhac et al., 1997). Deleting psaA reduces pneumococcal 
attachment to host cells, and attenuates its virulence in both intranasal and intraperitoneal 
mouse models of infection (Marra et al., 2002b, Tseng et al., 2002). PsaA is a potential vaccine 
target. Antibodies against PsaA reduce the adherence of pneumococcal cells to nasopharyngeal 
epithelial cells (Romero-Steiner et al., 2003). Mucosal immunization with PsaA is highly 
protective against pneumococcal carriage in mice (Johnson et al., 2002). Lipoproteins PiaA and 
PiuA are iron-uptake ABC transporters required for virulence (Brown et al., 2001). Immunization 
with PiaA and PiuA elicits protective antibodies that promote bacterial opsonophagocytosis 
(Jomaa et al., 2005). Lipoprotein PpmA and SlrA are chaperones involved in the secretion and 
the activation of surface proteins. Both PpmA and SlrA have been shown to be immunogenic 
(Adrian et al., 2004). 
 
1.3 Antibiotic treatment and resistance.  
Antibiotics routinely used to treat S. pneumoniae infections are beta-lactams, fluoroquinolone, 
macrolides and tetracycline. Increasing usage of antibiotics has contributed to the emergence of 
antibiotic resistant S. pneumoniae worldwide. Since the 1940s, penicillin has been used 
extensively to treat pneumococcal infections. The mechanism of beta-lactam resistance involves 
mutations in the penicillin binding proteins (PBPs), that lower their binding affinity to beta-lactam 
antibiotics (Bush and Jacoby, 2010). There is evidence that S. pneumoniae acquires the altered 
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form of PBPs from other streptococcal species through horizontal gene transfer. In S. 
pneumoniae, the genes that encode the altered forms of PBPs are called the mosaic genes. The 
main feature of these genes is the existence of additional DNA sequences within PBPs genes 
(Laible et al., 1991). The origin of the modified PBPs genes seems to be penicillin-resistant 
strains of commensal streptococcal species, including S. sanguis, S. mitis and S. oralis (Coffey 
et al., 1993, Hakenbeck et al., 1998, Chambers, 1999). Quinolones, including ﬂuoroquinolone, 
have been used as alternative therapeutic agents for treating pneumococcal infections. 
Fluoroquinolone targets DNA gyrase that mediates DNA supercoiling during replication. 
Fluoroquinolone resistance is mainly caused by target modifications in the gyrase genes (Janoir 
et al., 1996, Tankovic et al., 1996). Resistance to macrolide-lincosamide-streptogramins (MLS) 
involves both the target modification and the efflux of antibiotics. A transposon-encoded gene 
erm modifies 23S rRNA, reducing the binding affinity between 23S rRNA and MLS antibiotics 
(Lai and Weisblum, 1971). Chloramphenicol resistance involves converting chloramphenicol to 
its derivative by an enzyme encoded by the cat gene carried by conjugative transposons (Ayoubi 
et al., 1991). The glycopeptide antibiotics, for instance, vancomycin and teicoplanin, can prevent 
both the transglycosylation and transpeptidation that mediate the maturation of cell wall 
(Reynolds, 1989). Glycopeptides are considered as the last resort for treatment of infections 
caused by penicillin resistant S. pneumoniae. Thus far, no glycopeptides resistant S. 
pneumoniae strains have been identified. 
 
1.4 Vaccines 
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Currently, there are two major classes of licensed pneumococcal vaccines. The first class is 
the pneumococcal polysaccharide vaccine (PPSV). PPSV relies on the B-cell dependent 
response which allows the production of protective antibodies. In 1977, a 14-valent 
polysaccharide vaccine was licensed (1984). It was then improved into a 23-valent vaccine 
(Pneumovax 23) in 1983 (1984). Pneumovax 23 protects against serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 
9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F (1997). Pneumovax 
23 are recommended for adults 65 or older and adults between 19 and 65 that have conditions 
that increase susceptibility to S. pneumoniae infections (2010). Because polysaccharide antigens 
do not induce long term protective immunity, additional dosing is recommended to ensure 
protection (2010). Although Pneumovax 23 are very successful in adults, their responses are poor 
in children, especially those who are under the age of two. This is because the polysaccharide 
antigens are not a good inducer of T-cell response. Therefore, a more effective vaccine was 
developed to improve the responsiveness in children by stimulating T-cell dependent immunity 
against the capsule antigens. 
The second major class of pneumococcal vaccine is the protein conjugative vaccine (PCV). 
The new vaccine conjugates capsule polysaccharides with diphtheria toxoid that elicits strong 
immune response. The seven-valent protein conjugated vaccine (PCV7, Prevnar) was licensed in 
2000, and was recommended to be used by all children under two years old (2000). This vaccine 
conjugates diphtheria toxoid with capsule polysaccharides from serotypes 4, 6B, 9V, 14, 18C and 
19F and 23F (Hausdorff et al., 2000, Oosterhuis-Kafeja et al., 2007). Although the usage of PCV7 
was successful, in the meantime, serotype 19A, which was not covered by PCV7, became the 
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major cause of invasive pneumococcal diseases (2008). Due to this complication, a second 
generation of PCV called Prevnar 13, which includes the serotype 19A, was licensed and 
recommended for vaccination in all children in 2010 (2010).  
 
1.5 Major Virulence determinants 
S. pneumoniae has evolved to express many of virulence determinants for the successful 
colonization, invasion, dissemination and proliferation in humans.  
1.5.1 Capsule polysaccharide  
There are 91 distinct capsular serotypes in S. pneumoniae with different sugar compositions 
and linkages (Henrichsen, 1995). Genes for the synthesis of capsule polysaccharide are located 
in a locus (Paton et al., 1997) flanked by conserved regions, which make it easier for the genetic 
exchange and recombination of the capsular loci between different S. pneumoniae strains (Paton 
et al., 1997). Capsule is important for the virulence of S. pneumoniae because all clinical isolates 
that cause invasive diseases are encapsulated and loss of the capsule dramatically reduced the 
virulence of S. pneumoniae in the animal models of infection (Briles et al., 1992, Morona et al., 
2004, Morona et al., 2006, Watson and Musher, 1990). One important component of immune 
system affected by S. pneumoniae capsule is the complement system. S. pneumoniae capsule 
was shown to prevent the activation of complement system and the deposition of C3b/iC3b. 
Neutrophil-mediated phagocytosis is another major element of immunity against pneumococcal 
infection. Importantly, neutrophil phagocytosis is heavily dependent upon opsonization of S. 
pneumoniae by the complement system (Brown et al., 2002, Gross et al., 1978, Jonsson et al., 
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2005, Khandavilli et al., 2008, Yuste et al., 2008). Pneumococcal capsule prevents opsonization 
and thus reduces the efficiency of neutrophil phagocytosis. Interestingly, capsule expression is 
tailored to different host environments for the optimal survival of pneumococcus. During 
nasopharyngeal colonization, capsule expression is low, which facilitates the attachment of 
pneumococcus to host cells by exposing the adhesins (Kim and Weiser, 1998). In contrast, 
capsule expression level is high during the systemic infection, thereby protecting pneumococcus 
from opsonization and neutrophil phagocytosis (Kim and Weiser, 1998). 
1.5.2 Colonization factors 
Colonization of the respiratory tract by S. pneumoniae requires the adherence of the bacteria 
to the surface of lung epithelial cells. PsaA is required for the attachment to host cell surface 
carbohydrates (N-acetyl-glycosamine) under normal, non-inflamed conditions. 
Infection-mediated inflammation could change the type and number of receptors on epithelial 
cells. The phosphocholine of the pneumococcal cell wall has binding affinity to the 
platelet-activating-factor, a receptor that is upregulated during inflammatory response (Cundell et 
al., 1995, McCullers and Rehg, 2002). Similarly, choline-binding protein A (CbpA) has increased 
binding affinity for sialic acid and lacto-N-neotetraose on cytokine-activated human cells 
(Rosenow et al., 1997). CbpA is also purported to interact with the polymeric Ig receptor 
(Balachandran et al., 2002). Pneumococcal IgA1 protease also contributes to epithelial cell 
binding. Weiser and colleagues have shown that cleavage of IgA by IgA protease results in the 
change of surface charge and increased affinity of S. pneumoniae cell wall choline to the 
platelet-activating-factor on the host cell surface (Weiser et al., 2003). Neuraminidase is also 
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shown to improve colonization by cleaving glycolipids, glycoproteins and oligosaccharides, and 
expose N-acetyl-glycosamine receptors on the host epithelial cells (Tong et al., 2000).  
 
1.5.3. Glycosidase 
Nutrient acquisition is important for bacterial pathogens to survive in the upper respiratory 
tract, where carbohydrates are limited in the healthy individuals. Airway mucin on the epithelial 
cell surfaces are decorated with sugars for their optimum functions. S. pneumoniae possesses at 
least ten surface-localized or secreted glycosidases (Clarke et al., 1995, Jeong et al., 2009, 
Bongaerts et al., 2000, Berry et al., 1994, Caines et al., 2008). These glycosidases degrade sugar 
chains and release free carbohydrates to support pneumococcal growth. For example, it has 
been shown that carbohydrates released from the complex N-linked glycans on the alpha-1 
glycoprotein can sustain pneumococcal growth (King et al., 2006). The growth is dependent on 
the activity of pneumococcal glycosidases NanA, BgaA and StrH (King et al., 2006). It is also 
reported that the glycosaminoglycan hyaluronic acid present on the apical surface of airway 
epithelial cells could be utilized by S. pneumoniae as a carbon source (Marion et al., 2012). 
Hyaluronidase deficient mutant which cannot degrade hyaluronic acid is less able to colonize the 
nasal cavity (Marion et al., 2012).  
1.5.4. Pneumolysin  
Pneumolysin is a pore-forming toxin expressed by most clinical isolates of S. pneumoniae 
(Cockeran et al., 2002). Pneumolysin-deficient mutants are attenuated in both pneumonia and 
sepsis models of infection (Berry et al., 1989b). It has been shown that 50 pneumolysin 
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molecules are enough to form a 30 nm sized pore in host cell membranes (Morgan et al., 1995). 
Pneumolysin does not have a signal sequence for secretion. Partial pneumococcal cell lysis could 
promote the release of pneumolysin. However, recent result suggests that the release of 
pneumolysin is independent of the activity of pneumococcal major autolysin, LytA, suggesting 
other mechanisms of secretion may be involved (Balachandran et al., 2001). Apart from being 
cytotoxic, pneumolysin is also proinflammatory (Cockeran et al., 2002) and able to activate 
neutrophils and macrophages (Braun et al., 1999). Pneumolysin is a TLR4 ligand that activates 
NF-kappa B and thereby the expression of pro-inflammatory cytokines (Malley et al., 2003). 
Pneumolysin has been shown to induce lung inflammation in mice, similar to the inflammation 
observed in pneumococcal pneumonia (Feldman et al., 1991). Pneumolysin also activates the 
classical complement pathway without the help of antibody (Paton et al., 1984). Lastly, 
pneumolysin interferes with the ciliary function of respiratory epithelial cells, which in turn, 
prevents the removal of pneumococcal cells from the upper respiratory tract (Steinfort et al., 
1989).  
1.5.5 Autolysins 
S. pneumoniae expresses several cell wall hydrolases that digest PG. The most studied one 
is LytA (Whatmore and Dowson, 1999). LytA is a constitutively expressed choline binding protein 
(Steinmoen et al., 2002). However, its expression can be further upregulated by the alternative 
sigma factor ComX during competent induction by transcriptional read through from combox 
before the cinA gene (Peterson et al., 2004). LytA is important for both lung and systemic 
infection (Orihuela et al., 2004).  LytA mediates partial cell lysis, which releases highly 
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proinflammatory pneumococcal cell wall components PG and TA, as well as DNA into the host. 
Excessive inflammatory response may help the bacteria to breach the blood-lung barrier and 
enter the blood circulation. In addition, LytA-mediated cell wall digestion was purported to prevent 
phagocytosis and production of phagocyte-activating cytokines (Martner et al., 2009). CbpD is a 
minor cell wall hydrolase specifically expressed during the competent stage (Kausmally et al., 
2005) believed to facilitate partial cell lysis and bacterial DNA release. CbpD was identified as a 
virulence factor in a signature-tagged mutagenesis (STM) study (Hava and Camilli, 2002). LytB is 
important for mother-daughter cell partition (De Las Rivas et al., 2002). LytB- mutant forms very 
long chains (De Las Rivas et al., 2002). It has been reported that the size of bacterial cells 
influence their susceptibility to the complement system (Dalia and Weiser, 2011). Pneumococcal 
strains with their cells in longer chain are more vulnerable to opsonization. It is conceivable that 
LytB keeps the length of pneumococcal cells in check to minimize being attacked by the 
complement system. LytC is another constitutively expressed cell wall hydrolase (Moscoso et al., 
2005). The optimum temperature for LytC activity is 30oC (Moscoso et al., 2005). LytC is reported 
to be important for the nasopharyngeal colonization (Moscoso et al., 2005) where the 
temperature of nasal cavity is lower than 37 oC. It is conceivable that LytC has evolved and 
co-opted by pneumococcus for adaptations in the nasopharyngeal space.  
1.5.6 Nuclease  
EndA is reported to be a membrane-localized pneumococcal endonuclease (Rosenthal and 
Lacks, 1980). EndA was first implicated to play a role in genetic transformation by Kohoutova 
(Kohoutova, 1961), and subsequently confirmed by Lacks and colleagues (Lacks and Greenberg, 
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1973, Lacks et al., 1974, Lacks et al., 1975). During genetic transformation, EndA degrades one 
strand of the double stranded DNA (dsDNA) and converts it into single stranded DNA (ssDNA) 
for uptake and recombination (Lacks, 1962). Acid soluble DNA fragments or nucleotides 
generated during DNA degradation are released into the culture medium (Lacks et al., 1974), 
and are only detectable during competence development (Chen and Morrison, 1987).  
 Demonstration of EndA’s role in pneumococcal virulence is comparatively recent. An 
EndA-deficient mutant was identified in a STM screen in mouse lungs (Hava and Camilli, 2002). 
Furthermore, EndA degrades neutrophil extracellular traps (NETs) (Beiter et al., 2006). 
Composed of DNA and antibacterial proteins, NETs are released by activated neutrophils to 
capture and kill bacterial cells (Brinkmann et al., 2004). Degradation of NETs by EndA may 
release captured pneumococcal cells and facilitate their dissemination.  
1.5.7 HtrA 
HtrA is a heat shock-induced serine protease. It is best characterized in the Escherichia coli, 
and believed to be involved in the degradation of misfolded proteins (Pan et al., 2003). HtrA has 
both chaperone and protease activity. The protease activity is more obvious at higher 
temperatures (Ibrahim et al., 2004b). Pneumococcal htrA mutant growths slower than its parental 
strain at 40oC and is more susceptible to oxidative stress (Ibrahim et al., 2004b). The htrA mutant 
is attenuated in both murine pneumonia and bacteremia models of infection (Ibrahim et al., 
2004b). In addition, htrA mutant induces less IL-6 and TNF-alpha than does the parental wild type 
strain (Ibrahim et al., 2004b).  
1.5.8 Two-component regulatory systems 
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Sequence analysis of the S. pneumoniae genome has revealed 13 two-component 
regulatory systems (TCS) and one orphan response regulator (46, 60). Some of the TCS have 
been shown to contribute to pneumococcal pathogenesis (46). TCS 09 is a Lyt family TCS that 
contributes significantly to pneumococcal virulence in both mouse pneumonia and bacteremia 
models of infection (Blue and Mitchell, 2003). TCS 04, which belongs to the Pho TCS family, was 
also identified as a pneumococcal virulence factor that contributes to murine pneumonia (Throup 
et al., 2000). In TIGR4 strain, TCS 04 mutant was shown to have reduced expression of the psa 
operon. This operon encodes a manganese ABC transporter system and contributes to oxidative 
stress resistance (McAllister et al., 2004). TCS 12 is the ComDE TCS regulates both competence 
and virulence (Bartilson et al., 2001, Lau et al., 2001). ComD- mutant is attenuated in both 
pneumonia and bacteremia models of infection in mice. Other virulence factors regulated by the 
competence system include cell wall hydrolyses LytA, CbpD and serine protease HtrA. CiaRH 
(TCS 05) (CiaRH) was the first TCS identified pneumococcal (Guenzi et al., 1994). It plays 
important roles in pneumococcal biology, including virulence, competence and antibiotic 
resistance (Guenzi et al., 1994, Guenzi and Hakenbeck, 1995, Throup et al., 2000, Zahner et al., 
2002). The contribution of TCS 05 to virulence has been confirmed by many groups (Ibrahim et 
al., 2004b, Marra et al., 2002a, Throup et al., 2000). TCS 05 upregulates HtrA, which is important 
for virulence (Ibrahim et al., 2004b). TCS13 was identified to be important for respiratory tract 
infection by Throup et al (Throup et al., 2000). This system was named blp TCS for 
bacteriocin-like peptide because it regulates a 16-gene quorum-sensing system responsible for 
the biosynthesis and export of the bacteriocin-like peptides (de Saizieu et al., 2000). However, in 
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the virulent pneumococcal strains TIGR4 and D39, a reading frame shift occurs in the blpA gene. 
This indicates the significance of TCS 13 in virulence is strain dependent, and is dispensable in 
TIGR4 and D39. RR489 is an orphan response regulator. Its role in lung infection was first 
established by Throup (Throup et al., 2000) and subsequently confirmed by Ulijasz (Ulijasz et al., 
2004). RR489 is purported to repress the Piu iron uptake system. While iron is essential for the 
growth of many bacterial species, excessive iron can be deleterious to pneumococcal cells 
through the Fenton reaction that generate toxic reactive oxygen species deleterious to 
pneumococcus.  
 
1.6 Competence induction and regulation in S. pneumoniae 
A model of competence regulation in this S. pneumoniae is displayed in Figure 1. 
Competence is a transient physiological state in which cells are able to take up exogenous donor 
DNA and integrate it into their genomes (Hotchkiss, 1954). In S. pneumoniae, competence 
induction is controlled by ComDE TCS system, which activate the biosynthesis of comC (Pestova 
et al., 1996). comC encodes a 42 amino acid pre-CSP which matures into a 17 amino acid peptide 
pheromone by proteolytic cleavage upon exportation through its transporter ComAB (Havarstein 
et al., 1995). Mature CSP is secreted by pneumococcus during the growth, and accumulates in 
the extracellular environment. When a threshold concentration is reached, CSP stimulates 
ComD, which in turn activates ComE (Pestova et al., 1996). Activated ComE positively regulate 
the expression of its own operon by recognizing an imperfect direct repeat (DR) sequence in its 
promoter region (Ween et al., 1999). Including its own operon, ComE up-regulates the expression 
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of 10 genetic loci possessing a similar DR sequence in their promoters. The expression of 
ComE-regulated genes reaches its peak at approximately 7.5 mins post CSP induction, these 
genes are called the “early” competence genes (Peterson et al., 2004). One of these “early” 
genes positively regulated by ComE is comX. ComX is an alternative pneumococcal sigma factor 
essential for genetic transformation. ComX associates with the core RNA polymerase and 
initiates the transcription of 19 ‘late” gene operons possessing a non-canonical promoter 
sequence, TACGAATA (Campbell et al., 1998, Pestova and Morrison, 1998, Lee and Morrison, 
1999, Luo and Morrison, 2003). This ComX binding site is also called the “combox”. The 
expression of ComX-controlled “late” genes reaches a maximum at 12.5 mins post CSP 
exposure. Recently it has been demonstrated that ComX is under the regulation by another 
competence inducible early gene, comW  (Bartilson et al., 2001, Luo et al., 2004, Sung and 
Morrison, 2005). ComW is necessary for both the stability and the activity of ComX (Luo et al., 
2004, Sung and Morrison, 2005). The 19 “late” gene operons contain 80 genes. Among these, 
cclA, celAB, cflAB, and cglA-G encode proteins for DNA uptake; dprA, ssbB, coiA, and recA 
encode proteins required for DNA integration; and lytA, cbpD, and cibAB encode proteins 
essential for allolysis, an unique process during competence that leads to partial cell lysis and 
release of bacterial DNA. Approximately 64 genes up-regulated by ComX during competence 
are not essential for genetic transformation.  
Competence in S. pneumoniae is strictly-regulated. The mechanism of competence 
induction has been studied for a long time. However, how pneumococcus exits the competence 
state remains unclear until recently. Two recent studies have reported that DprA, a late 
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competence protein, is required for competence shut off (Mirouze et al., 2013, Weng et al., 
2013). They showed that DprA binds to ComE and prevents the binding of ComE to its promoter. 
DprA- mutant has difficulty exiting from competence state and has severe growth defect when 
induced with CSP. These results suggest that continuous unregulation of competence state is 
detrimental to pneumococcus.  
Aside from both the early and the late competence genes, there is a third wave of gene 
expression that peaks after late competence genes. They are called the “delayed” genes. The 
induction of delayed genes is not dependent on the ComX. Delayed genes encode several 
chaperons and heat shock proteins, a TCS ciaRH and several proteins with unknown functions.  
 
1.7 Potential relations between competence and virulence 
The competence regulon of S. pneumoniae has been shown to cross regulate virulence 
(Ibrahim et al., 2004a, Guiral et al., 2005, Claverys et al., 2007). Lau et al reported that loss of 
function in ComB, an accessory protein to the ComA ABC transporter required for the export of 
CSP, as well as loss of function in the ComD, attenuate the ability of S. pneumoniae to cause 
pneumonia and bacteremia in mice (1). Additional studies have shown that 
competence-mediated cell autolysis may release pneumolysin, as well as the pro-inflammatory 
cell wall component LTA, the former being an important virulence factor of S. pneumoniae 
(Ibrahim et al., 2004a, Guiral et al., 2005, Claverys et al., 2007). Furthermore, microarray 
analysis indicates that CSP induces the transcription of both virulence (i.e. autolysins cbpD, lytA) 
and stress responsive genes (Peterson et al., 2004). Collectively, these studies suggest that 
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competence regulon is not only essential for DNA transformation, but also for virulence.  
 
1.8 Objectives of the research projects 
There are two main objectives for my projects. (i) To devise strategies that suppress 
competence development in S. pneumoniae so as to prevent horizontal gene transfer and 
reduce virulence. (ii) To decipher the mechanisms by which the competence regulon contributes 
to bacterial fitness during infection.  
The first aim explores the possibility of shutting off the activation of competence regulon by 
disrupting the interaction between CSP and ComD. Previous studies have shown that the 
variable central region of CSP is important for receptor specificity. However, the roles of the 
conserved amino acid residues on both the N- and C-termini are unknown. I examined the 
hypothesis that amino acid substitution or deletion of these conserved residues could generate 
peptide analogs that inhibit competence induction by wild-type CSP. This portion of study is 
described in detail in both Chapter 2 and Chapter 3. 
The second aim seeks to examine the mechanism behind the importance of the 
competence regulon for S. pneumoniae infection. One important feature of pneumococcal DNA 
uptake during the competent state is the degradation of one strand of donor DNA by EndA, a 
membrane associated nuclease. EndA mediated DNA degradation and small DNA fragment 
release was used as an indicator of competence development. It is also reported that EndA is 
required for degradation of NETs and virulence. I examined the hypothesis that 
competence-associated EndA activity contributes to virulence. Contrary to my expectation, I 
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presented experimental evidence that majority of the nucleolytic activities of EndA are 
independent of competence development, and the “competence-independent activity” of EndA 
contributes to lung infection. In addition, EndA is secreted during pneumococcal growth. This 
portion of study will be detailed in Chapter 4.  
One of the key events of competence development in S. pneumoniae is the expression of 
pneumococcal alternative sigma factor ComX. ComX initiates the expression of 80 late 
competence genes in pneumococcal cells competent for genetic transformation. Of these, only 16 
late genes are important for genetic transformation. I examined the hypothesis that the 
expression of the remaining late genes is beneficial to the fitness of S. pneumoniae during 
infection. I have conducted a systematic deletion study on the contribution ComX-regulated 
genes to pneumococcal infection using both the acute pneumonia and the bacteremia models of 
infection. This portion of study is detailed in the chapter 5. 
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Figure 1.  Competence regulation in Streptococcus pneumoniae.  
Arrows – positive regulation, rectangular boxes with horizontal line represents all the genes in the 
early and late gene class respectively. DR – Direct repeat sequence, combox – combox promoter 
sequence. Circle and edged squares represent indicated protein products respectively. 
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CHAPTER 2: INHIBITION OF COMPETENCE DEVELOPMENT, HORIZONTAL GENE 
TRANSFER AND VIRULENCE IN STREPTOCOCCUS PNEUMONIAE BY A 
MODIFIED COMPETENCE STIMULATING PEPTIDE 
Abstract 
Competence stimulating peptide (CSP) is a 17-amino acid peptide pheromone secreted 
by Streptococcus pneumoniae. Upon binding of CSP to its membrane-associated receptor kinase 
ComD, a cascade of signaling events is initiated, leading to activation of the competence regulon 
by the response regulator ComE. Genes encoding proteins that are involved in DNA uptake and 
transformation, as well as virulence, are upregulated. Previous studies have shown that 
disruption of key components in the competence regulon inhibits DNA transformation and 
attenuates virulence. Thus, synthetic analogues that competitively inhibit CSPs may serve as 
attractive drugs to control pneumococcal infection and to reduce horizontal gene transfer during 
infection. We performed amino acid substitutions on conserved amino acid residues of CSP1 in 
an effort to disable DNA transformation and to attenuate the virulence of Streptococcus 
pneumoniae. One of the mutated peptides, CSP1-E1A, inhibited development of competence in 
DNA transformation by outcompeting CSP1 in time and concentration-dependent manners. 
CSP1-E1A reduced the expression of pneumococcal virulence factors choline binding protein D 
(CbpD) and autolysin A (LytA) in vitro, and significantly reduced mouse mortality after lung 
infection. Furthermore, CSP1-E1A attenuated the acquisition of an antibiotic resistance gene and 
a capsule gene in vivo. Finally, we demonstrated that the strategy of using a peptide inhibitor is 
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applicable to other CSP subtype, including CSP2. CSP1-E1A and CSP2-E1A were able to cross 
inhibit the induction of competence and DNA transformation in pneumococcal strains with 
incompatible ComD subtypes. These results demonstrate the applicability of generating 
competitive analogues of CSPs as drugs to control horizontal transfer of antibiotic resistance and 
virulence genes, and to attenuate virulence during infection by Streptococcus pneumoniae. 
 
Introduction 
The incidence of antibiotic resistance in Streptococcus pneumoniae has increased 
dramatically in the recent decades (Coker et al., 2010, Lynch and Zhanel, 2010, Linares et al., 
2010). The acquisition and spread of antibiotic resistance genes in Streptococcus pneumoniae is 
at least partly due to genetic transformation, which occurs when the bacteria enter the competent 
state (Johnsborg and Havarstein, 2009, Claverys et al., 2009, Morrison and Lee, 2000). The 
binding of competence stimulating peptide (CSP) to its membrane-associated histidine kinase 
receptor ComD initiates competence in Streptococcus pneumoniae (Johnsborg and Havarstein, 
2009, Claverys et al., 2009, Morrison and Lee, 2000, Havarstein et al., 1995). Upon interacting 
with CSP, ComD phosphorylates the cognate transcriptional regulator ComE (Pestova et al., 
1996, Havarstein et al., 1996, Martin et al., 2010). ComE then initiates the transcription of a set of 
24 genes (early genes), including comX. As an alternative sigma factor, ComX positively 
regulates the transcription of 81 genes (late genes) in the competence regulon (Peterson et al., 
2004, Luo et al., 2003). Some of these late genes encode effectors for DNA uptake and 
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recombination (Peterson et al., 2004). DNA sequence analysis from 60 pneumococcal isolates 
predicts the existence of six distinct CSP subtypes (Pozzi et al., 1996, Whatmore et al., 1999). 
However, an overwhelming majority of Streptococcus pneumoniae strains produce two of these 
subtypes: CSP1 or CSP2 (Whatmore et al., 1999). Furthermore, apart from CSP1 and CSP2, the 
ability of other CSP subtypes to induce DNA transformation has not been analyzed. There are two 
major corresponding variants of ComD, named ComD1 and ComD2 (Iannelli et al., 2005). CSP1 
and CSP2 share 50% amino acid identity. The major sequence variation between CSP1 and 
CSP2 occurs in the central region of these peptides, which confers receptor 
specificity (Johnsborg et al., 2006). In contrast, the first three amino acid residues of the 
N-terminus and the last two amino acid residues of the C-terminus are conserved between CSP1 
and CSP2. Competence in pneumococcal strains with the ComD1 receptor could be induced 
more efficiently with the “compatible” CSP1. In contrast, ComD2 strains are more sensitive to 
induction by the “compatible” CSP2 (Johnsborg et al., 2006). 
Competence for DNA transformation plays a crucial role in the ability of Streptococcus 
pneumoniae to gain virulence and antibiotic resistance genes from other species. Importantly, in 
recent years, the competence regulon of Streptococcus pneumoniae has been shown to cross 
regulate virulence (Lau et al., 2001, Kowalko and Sebert, 2008, Ibrahim et al., 2004b, Guiral et al., 
2005, Claverys et al., 2007). For example, Lau et al (Lau et al., 2001) reported that a loss of 
function in ComB, an accessory protein to the ComA ABC transporter required for the export of 
CSP, as well as a loss of function in the ComD histidine kinase, attenuate the ability 
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of Streptococcus pneumoniae to cause pneumonia and bacteremia in mice. This report has been 
subsequently confirmed by other studies (Kowalko and Sebert, 2008, Ibrahim et al., 2004b, Guiral 
et al., 2005). In addition, it has been shown that competence-mediated cell lysis may mediate the 
release of pneumolysin, as well as the cell wall component lipoteichoic acid (LTA), the former 
being an important virulence factor of Streptococcus pneumoniae (Guiral et al., 2005, Claverys et 
al., 2007). Microarray analysis has indicated that CSP induces the transcription of both virulence 
and stress responsive genes (Peterson et al., 2004). These above-mentioned studies indicate 
that activation of the competence regulon is not only essential for DNA uptake and transformation, 
but also important for virulence. Therefore, the competence regulon represents a potential drug 
target to combat both pneumococcal infections and the spread of antibiotic resistance genes. 
In this study, we performed amino acid substitutions in CSP1 and CSP2, and examined the 
ability of these CSP variants to inhibit the development of competence, horizontal gene transfer, 
and virulence of Streptococcus pneumoniae both in vitro and in mice. One of these modified 
peptides, CSP1-E1A, was able to competitively inhibit the development of competence for DNA 
transformation and expression of virulence gene in vitro. Importantly, CSP1-E1A was able to 
attenuate the virulence of Streptococcus pneumoniae during lung infection in mice, as well as 
inhibiting the ability of pneumococcus to acquire both an antibiotic resistance gene and a capsule 
gene during mouse models of acute pneumonia and bacteremia infections. Significantly, we 
demonstrated that the same amino acid substitution on CSP2 (CSP2-E1A) also inhibits 
CSP2-mediated competence development. Moreover, both CSP1-E1A and CSP2-E1A were 
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capable of cross inhibiting the induction of competence regulon mediated by incompatible 
receptors, ComD2 and ComD1, respectively. 
 
Material and methods 
Chemicals 
All chemicals, except where noted, were purchased from Sigma Chemical Co. (St. Louis, 
MO). 
 
Bacterial strains and growth conditions 
Streptococcus pneumoniae strains D39 (Avery et al., 1944), R6 (Kilian et al., 2008) and 
TIGR4 (Tettelin et al., 2001) were generous gifts from Dr. David Briles (University of 
Alabama-Birmingham). Strains D39pcomX::lacZ and TIGR4pcomX::lacZ, both of which carry an 
insertion of the lacZ gene under the control of the comX promoter, were generated by 
transforming D39 and TIGR4 with the genomic DNA from CPM3 (Sung and Morrison, 2005). 
Strain D39pcbpD::lacZ was generated using previously described primers (Kausmally et al., 
2005). Briefly, a 500 bp fragment within cbpD gene was amplified and cloned into lacZ reporter 
plasmid pEVP3 (Claverys et al., 1995). The recombinant plasmid was transformed into D39 to 
generate D39pcbpD::lacZ. The capsule-deficient cap3A mutant was generated by deleting 
cap3A gene from the serotype 3 clinical isolate 0100993 (Lau et al., 2001) using the Janus 
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cassette (Sung and Morrison, 2005). Aliquots of bacteria were stored at −70°C in THB containing 
25% glycerol. For routine experiments, bacteria from frozen stocks were streaked onto THB agar 
containing 5% defibrinated horse blood and incubated for 12–24 h at 37°C with 5% CO2. Fresh 
colonies were scraped and transferred to THB and grew to desired density as measured by a 
spectrophotometer at OD 600nm.  
 
Synthetic CSPs 
CSP1, CSP2 and their analogues (≥95% purity) were synthesized by Elim Biopharm 
(Hayward, CA). 
 
Activation assays of comX and cbpD promoters 
The ability of synthetic CSPs to activate the promoters of comX gene was compared in 
D39pcomX::lacZ or TIGR4pcomX::lacZ bacteria grown in THB (pH 6.8) until OD 600nm of 0.1, 
washed and resuspended in THB (pH 8.3). Induction of cbpD promoter was monitored using the 
D39pcbpD::lacZ cells grown under the same conditions. CSP1 or CSP2 and their analogues were 
added at indicated concentrations to the culture and incubated at 37°C for 30 min. 
ß-galactosidase activity was measured according to previously published protocols (Johnsborg et 
al., 2006), and expressed as Miller units. 
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In vitro Streptococcus pneumoniae transformation assay 
In vitro transformation experiments were performed as we had previously described (Lau et 
al., 2001). Briefly, Streptococcus pneumoniae cells were grown to early log phase (OD 600nm 0.1) 
in THB (pH 6.8), washed and resuspended in THB (pH 8.3) containing rpsL DNA (1 µg). CSP1, 
CSP2 and their analogues were added alone or in combination at desirable concentrations. 
The rpsL gene, which confers resistance to streptomycin, and its flanking regions (combined 
length 1633 bp), were amplified from pneumococcal strain CP1296 (Sung et al., 2001) using the 
following 
primers: rpsL upper 5′-GGGCTAGTAGAAGTAGTTGG-3′, rpsLlower: 5′-CGGAAGTGTGCGAAT
GCACG-3′). The transformation mix was then incubated at 37°C with 5% CO2 for 1 hr. 
Transformants were selected on THB agar supplemented with 100 µg/mL streptomycin. 
 
Ethics statement 
This study was carried out in strict accordance with the recommendations in the Guide for the 
Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was 
approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Illinois 
at Urbana-Champaign (Protocol Number: 10144). 
 
Mouse acute pneumonia infection assays 
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Mice used in this study were housed in positively ventilated microisolator cages with 
automatic recirculating water, located in a room with laminar, high efficiency particle 
accumulation–filtered air. The animals received autoclaved food, water, and bedding. Six-week 
old adult male CD-1 mice (Charles River, Boston) (groups of 10) were anesthetized with 
isoflurane and intranasally administered 3×106CFU of D39 bacteria or D39-20 µg CSP1-E1A 
mixture in 50 µl PBS. In a second experiment, CD-1 mice (groups of 20) were exposed to 
2×106 CFU of D39 bacteria or D39-100 µg CSP1-E1A mixture in 50 µl PBS. The Infected mice 
were monitored every 6 hr for 96 hr. Moribund animals that displayed rough hair coat, hunched 
posture, distended abdomen, lethargy or inability to eat or drink were euthanized. 
 
In vivo horizontal gene transfer studies 
The rpsL donor DNA was amplified from pneumococcal strain CP1296 (Sung et al., 
2001). Streptococcus pneumoniae strain D39 cells were used as recipients. D39 cells were 
grown to OD 600nm 0.1 in THB (pH 6.8), washed and resuspended in fresh THB (pH 8.3). Adult 
CD-1 mice were intranasally or intraperitoneally infected with D39 (3×107, 50 µl volume) 
supplemented with a mixture of 100 ng CSP1 and 10 µg of rpsL gene DNA, or D39 supplemented 
with a mixture 100 ng CSP1, 800 ng CSP1-E1A, and 10 µg of rpsL gene DNA in THB. For natural 
transformation studies, a capsule-deficient cap3A mutant (Table S1) derived from a clinical 
serotype 3 strain 0100993 (Lau et al., 2001) was used as recipient. Natural transformation were 
performed intraperitoneally in mice with 2×109 cap3A cells and 100 µg of chromosomal DNA from 
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0100993, with or without 100 µg of CSP1-E1A. No CSP1 peptide was used. For all transformation 
assays, individual reagents were kept separately on ice, mixed and immediately inoculated into 
animals to prevent the induction of competence prior to injection. Transformation did not occur 
before or after the experiments because no transformants was recovered from plating the 
transformation mix before or after the experiments (data not shown). For intranasally infected 
mice, lungs were harvested 6hr post-infection, homogenized and plated on THB agar (total output) 
or THB agar supplemented with 100 µg/ml streptomycin for transformants. Intraperitoneally 
infected mice were monitored until they were moribund (∼16–24 hr) at which time the animals 
were euthanized, and the spleens were harvested for bacterial enumeration. The number of total 
bacteria and streptomycin resistant transformants in spleens were enumerated as described 
above. 
 
S. pneumoniae growth inhibition by CSP1 and derivatives 
D39 cells were collected at early log phase (OD 600nm 0.1). Cells (2×106 cfu) were 
resuspended in 50 µl of sterile PBS and incubated with 20 µg or 100 µg of CSP1, CSP1-E1A or 
CSP1-R3A or CSP1, and incubated on ice for 10 min. THB (500 µl) was added to the cells/peptide 
mixtures, and incubated at 37°C in a CO2 incubator. Bacterial growth was monitored at OD 
600nm using a spectrophotometer for the indicated time intervals. 
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Zymogram analysis of murein hydrolases 
D39 cells were grown in THB (pH 6.8) to OD 600nm of 0.1. Cells were washed and 
resuspended in fresh THB (pH 8.3). Cells were exposed to CSP1 (100 ng/ml) alone or to a 
combination of CSP1 and increasing amounts of CSP1-E1A (0, 100, 200, 400 or 800 ng/ml). After 
30 minutes of incubation, cells were lysed by mixing with 2X SDS loading buffer, and subjected to 
zymogram analysis as previously published (Eldholm et al., 2010). Lytic activity was observed as 
bands of clear zones in the turbid gel. 
 
Statistical analyses 
Statistical analyses of in vitro experiments were performed using the Student's t-test and 
one-way analyses of variance (ANOVA). Statistical significance of survival studies was performed 
using the log-rank (Mantel-Cox) test in GraphPad Prism statistical software package. A significant 
difference was considered to be p<0.05. 
 
Results 
The first and the third amino acid residues on the N terminus of CSP1 are critical for the 
induction of competence 
Because amino acid residues in the central region of CSP1 are important for receptor 
specificity (Johnsborg et al., 2006), we hypothesized that conserved amino acid residues on both 
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the N-terminus and the C-terminus of CSP1 are important for its ability to induce competence. By 
amino acid substitutions or deletions of the first three amino acid residues on the N-terminus and 
of the last two amino acids on the C-terminus, we synthesized five CSP1 variants (Table 1). The 
ability of these modified peptides to induce competence in Streptococcus pneumoniae wild-type 
strain D39 (Table S1) grown in Todd Hewitt Broth (THB) was compared to that of CSP1 by: (i) 
monitoring the transformation frequency of a rpsL gene that confers resistance to streptomycin, 
and (ii) monitoring the promoter activity of the competence specific sigma factor gene (Sung et al., 
2001) comX. Induction of ComX indicates that Streptococcus pneumoniae cells have entered a 
competent state. The promoter activity of comX was monitored by assaying the ß-galactosidase 
activity in D39pcomX::lacZ, a D39 derivative with a lacZ gene fused behind the comX promoter 
(Table S1) (Pozzi et al., 1996). Deletion or substitution of either of the two lysine (K) residues on 
the C-terminus (CSP1-K16DK17D, CSP1-ΔK16ΔK17) did not alter the ability of these peptides to 
induce competence (Fig. 2A–2B). In contrast, substitution of the first amino acid (glutamate to 
alanine) (CSP1-E1A) severely reduced the ability of this peptide to induce comX (Fig. 2A) and 
DNA transformation (Fig. 2B). CSP1-E1A could only induce about 1% of comX promoter activity 
and > 3 logs lower DNA transformation when compared to CSP1. Similarly, alanine substitution of 
the third residue of the N terminus (CSP1-R3A) impaired its ability to induce both comX and DNA 
transformation (Fig. 2–2B). In contrast, alanine substitution of the second amino acid residue on 
the N terminus (CSP1-M2A) did not alter its ability to induce both comX and DNA transformation 
(Fig. 2A–2B). 
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CSP1-E1A but not CSP1-R3A out-competes and inhibits CSP1-mediated comX induction 
in a dose and time dependent manner 
As presented in Figure 2, two modified CSP peptides—CSP-E1A and CSP-R3A—are 
attenuated in their ability to induce the comX gene and the competence of DNA transformation. 
We examined the ability of these two peptides to competitively inhibit the induction of competence 
by CSP1. D39pcomX::lacZ cells were exposed to 100 ng of CSP1 alone or simultaneously to 
increasing amounts of CSP1-E1A (Fig. 3A) or CSP1-R3A (Fig. 3B). In the absence of CSP1-E1A, 
CSP1 induced the promoter activity of comX gene to approximately 45 Miller units of 
ß-galactosidase. However, in the presence of CSP1-E1A, the ability of CSP1 to induce comX (Fig. 
3A) was severely inhibited in a concentration dependent manner. CSP1-E1A by itself only 
induced low expression of comX. In contrast, even though CSP1-R3A by itself was unable to 
induce the expression of comX, it did not competitively inhibit CSP1-dependent comX expression 
(Fig. 3B). These results suggest that CSP1-E1A has the unique ability to competitively inhibit the 
ability of CSP1 to induce competence. 
 
CSP-E1A but not CSP1-R3A inhibits CSP1-mediated genetic transformation 
Because of their inability to induce competence and DNA transformation, we next examined 
whether CSP1-E1A and CSP1-R3A were able to competitively inhibit CSP1-mediated DNA 
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transformation. In vitro transformation with the rpsL gene was performed with Streptococcus 
pneumoniae D39 cells exposed to 100 ng of CSP1 alone or simultaneously in the presence of 
increasing amounts of CSP1-E1A or CSP1-R3A. As expected, in the absence of CSP1-E1A, 
CSP1 induced DNA uptake and transformation at high frequency (Fig. 3C). However, the 
presence of increasing concentrations of CSP1-E1A drastically inhibited the transformation of 
D39. For example, at equal concentration of 100 ng/ml, CSP1-E1A reduced CSP1-mediated 
transformation by 5.6-fold. Interestingly, increasing concentration of CSP1-R3A failed to 
competitively inhibit the ability of CSP1 to induce DNA transformation in D39 cells (Fig. 3D). 
These results are consistent with the inability of CSP1-R3A to inhibit the induction of comX by 
CSP1 (Fig. 3B). Collectively, these data suggest that CSP1-E1A is uniquely capable of 
competitively inhibiting CSP1-mediated competence induction and DNA transformation. 
 
CSP1-E1A inhibits the competence regulon in a time-dependent manner 
Because CSP1-E1A is capable of competitively inhibiting CSP1-mediated competence 
induction in Streptococcus pneumoniae, we examined whether this inhibition occurred in a 
time-dependent manner. D39pcomX::lacZ cells were pre-exposed to 100 ng/ml CSP1, then 
chased by the addition of CSP1-E1A at indicated time intervals. Activation of the comX promoter 
was calculated against D39pcomX::lacZ cells exposed to CSP1 alone (100%). As shown 
in Figure 4, CSP1-E1A at concentration of 100 ng/ml was able to inhibit approximately 40–50% 
of comX induction 10 minutes after pre-induction with CSP1. The inhibition was abolished at 
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approximately 30 minutes after pre-induction with CSP1. At the concentration of 800 ng/ml, 
CSP1-E1A was highly effective, and able to inhibit 50% of CSP1-mediated comX induction 25 
min after pre-induction by CSP1. These results suggest that under our in vitro experimental 
conditions, 30 min was roughly the time span required for the distribution and binding of CSP1 to 
ComD to prevent competitive inhibition by CSP1-E1A. In addition, these results also indicate that 
30 minutes was approximately the amount of time required for establishment of full competence 
when Streptococcus pneumoniae D39 cells are exposed to CSP1. 
 
CSP1-E1A delays and inhibits the development of spontaneous competence in vitro in a 
concentration dependent manner 
During its normal growth, Streptococcus pneumoniae cells spontaneously enter a 
developmental stage of competence for DNA uptake and transformation by activating the 
biosynthesis of CSP. Because CSP1-E1A competitively inhibits the competence development in 
pneumococcal cells exposed to exogenously supplied CSP1, we further investigated its ability to 
suppress spontaneous development of competence. D39pcomX::lacZ cells grown in THB (pH 8.3) 
were exposed to sterile water (control) or to CSP1-E1A. The promoter activity of comX began to 
increase dramatically in the D39pcomX::lacZ cells incubated with sterile water at approximately 
90 min (Fig. 5A). In contrast, in the D39pcomX::lacZ cells treated with 100 ng or 1 µg of 
CSP1-E1A, the induction of comX promoter was delayed for 30 min and 60 min, respectively (Fig. 
5A). Furthermore, the maximum level comX promoter activity was only 38% in cells treated with 1 
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µg of CSP1-E1A when compared to those cells treated with sterile water. CSP1-E1A at the 
concentration of 10 µg/ml completely abolished the induction of comX promoter in D39 (Fig. 5A). 
Similarly, CSP1-E1A delayed and inhibited the promoter activity of a virulence gene cbpD, a late 
gene in the competence regulatory circuit, in a concentration dependent manner (Fig. 5B). 
CSP1-E1A did not interfere with the growth D39 cells (Fig. 5C). These results suggest that 
CSP1-E1A has the ability to delay and inhibit spontaneous competence development during 
normal growth in Streptococcus pneumoniae in a concentration-dependent manner. 
 
CSP1-E1A attenuates the expression of Streptococcus pneumoniae virulence factor in 
vitro 
We and others have previously shown that the competence regulon regulates both DNA 
transformation and virulence (Lau et al., 2001, Kowalko and Sebert, 2008, Ibrahim et al., 2004b, 
Guiral et al., 2005, Claverys et al., 2007), although the mechanism behind this regulation is not 
fully understood. Guiral et al (Guiral et al., 2005) have proposed a possible connection between 
competence induced cell lysis and virulence. Induction of competence triggers the expression of 
the murein hydrolases autolysin A (LytA) and Choline-Binding Protein D (CbpD). Together, they 
induce pneumococcal cell lysis and the release of virulence factors including pneumolysin and 
cell wall component LTA into the hosts. Therefore, we examined whether CSP1-E1A could inhibit 
the synthesis and the release of pneumococcal murein hydrolases. Streptococcus 
pneumoniae D39 cells were treated with CSP1 (100 ng/ml) alone or simultaneously with 
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increasing amounts of CSP1-E1A (0, 100, 200, 400 or 800 ng/ml), and subjected to zymogram 
analysis. As shown in Figures 6A–C, The expression of CbpD and LytA decreased by 63% and 
44% respectively when D39 cells were simultaneously treated with a combination of 100 ng/ml 
CSP1 and 200 ng/ml CSP1-E1A. The decrease is even more profound as the concentrations of 
CSP1-E1A was increased to 400 ng/ml or 800 g/ml, reducing the expression of LytA by 73% and 
72% (Fig. 6B). Similarly, at the concentrations of 400 ng/ml or 800 g/ml, CSP1-E1A reduced the 
expression of CbpD by 87% and 94%, respectively (Fig. 6C). Inhibition of cbpD promoter activity 
(Fig. 6D) mirrored the zymogram analysis. These results suggest that CSP1-E1A is able to inhibit 
the expression of virulence genes regulated by competence regulon. 
 
CSP1-E1A attenuates the virulence of Streptococcus pneumoniae during infection of 
mouse lungs 
The ability of CSP1-E1A to inhibit the expression of LytA and CbpD in vitro reveals the 
possibility of using this peptide analogue to attenuate pneumococcal infection. We examined 
whether CSP1-E1A could attenuate the virulence of Streptococcus pneumoniae D39 using 
mouse model of acute pneumonia in two independent experiments. In Experiment 1, adult CD1 
mice (groups of 10) were intranasally infected with D39 alone or a mixture of D39 and 20 µg 
CSP1-E1A. Animals were monitored closely, and those that were moribund were considered 
dead. As shown in Figure 7A, inclusion of CSP1-E1A in the infection mix significantly reduced the 
mortality rate of infected mice from 60% (D39 alone) to 30% (D39 coinoculated with CSP1-E1A). 
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However, the difference in kinetics of mouse survival between the two groups was not statistically 
significant (p = 0.21) as analyzed by the log rank (Mantel-Cox) survival analysis. Thus, we 
repeated the experiment with higher number of mice and increased concentration of CSP1-E1A. 
In Experiment 2, CD1 mice (groups of 20) were intranasally infected with D39 alone or a mixture 
of D39 and 100 µg CSP1-E1A. As shown in Figure 7B, increasing the CSP1-E1A concentration to 
100 µg/mouse in the infection mix significantly reduced the mortality rate of infected mice from 
75% (D39 alone) to 40% (D39 coinoculated with CSP1-E1A). In addition, the kinetics of death 
was delayed, and was statistically significant (p = 0.01) (Fig. 7B). In contrast, the survival rate and 
mortality kinetics were indistinguishable between mice infected with D39 alone or in mice infected 
with a mixture of D39 and 100 µg CSP1-R3A (Fig. 7C) (p = 0.96). These results suggest that 
CSP1-E1A is uniquely able to attenuate virulence mechanisms regulated by the competence 
regulon during Streptococcus pneumoniae-mediated lung infections. 
 
CSP1-E1A inhibits the horizontal gene transfer in vivo 
The competence regulon plays a role in the acquisition and spread of antibiotic resistant 
genes in Streptococcus pneumoniae (Johnsborg and Havarstein, 2009, Claverys et al., 2009, 
Morrison and Lee, 2000). In vivo gene uptake and transformation of Streptococcus 
pneumoniae have been previously reported to occur at extremely low frequency (Griffith, 1928, 
Ottolenghi and Macleod, 1963, Conant and Sawyer, 1967, Auerbach-Rubin and 
Ottolenghi-Nightingale, 1971). As we have shown above, CSP1-E1A has the ability to 
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competitively inhibit CSP1-mediated DNA transformation, and attenuate the development of 
spontaneous competence in Streptococcus pneumoniae in vitro. Here, we examined whether 
CSP-E1A could inhibit acquisition of the streptomycin resistance rpsL gene in vivo, using mouse 
models of acute pneumonia and bacteremia that we had previously described (Lau et al., 2001). 
Adult CD1 mice were intranasally or intraperitoneally infected with a transformation mixture 
composed of D39 bacteria and rpsL donor DNA and CSP1, or a transformation mixture 
composed of D39 bacteria and rpsL donor DNA and CSP1 and CSP1-E1A. To ensure that no 
transformation occurred outside animals, each component of the transformation mixture was kept 
on ice. Individual transformation components were mixed on ice and immediately inoculated into 
the animals. Plating of the ice-cold transformation mixture before infection or at time intervals 10, 
20 and 30 min after infection did not give rise to any transformants (data not shown). 
Intranasally-infected mice were incubated for 6 hr whereas intraperitoneally-infected mice were 
incubated until moribund (∼16–24 hr). As shown in Table 2, all five mice intranasally-infected with 
the D39-rpsL DNA-CSP1 mixture gave rise to a range of 3 to 41 streptomycin resistant 
transformants out of the total lung output of 106–107 D39 cells. In contrast, no streptomycin 
resistant D39 was recovered in the five mice infected with D39-rpsL DNA-CSP1-CSP1-E1A 
mixture. Similarly as shown in Table 3, all four mice intraperitoneally-infected with the D39-rpsL 
DNA-CSP1 mixture gave rise to a range of 273 to 517 streptomycin resistant transformants out of 
the total 108 D39 cells. In contrast, no streptomycin resistant D39 cells were recovered in the four 
mice intraperitoneally-infected with D39-rpsL DNA-CSP1-CSP1-E1A. Collectively, these results 
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suggest that CSP1-E1A is efficient in suppressing the ability of CSP1 to activate competence 
regulon in vivo. 
Spontaneous transformation of encapsulated Streptococcus pneumoniae strains including 
D39 occurs at extremely low frequency in vivo. Thus, CSP1 was included to increase the 
efficiency of DNA transformation experiments reported in Tables 2 and 3. Inclusion of CSP1 
beckoned the question of whether CSP1-E1A could attenuate natural transformation events in 
vivo. Natural transformation experiments were performed using a capsule mutant cap3A (Table 
S1) derived from a serotype 3 isolate 0100993 (Lau et al., 2001). The colonies of serotype 
3 Streptococcus pneumoniae isolates are large and mucoid, and can be easily distinguished from 
small colonies formed by non-encapsulated rough mutants. Mice were intraperitoneally 
inoculated with a mixture of 3×109 cap3A cells and 100 µg of chromosomal DNA from 0100993, 
or with a mixture of 3×109 cap3A cells and 100 µg of 0100993 chromosomal DNA and 100 µg of 
CSP1-E1A. Higher amount of CSP1-E1A was used because we did not know the length of the 
inhibitory effect of this peptide analogue in vivo. In addition, the timing of Streptococcus 
pneumoniae cells entering the competent state for DNA transformation in vivo was also not clear. 
Transformation mixtures were assembled under ice-cold condition as described for Tables 2. 
Plating of transformation mixtures immediately before and after inoculation did not recover any 
transformants (data not shown). As shown in Table 4, transformants with wild-type capsule were 
recovered from four of the five mice inoculated with the mixture of cap3A bacteria and 0100993 
genomic DNA. In contrast, transformants with wild-type capsule were only recovered from one out 
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of five mice co-inoculated with cap3A bacteria and 0100993 DNA and CSP1-E1A. Furthermore, 
we used CSP1-R3A (Fig. 2) as a control to demonstrate the specificity of CSP1-E1A inhibition. 
CSP1-R3A was unable to inhibit development of natural competence in vivo (Table 4). In the 
group treated with a mixture of 3×109 cap3A cells and 100 µg of 0100993 chromosomal DNA and 
100 µg of CSP1-R3A, transformants were isolated from all the 5 mice, indicating high 
concentration of CSP1-R3A was unable to inhibit natural DNA transformation in vivo. These 
results suggest that CSP1-E1A has the unique ability to reduce the incidence of natural DNA 
transformation process in vivo. CSP1-E1A is not bacteriostatic against S. pneumoniae 
A previous study has shown that CSP2 has bacteriostatic activity against Streptococcus 
pneumoniae (Oggioni et al., 2006). To rule out non-specific effects due to a much higher 
concentration of CSP1-E1A used in the virulence attenuation (Fig. 7B) and in vivo natural 
transformation (Table 4) studies, we examined whether CSP1-E1A was bacteriostatic 
against Streptococcus pneumoniae. As shown in Figure 10A, CSP1 at concentrations of 20 µg or 
100 µg caused a slight delay in the growth of D39 cells. In contrast, same concentrations of 
CSP1-E1A or CSP1-R3A did not slow the growth of D39 cells (Fig. 10B–10C). These results 
suggest that high concentrations of CSP1-E1A is not bacteriostatic, and that attenuation of 
virulence and DNA transformation by CSP1-E1A is due to inhibition of competence regulon 
induction. 
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A CSP2 analogue CSP2-E1A effectively inhibits the competence development and 
transformation in ComD2 strain TIGR4 
Because CSP1-E1A is an efficient inhibitor of competence induced by CSP1, we hypothesize 
that a synthetic CSP2 analogue with the substitution of first residue (glutamate) with alanine 
(CSP2-E1A) will competitively inhibit CSP2 (Fig. 2). We examined the ability of CSP2-E1A to 
inhibit the induction of competence by CSP2 in the compatible ComD2 strain TIGR4 (Table S1). 
CSP2-E1A was barely able to induce the promoter activity of comX (Fig. 8A), and its ability to 
induce DNA transformation was reduced by approximately 3 logs when compared to CSP2 (Fig. 
8B). Importantly, CSP2-E1A competitively inhibited the ability of CSP2 to 
induce comX expression in the TIGR4pcomX::lacZ cells in a concentration-dependent manner 
(Fig. 8C). Similarly, CSP2-E1A inhibited the ability of CSP2 to induce DNA transformation of 
TIGR4 in a concentration dependent manner. At equal concentration of 100 ng/ml, CSP2-E1A 
reduced the number of transformants generated by CSP2 by 68% (Fig. 8D). At higher 
concentrations of 400 and 800 ng/ml, CSP2-E1A almost completely abolished CSP2-mediated 
DNA transformation. These results suggest that CSP2-E1A is a strong competitive inhibitor 
of comX expression and DNA transformation in ComD2 strain TIGR4. 
 
CSP1-E1A and CSP2-E1A cross inhibit the competence in S. pneumoniae strains with 
incompatible ComD subtypes 
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A previous study has shown that individual CSP peptide is capable of inducing the 
competence of DNA transformation in Streptococcus pneumoniae strains expressing an 
incompatible ComD subtype, albeit at lower efficiency (Johnsborg et al., 2006). For example, 
CSP1 is able to induce the competence at lower efficiency in TIGR4, a pneumococcal strain with 
an incompatible ComD2 subtype. Because the first amino acid (glutamate) at the N-terminus is 
conserved across all six CSP subtypes, this raises the possibility that our CSP analogues 
CSP1-E1A and CSP2-E1A can be broad spectrum in their ability to inhibit the development of 
competence, horizontal gene transfers and virulence, regardless of Streptococcus 
pneumoniae serotypes or ComD subtypes. To test this hypothesis, we examined the ability of 
CSP1-E1A and CSP2-E1A (Table 1) to cross inhibit the induction of comX and DNA 
transformation in ComD2 strain TIGR4 or ComD1 strain D39, respectively. As shown in Figure 
10A, CSP1-E1A inhibited the induction of comX and DNA transformation by CSP2 in TIGR4 by a 
concentration dependent manner, though at a lesser efficiency. For example, CSP1-E1A at 800 
ng/ml was able to inhibit approximately 50% of comX promoter activity in the presence of 100 
ng/ml CSP2. Similarly, CSP1-E1A (800 ng/ml) decreased the CSP2-induced DNA transformation 
frequency by 67% (Fig. 9B). Finally, we examined the ability of CSP2-E1A to inhibit the induction 
of comX and DNA transformation by CSP1 in the ComD1 strain D39. As shown in Figure 9C, 
CSP2-E1A inhibited CSP1-mediated comX induction and DNA transformation in D39 by a 
concentration dependent manner. For example, CSP2-E1A at 800 ng/ml was able to inhibit 
approximately 77% of comX induction and 90% of DNA transformation in the presence of 100 
ng/ml CSP1 (Fig. 9D). Collectively, these results suggest that CSP1-E1A and CSP2-E1A have 
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the potential of inhibiting the development of competence, horizontal gene transfer and virulence, 
regardless of pneumococcal serotypes and CSP/ComD subtypes. 
 
Discussion 
The competence regulon is known to regulate DNA transformation and virulence 
in Streptococcus pneumoniae. In this study, we explored the use of synthetic analogues of CSPs 
to competitively inhibit: (i) the development of competence, (ii) horizontal gene transfer, and (iii) 
virulence, under both in vitro and in vivo experimental conditions. Amino acid substitution or 
deletion of conserved residues in C-terminus of CSP1 did not alter their ability to induce 
competence and DNA transformation. In contrast, amino acid substitutions on the first 
(CSP1-E1A) and third residue (CSP1-R3A) on the N-terminus impair the ability of these CSP 
analogues to induce competence. Our findings are consistent with the previously thesis work by 
Coomaraswamy, which has been summarized by Haverstein and Morrison. By alanine scanning, 
Coomaraswamy demonstrates that both the N-terminus and the central region are more 
important than the C-terminus of CSP1 for the induction of competence regulon. One discrepancy 
of our finding from that of Coomaraswamy is on the requirement for the 2nd amino acid residue at 
the N-terminus. Coomaraswamy has shown that substituting the methionine at this position with 
an alanine reduces the ability of the CSP1-M2A to induce competence by 96%. By contrast, our 
analysis suggests that the methionine residue is dispensable for competence induction. One 
possible explanation for the discrepancy is that our comX induction and DNA transformation 
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experiments were performed with 100 ng/ml CSP1-M2A, approximately 10-fold higher than the 
amounts used by Coomaraswamy. Thus, despite its lower activity, excess amounts of CSP1-M2A 
might have masked our ability to see reduced efficiency of this analogue to induce competence. 
Of the five CSP1 analogues examined, only CSP1-E1A is capable of competitively inhibiting 
the induction of competence and DNA transformation by CSP1. Furthermore, CSP1-E1A inhibits 
the development of spontaneous competence in Streptococcus pneumoniae in a concentration 
dependent manner. Importantly, CSP1-E1A is able to attenuate the expression of 
competence-regulated pneumococcal virulence factors LytA and CbpD in vitro, and reduced the 
mortality of mice in a pneumonia model of lung infection by Streptococcus pneumoniae. In 
addition, we provide evidence that CSP1-E1A is able to inhibit the horizontal gene transfer of the 
streptomycin resistance rpsL and the capsule cap3A genes in vivo. Finally, we demonstrate a 
broader applicability of the peptide inhibitor strategy. CSP1-E1A and CSP2-E1A cross inhibits the 
induction of competence and DNA transformation in pneumococcal strains with incompatible 
ComD subtypes. For example, CSP1-E1A reduces the CSP2-mediated competence and DNA 
transformation in ComD2 strain TIGR4. Similarly, CSP2-E1A cross inhibits the CSP1-mediated 
competence and DNA transformation in ComD1 strain D39. 
Among the five CSP1 analogues, we found that only CSP1-E1A inhibits CSP1-mediated 
competence in time and concentration-dependent manners. These results suggest that glutamate, 
the first amino acid residue of CSPs, is only required for the activity of CSPs. Substituting the 
glutamate with alanine disrupts the ability of the analogue to activate ComD1, but does not 
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interfere with its binding affinity to ComD1. Competitive inhibition of CSP1 by CSP1-E1A suggests 
that this analogue, which barely activates competence, can bind to the receptor kinase ComD1, 
and outcompete CSP1. In contrast, another CSP1 analogue, CSP1-R3A, not only loses the ability 
to induce competence, but also could not out compete CSP1 even when added in over-saturating 
concentrations. This observation may suggest that CSP1-R3A has lost its ability to bind and 
activate ComD1. The importance of the first glutamate residue has been confirmed by our data 
demonstrating that the synthetic analogue CSP2-E1A also efficiently inhibits the CSP2-mediated 
DNA transformation in the compatible ComD2 strain TIGR4. 
Several studies have revealed that the competence regulon of Streptococcus pneumoniae is 
important for virulence in mammalian hosts (Lau et al., 2001, Ibrahim et al., 2004a, Guiral et al., 
2005, Claverys et al., 2007). For example, we have previously shown that the loss-of-function 
mutation in the comB gene, which encodes an accessory protein of the ComA ABC transporter 
for the export of CSP, is attenuated in a mouse model of bacteremia (Lau et al., 2001). Mutation of 
CSP receptor gene comD severely attenuates virulence in both mouse models of pneumonia and 
bacteremia (Lau et al., 2001). Also, microarray analysis has showed that some virulence and 
stress responsive genes are upregulated during development of competence, suggesting that 
genes that are important for the fitness of Streptococcus pneumoniae are also regulated by 
competence CSP-ComDE cascade (Peterson et al., 2004). Thus, suppression of the 
CSP-ComDE cascade or downstream genes dependent on this signaling pathway may attenuate 
the virulence of this pathogen. Our results, which show that CSP1-E1A delays the kinetics and the 
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rate of mouse mortality, demonstrate that this peptide has the potential to inhibit the virulence 
of Streptococcus pneumoniae by disrupting the CSP-ComDE- dependent competence regulon. 
Our findings are in agreement with previous reports by Oggioni et al, which show that 
administration of CSP in a mouse model of pneumonia infection increases virulence of 
pneumococci (Oggioni et al., 2006), suggesting that competence regulon is important for lung 
infection. In contrast, the same authors also reported that intravenous (IV) injection of CSP 
reduces virulence in an IV model of mouse bacteremia (Oggioni et al., 2004). Based on this 
finding, one can surmise that administration of CSP1-E1A may have the unintended 
consequence of exacerbating virulence in IV model of mouse bacteremia. However, one 
unresolved issue with the results of the IV model of sepsis (Oggioni et al., 2004) is that it is in 
disagreement with the findings by Lau et al (Lau et al., 2001), which showed the requirement of 
competence regulon during pneumococcal-mediated sepsis. The discrepancy can be explained 
because the sepsis studies by Lau et al was performed by intraperitoneal model of infection 
whereas the studies by Oggioni et al was performed by IV model of infection. Nevertheless, 
collectively, these studies indicate the important contribution of the pneumococcal competence 
regulon to virulence during mouse model of pneumonia infection, and offer a tantalizing clue that 
the competence system as interesting drug target to combat pulmonary pneumonia. In contrast, 
inhibition of competence regulon by systemic delivery of CSP1-E1A in an IV model of bacteremia 
should be avoided until further clarification. 
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Within the last few decades, resistance of Streptococcus pneumoniae to β-lactams, 
macrolides, and other antibiotic classes has escalated dramatically throughout the world. While 
conjugative elements appear to be the most important causes for the spread of antibiotic 
resistance genes in Streptococcus pneumoniae (Pozzi et al., 2004, Widdowson and Klugman, 
1998, Croucher et al., 2009, Shen et al., 2008), horizontal gene transfer of penicillin binding 
protein genes has occurred in clinical isolates of Streptococcus pneumoniae (Dowson et al., 
1989). Importantly, it has been shown that under in vitro conditions, antibiotic stress induces 
genetic transformability in Streptococcus pneumoniae (Prudhomme et al., 2006). This suggests 
that under certain in vivo circumstances, instead of being killed, Streptococcus 
pneumoniae actively exploits the opportunity of antibiotic stress to acquire exogenous genes. 
These authors also reported that unlike wild type Streptococcus pneumoniae, antibiotic 
stress-mediated competence could not be induced in a comA mutant that lacks the ABC 
transporter needed to export CSP, suggesting that this process is CSP-dependent. Because 
antibiotic resistance is a serious clinical concern, the development and use of non-antibiotic 
based therapy to reduce horizontal gene transfer is urgently needed. Our studies suggest that 
CSP1-E1A and CSP2-E1A competitively inhibit CSP from binding to ComD, leading to 
suppression of horizontal gene transfer. The use of CSP1-E1A and CSP2-E1A, which does not 
inhibit the bacterial growth, is predicted to pose less selection pressure toward the survival 
of Streptococcus pneumoniae. This may alleviate the emergence of resistance in pneumococcus. 
More importantly, CSP1-E1A and CSP2-E1A have the ability to cross inhibit the induction of the 
competence regulon in Streptococcus pneumoniae strains with incompatible ComD subtypes. 
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Thus, it may be beneficial to generate analogues of CSPs as drugs to reduce horizontal transfer 
of antibiotic resistance and virulence genes, and to attenuate virulence during infection 
by Streptococcus pneumoniae irrespective of their serotypes. In the same context, chemical 
inhibitors of that interfere with CSP functions may be useful as well. 
In previously published studies, some of the in vivo transformation experiments involved 
infections were allowed to run their course, and success or failure of gene transfers were 
expressed by the number of deceased animals harboring encapsulated or antibiotic resistant 
transformants (Griffith, 1928, Ottolenghi and Macleod, 1963, Conant and Sawyer, 1967, 
Auerbach-Rubin and Ottolenghi-Nightingale, 1971). However, at these late stages of infection, 
most transformants are expected to have over-proliferated, and it may be difficult to assess the 
actual transformation frequency. Other transformation studies lasted for eight hr 
(Ottolenghi-Nightingale, 1969, Ottolenghi-Nightingale, 1972). In this study, we used both 
approaches. We assessed the infected lungs for streptomycin resistant transformants 6 hr 
post-infection in an effort to estimate the actual transformation frequency. Our results suggest that, 
despite the provision of CSP1 and abundant amounts of DNA, in vivo transformation events for 
the encapsulated wild-type Streptococcus pneumoniae strain D39 in mouse lungs remain low, in 
the range of 10−6 to 10−7 under our experimentation conditions. In comparison, we also examined 
the in vivo transformation within intraperitoneally-infected mice in which the infection was allowed 
to take its full course (24 hr), similar to previously published studies  (Griffith, 1928, Ottolenghi 
and Macleod, 1963, Conant and Sawyer, 1967, Auerbach-Rubin and Ottolenghi-Nightingale, 
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1971). The percentage of transformants in D39 increases to the range of 10−4 to 10−5. The 
different rate of transformation may suggest that the environment in the lung is more complex and 
less conducive to DNA uptake and transformation than the intraperitoneal space. Alternatively, 
longer period of infection may have allowed more recipient D39 cells to be transformed. 
Importantly, we show that CSP1-E1A also attenuates natural transformation in the absence of 
exogenously provided CSP1. The capsule-deficient cap3A mutant derived from the serotype 3 
strain 0100993 was used as recipient. It is well known that natural transformation frequency of 
capsule-deficient Streptococcus pneumoniae mutants is much higher than their respective 
encapsulated parental wild-type strains. Furthermore, recipients that have acquired the wild-type 
capsule gene will be more resistant to phagocytosis by host leukocytes, allowing a better 
possibility for the transformants to proliferate inside the host. Because of the higher 
transformation frequency was anticipated for the rough cap3A mutants, larger amounts of 
CSP1-E1A was used to attenuate natural transformation to ensure that the inhibition effect of 
CSP1-E1A could outlast and suppress spontaneous development of competence of cap3A cells 
in the peritoneal cavity. In contrast, the presence of capsule in D39 cells reduces the spontaneous 
transformation frequency to a very low level. Not surprisingly, 800 ng of CSP1-E1A was adequate 
to completely abolish transformation of D39 cells in vivo. 
In summary, we have demonstrated the efficacy of using competitive inhibitor of CSPs to 
attenuate virulence and to inhibit horizontal gene transfer in Streptococcus pneumoniae. Because 
competence peptide-mediated quorum sensing systems are conserved in many pathogenic 
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species of Gram-positive bacteria (Dunny and Leonard, 1997, Kleerebezem et al., 1997, Sturme 
et al., 2002, Lyon and Novick, 2004, Thoendel and Horswill, 2010), the strategy of using peptide 
analogue may be applicable to reduce the incidence of horizontal gene transfer and acquisition of 
antibiotic resistance genes, and to also treat lung infections mediated by this class of pathogens. 
In addition, competence systems in other streptococcal species, including S. mitis, are very 
similar to that of Streptococcus pneumoniae, lending to the idea that the former could be 
transformed by pneumococcal DNA (Havarstein et al., 1997, Kilian et al., 2008). S. mitis is 
generally considered as an avirulent species, but it has the potential to acquire virulence 
determinants from Streptococcus pneumoniae to transform itself into a pathogen. In this scenario, 
strategies that prevents competence development may have the potential to reduce the 
emergence of the new pathogen. 
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Figure 2. The first and third amino acid residues of CSP1 are essential for induction of 
competence. 
(A) D39pcomX::lacZ cells were incubated with CSP1 or with individual modified peptides at a final 
concentration of 100 ng/ml for 30 min. The ability of each peptide to induce competence regulon 
was measured by induction of the comX promoter in D39pcomX::lacZ. The amino acid 
substitution of 1stamino acid (CSP1-E1A) and 3rd amino acid (CSP1-R3A) in the N-terminus 
abolished the peptide's ability to induce the expression of comX. (B) D39 cells were exposed to 
100 ng/ml of CSP1 or individual modified peptides. DNA transformation was performed using 
the rpsL gene. Transformants were selected on THB agar containing 100 µg/ml streptomycin. 
Experiments were performed in triplicates and repeated three times. The means ± SD of one 
typical experiment are shown. *p<0.01 when compared against CSP1-treated cells. 
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Figure 3. Dose dependent inhibition of comX expression and DNA transformation by 
CSP-E1A. (A–B) CSP-E1A but not CSP1-R3A inhibits CSP1-mediated induction of comX in a 
dose dependent manner. D39pcomX::lacZ cells were exposed to 100 ng/ml of CSP1 alone or 
simultaneously with increasing concentrations of CSP-E1A or CSP-R3A. The activity 
of comX gene promoter was measured by b-galactosidase activity. (A) CSP-E1A competitively 
inhibits the ability of CSP1 to induce comX. (B) CSP-R3A is unable to induce comX, and does not 
competitively inhibit CSP1. (C–D) CSP-E1A but not CSP1-R3A outcompetes and inhibits 
CSP1-mediated genetic transformation in a dose dependent manner. In vitro transformation was 
performed by treating D39 with 100 ng/ml CSP1 alone or simultaneously with increasing 
concentrations of CSP1-E1A or CSP1-R3A. Purified PCR product harboring a mutated rpsL gene 
was used for genetic transformation. Transformants were selected on THB agar plates 
supplemented with 100 µg/ml streptomycin. CSP1-E1A competitively inhibited the ability of CSP1 
to induce DNA transformation (C). CSP1-R3A was unable to competitively inhibit DNA 
transformation (D). Experiments were performed in triplicates and repeated three times. The 
means ± SD of one typical experiment are shown. *p<0.01 when compared against cells treated 
with CSP1 only. 
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Figure 4. Time-dependent inhibition of competence development by CSP1-E1A. 
CSP1-E1A competitively inhibits CSP1 mediated competence in a time-dependent manner. 
D39pcomX::lacZ cells (OD 600nm 0.1) were pre-exposed to 100 ng/ml CSP1. At Time 0, 5, 10, 15, 
20, 25 and 30 min, CSP-E1A (100 ng or 800 ng) was added to chase CSP1. Cells were collected 
30 min after each addition of CSP1-E1A for b-galactosidase assays. Activation of comX promoter 
was calculated against D39pcomX::lacZ cells exposed to CSP1 alone (100%). Experiments were 
performed in triplicates and repeated three times. The means ± SD of one typical experiment are 
shown. 
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Figure 5. CSP1-E1A delays and inhibits the spontaneous development of competence in S. 
pneumoniae in a concentration-dependent manner. 
(A–B) D39pcomX::lacZ and D39pcbpD::lacZ cells grown in THB (pH 8.3) were incubated with 100 
ng/ml, 1 µg/ml or 10 µg/ml of CSP1-E1A or with same volume of sterile water, and monitored 
for comX promoter activity (A) or for the cbpD promoter activity (B) by β-galactosidase assays at 
indicated time intervals. (C) CSP1-E1A does not inhibit the growth of S. pneumoniae. Similar 
results were obtained from three independent experiments. The data from one typical experiment 
are shown. 
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Figure 6. CSP1-E1A inhibits the expression of competence regulated virulence factors LytA and 
CbpD in vitro. 
(A) CSP1-E1A attenuates the expression of LytA and CbpD. D39 cells (OD 600nm 0.1) were 
exposed to CSP1 (100 ng/ml) alone or simultaneously to increasing amounts of CSP1-E1A (0, 
100, 200, 400 or 800 ng/ml). Cells were incubated for 30 minutes, lysed and subjected to 
zymogram analysis. Lytic activity was observed as bands of clear zones in the turbid gel. 
Experiments were repeated three times. The gel from one typical experiment is shown. (B–C) 
Densitometry analysis of LytA (B) and CbpD (C) from the zymogram in A. (D) CSP1-E1A inhibits 
the promoter activity of cbpD in a concentration dependent manner. D39pcbpD::lacZ cells were 
exposed to CSP1 alone, pure water alone or to a mixture of 100 ng/ml CSP1 and CSP-E1A.Cells 
were collected for β-galacosidase assays 30 min after exposure.    
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Figure 7. CSP1-E1A attenuates the mortality of mice infected with S. pneumoniae. 
(A) Six-week old CD-1 mice (n = 10) were intranasally infected with S. pneumoniae D39 (3×106, 
50 µl) alone, or with a mixture of D39-CSP-E1A (20 µg/mouse). Infected mice were monitored 
every 6 hr. Moribund mice were euthanized and considered dead. The difference in kinetics of 
mouse survival between the two groups was not statistically significant (p = 0.21) as analyzed by 
the log rank (Mantel-Cox) survival analysis. (B) Infection assay was repeated with CD-1 mice (n =
20) using D39 (2×106, 50 µl) alone or with a mixture of D39-CSP-E1A (100 µg/mouse). Infected 
mice were monitored as described in (A). The kinetics of death was significantly delayed (p = 0.01) 
as determined by the log rank (Mantel-Cox) survival analysis. (C) The survival kinetics was 
indistinguishable between mice infected with D39 alone or in mice infected with a mixture of D39 
and 100 µg CSP1-R3A (p = 0.96). 
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Figure 8. CSP2-E1A inhibits competence development and transformation in ComD2 
strain TIGR4. 
(A–B) CSP2-E1A was drastically reduced in its ability to induce the promoter activity of comX (A) 
and DNA transformation in TIGR4 (B). Experiments were performed in triplicates and repeated 
three times. The means ± SD of one typical experiment are shown. *p<0.01 when compared 
against TIGR4pcomX::lacZ cells (A) or TIGR4 cells (B) treated with CSP2 only. (C) CSP-E2A 
out-competes CSP2 and inhibits activation of the comX promoter activity. TIGR4pcomX::lacZ 
cells (OD 600nm 0.1) were incubated with 100 ng/ml CSP2 alone or simultaneously with 
increasing amounts of CSP2-E1A. The activity of comX promoter was measured by 
β-galactosidase assays. (D) CSP-E2A inhibits CSP2-mediated DNA transformation of TIGR4. In 
vitro transformation was performed by treating TIGR4 cells with 100 ng/ml CSP2 alone or 
simultaneously with increasing amount of CSP2-E1A. Purified PCR product of a 
mutated rpsL gene was used for genetic transformation. Transformants were selected on THB 
agar supplemented with 100 µg/ml streptomycin. Experiments in were performed in triplicates and 
repeated three times. The means ± SD of one typical experiment are shown. *p<0.01 when 
compared against TIGR4pcomX::lacZ cells (A) or TIGR4 cells (B) treated with CSP2 only. 
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Figure 9. Cross inhibition of competence by CSP1-E1A and CSP2-E1A in S. 
pneumoniae strains with incompatible ComD subtypes. 
(A-B) TIGR4 (ComD2 subtype) or TIGR4pcomX-lacZ cells (OD 600nm 0.1) were incubated with 
CSP2 alone or simultaneously with increasing amounts of CSP1-E1A (100–800 ng/ml). (C-D) 
D39 (ComD1 subtype) or D39pcomX-lacZ cells were incubated with the mixture of 100 ng/ml 
CSP1 alone or simultaneously with increasing amounts of CSP2-E1A (100–800 ng/ml). 
Pneumococcal cells were assayed for β-galactosidase activity and transformation frequency 60 
minutes after exposure. (A–B) Cross inhibition of competence in ComD2 strain TIGR4 by 
CSP1-E1A as measured by the induction of comX promoter activity (A) and transformation 
frequency (B). (C–D) Cross inhibition of competence in ComD1 strain D39 by CSP2-E1A as 
measured by the induction of comX promoter activity (C) and transformation frequency (D). 
Experiments were performed in triplicates and repeated three times. The means ± SD of one 
typical experiment are shown. *p<0.05 when compared against TIGR4 cells or TIGR4pcomX-lacZ 
cells treated with CSP2 alone, or D39 cells or D39pcomX-lacZ cells treated with CSP1 alone. 
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Figure 10. CSP1-E1A is not bacteriostatic against S. pneumoniae. (A-C) D39 cells 
(2×106 cfu) (OD 600nm0.1) were resuspended in 50 µl of PBS and incubated with 20 µg or 100 µg 
of CSP1, CSP1-E1A or CSP1-R3A or CSP1. After 10 min of incubation on ice, the cells/peptide 
mixture was added to 500 µl of THB, and incubated at 37°C. Bacterial growth was monitored by 
OD 600nm for the indicated time intervals. Experiments were performed in triplicates and repeated 
three times. The means ± SD of one typical experiment are shown. 
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Table 1. Amino acid sequences of CSP1 and CSP2, and their analogues. 
CSP1, CSP2 and their 
derivatives 
Peptide sequence Induction of 
competence 
Inhibition of 
competence 
CSP1 EMRLSKFFRDFILQRKK Yes / 
CSP1-E1A AMRLSKFFRDFILQRKK No* Yes 
CSP1-M2A EARLSKFFRDRILQRKK Yes No 
CSP1-R3A EMALSKFFRDFILQRKK No* No 
CSP1-K16DK17D EMRLSKFFRDFILQRDD Yes No 
CSP1-∆16K∆17K EMRLSKFFRDFILQR_ Yes No 
CSP2 EMRISRIILDFLFLRKK Yes / 
CSP2-E1A AMRISRIILDFLFLRKK No* Yes 
Modified CSPs were synthesized based on the sequence of CSP1 or CSP2 by amino acid 
substitutions or by deletion. The ability of each CSP analogue to induce competence and to 
competitively inhibit CSP1 or CSP2-mediated competence is presented. *No represents < 1% of 
CSP1 or CSP2 activity during the induction of competence. 
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Table 2 
CSP1-E1A inhibits the ability of S. pneumoniae to acquire the rpsL streptomycin 
resistance gene in mouse lungs during acute pneumonia. 
 
Treatment Mice # of output bacteria/lung # transformants 
CSP1 1 5.7×106 3 
 2 3.3×107 15 
 3 7.2×106 7 
 4 1.4×107 23 
 5 2.3×107 41 
CSP1 + CSP1-E1A 1 5.3×106 0 
 2 1.7×107 0 
 3 2.1×107 0 
 4 3.2×107 0 
 5 1.2×107 0 
 
Mice (n = 5) were intranasally inoculated with D39 (3×107, 50 µl volume) supplemented with 100 
ng CSP1 and 10 µg of rpsL gene DNA, or D39 supplemented with a mixture 100 ng CSP1, 800 
ng CSP1-E1A and 10 µg of rpsL gene DNA in THB. Mouse lungs were harvested 6 hr 
post-inoculation, homogenized and plated on THB agar for total bacterial load or THB agar 
supplemented with streptomycin (100 µg/ml) for rpsL transformants. 
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Table 3 
CSP1-E1A inhibits the ability of S. pneumoniae to acquire the rpsL streptomycin 
resistance gene in mouse peritoneal cavity. 
 
Treatment Mice # of output bacteria/spleen # transformants 
CSP1 1 3.1×108 273 
 2 4.5×108 251 
 3 2.7×108 372 
 4 5.7×108 517 
CSP1 + CSP1-E1A 1 1.3×108 0 
 2 4.3×108 0 
 3 2.2×108 0 
 4 2.4×108 0 
 
Mice were intraperitoneally infected with D39 (3×107, 50 µl volume) supplemented with 100 ng 
CSP1 and 10 µg of rpsL gene DNA, or D39 supplemented with a mixture 100 ng CSP1, 800 ng 
CSP1-E1A and 10 µg of rpsL gene DNA in THB. Mouse spleens were harvested between 16–24 
hr post-infection, homogenized and plated on THB agar for total bacterial load or THB agar 
supplemented with streptomycin (100 µg/ml) for rpsL transformants. 
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Table 4 
CSP1-E1A attenuates the ability of cap3A mutant S. pneumoniae to acquire capsule gene 
during natural transformation in mouse peritoneal cavity. 
Treatment Mice # of transformants 
cap3A bacteria + 0100993 chromosomal DNA 1 4.7×106 
 2 2.5×106 
 3 2.0×107 
 4 7.7×106 
 5 0 
cap3A bacteria + 0100993 chromosomal DNA + CSP1-E1A 1 0 
 2 0 
 3 0 
 4 3.3×106 
 5 0 
cap3A bacteria + 0100993 chromosomal DNA + CSP1-R3A 1 7.3×105 
 2 4.2×106 
 3 2.7×105 
 4 1.1×107 
 5 5.4×106 
Mice were intraperitoneally infected with S. pneumoniae cap3A mutant bacteria (3×109, 100 µl 
volume) supplemented with 100 µg of chromosomal DNA from the parental wild-type strain 
0100993 in the presence or absence of 100 µg CSP1-E1A or CSP1-R3A. Mouse spleens were 
harvested at 24 hr post-infection, homogenized, serially diluted and plated on THB agar for 
enumeration of mucoid colonies. 
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CHAPTER 3: SATURATED ALANINE SCANNING MUTAGENESIS OF THE 
PNEUMOCOCCUS COMPETENCE STIMULATING PEPTIDE IDENTIFIES ANALOGS 
THAT INHIBIT GENETIC TRANSFORMATION 
 
Introduction 
Streptococcus pneumoniae is a major cause of numerous diseases worldwide, including 
pneumonia, otitis media, meningitis, bacteremia and sepsis (Kadioglu et al., 2008). In recent 
decades, antibiotic resistant Streptococcus pneumoniae have been increasingly isolated in 
clinical settings (Klugman and Lonks, 2005, Jacobs, 2008, Croucher et al., 2009, Coker et al., 
2010, Linares et al., 2010, Lynch and Zhanel, 2010, Jones et al., 2010). Genetic transformation, 
which occurs when Streptococcus pneumoniae enters the competent state, contributes to the 
transfer and acquisition of antibiotic resistance genes (Dowson et al., 1989, Morrison and Lee, 
2000, Claverys et al., 2009). The competence regulon is activated when CSP binds to its 
membrane-associated histidine kinase receptor ComD, which phosphorylates the response 
regulator ComE (Havarstein et al., 1996, Pestova et al., 1996, Havarstein, 2010, Martin et al., 
2010, Luo et al., 2003). In turn, ComE activates the transcription of genes in the competence 
regulon, including the transcription of ComX, a competence specific sigma factor. ComX 
positively regulates the transcription of genes encoding effectors for DNA uptake and 
recombination (Luo et al., 2003). Interestingly, we and others have shown that the competence 
regulon is also important for virulence during acute pneumonia and bacteremia models of mouse 
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infection (Lau et al., 2001, Bartilson et al., 2001, Hava and Camilli, 2002, Guiral et al., 2005, 
Claverys et al., 2007). 
DNA sequence analysis predicts the existence of six distinct CSP subtypes, with an 
overwhelming majority of Streptococcus pneumoniae strains producing CSP1 or CSP2 (Pozzi et 
al., 1996, Whatmore et al., 1999), corresponding to two variants of ComD, namely ComD1 and 
ComD2 (Iannelli et al., 2005). Competence in ComD1 strains could be induced more efficiently 
with the “compatible” CSP1. In contrast, ComD2 strains are more sensitive to induction by the 
“compatible” CSP2 (Johnsborg et al., 2006, Zhu and Lau, 2011). 
Alanine scanning was previously used to identify amino acid residues that are important for the 
activity of CSP1. However, the author did not test the ability of these analogs to competitively 
inhibit CSP1. Most recently, by using amino acid substitution and deletion, we have identified 
synthetic analogs of CSP1 and CSP2 that competitively inhibit CSPs’ ability to induce the 
competence regulon, to control pneumococcal pneumonia and to reduce horizontal gene transfer 
of an antibiotic resistance gene during infection (Zhu and Lau, 2011). In this study, we performed 
a saturated alanine scanning mutagenesis of CSP1, as well as substitution of amino acids based 
on differing charges, acidity, hydrophobicity and enantiomericity, and examined the ability of 
these analogs to inhibit the development of competence. 
 
Materials and Methods 
Bacterial Strains and Growth Conditions 
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Streptococcus pneumoniae strain D39 (Avery et al., 1979) was a generous gift from Dr. 
David Briles (University of Alabama-Birmingham). Strain D39pcomX::lacZ was generated by 
transforming D39 with the genomic DNA from CPM3 that harbored an insertion of the lacZ gene 
under the control of the comX promoter (Zhu and Lau, 2011). Aliquots of bacteria were stored at 
−80°C in Todd Hewitt broth (THB) containing 25% glycerol. For routine experiments, bacteria 
from frozen stocks were streaked onto THB agar containing 5% defibrinated horse blood and 
incubated for 12–24 hr at 37°C with 5% CO2. Fresh colonies were transferred to THB and 
cultured to desired density as measured by a spectrophotometer at OD 600 nm. 
 
Synthetic CSPs 
Both CSP1 and its analogs (≥95% purity) were synthesized by Elim Biopharm (Hayward, 
CA). 
 
Activation Assay of comX 
The ability of synthetic CSP-1 and its analogs to activate the expression of comX gene was 
compared in D39pcomX::lacZ cells grown in THB (pH 6.8) until OD 600 nm of 0.1, washed and 
resuspended in THB (pH 8.3). CSP1 and their analogs were added at indicated concentrations to 
the culture and incubated at 37°C for 30 min. ß-galactosidase activity in pneumococcal cells was 
measured according to previously published protocols (Johnsborg et al., 2006), and expressed 
as Miller units. 
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Streptococcus pneumoniae Transformation Assay 
Genetic transformation experiments were performed as we had previously described (Bartilson et 
al., 2001, Johnsborg et al., 2006). Briefly, Streptococcus pneumoniae cells were grown to early 
log phase (OD 600 nm ~ 0.1) in THB (pH 6.8), washed and resuspended in THB (pH 8.3) 
containing 30 µg/ml of D39 genomic DNA carrying a copy of the streptomycin 
resistance rpsL gene originated from strain CP1296 (Morrison and Baker, 1979). Transformation 
experiments were performed in the present CSP1 or its analogs. The transformation mix was 
incubated at 37°C with 5% CO2 for 1 hr. Transformants were selected on THB agar supplemented 
with 100 µg/ml streptomycin. 
 
Results 
Saturated Alanine Mutagenesis Screen Identifies CSP1 Analogs That are Unable to 
Induce comX Expression and Genetic Transformation 
We performed a saturated alanine scanning mutagenesis on CSP1 to identify additional 
synthetic analogs that would outcompete CSP1 and attenuate competence development and 
genetic transformation (Fig. 11). The ability of CSP1 and its analogs to induce competence in the 
wild-type Streptococcus pneumoniae strain D39 was compared by monitoring the: (i) promoter 
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activity of comX, (ii) transformation frequency of rpsL gene that confers resistance to 
streptomycin (Sung and Morrison, 2005). Induction of ComX indicates that Streptococcus 
pneumoniae cells have entered the competent state for genetic transformation. Activation of 
the comX gene promoter was monitored by assaying ß-galactosidase activity in pneumococcal 
strain D39pcomX::lacZ (Zhu and Lau, 2011). The ability of several CSP1 analogs to activate the 
expression of comX, including CSP1-E1A, CSP1-R3A, CSP1-F7A, CSP1-F8A and CSP1-F11A, 
were attenuated by 95.5, 100, 95, 92.5, 95%, respectively (Fig. 12A). Because ComX regulates 
DNA uptake and transformation, we examined the ability of all analogs to induce genetic 
transformation. Consistent with their reduced ability to induce the expression of comX, CSP1-E1A, 
CSP1-R3A, CSP1-F7A, CSP1-F8A and CSP1-F11A were attenuated in their ability to induce 
genetic transformation, by 99.9, 100, 77.1, 68.9 and 84.5%, respectively (Fig. 12B). 
 
CSP1-E1A is An Analog that Competitively Inhibits CSP1 
Because of their inability to induce comX expression and genetic transformation, we next 
determined whether these five analogs could competitively inhibit wild type CSP1. Analogs 
CSP1-R3A, CSP1-F7A, CSP1-F8A and CSP1-F11A failed to inhibit CSP1-induced comX 
expression (Fig. 13A), suggesting that these analogs were incapable of binding to ComD1 
receptor. In contrast, CSP1-E1A, with glutamate residue at the first position substituted with 
alanine, competitively inhibited CSP1 in a concentration-dependent manner. The inductive 
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activity of 100 ng CSP1 on comX expression was inhibited by 69, 86.7, 94 and 97% in the 
presence of 100, 200, 400 or 800 ng of CSP1-E1A, respectively (Fig. 13A). Similarly, 
CSP1-mediated genetic transformation was inhibited by 81.6, 94.4, 98.5 and 99.8% in the 
presence of indicated concentrations of CSP1-E1A, respectively (Fig. 13B). These results 
suggest that among the five CSP1 analogs with defective ability to activate the competence 
regulon, only CSP1-E1A is uniquely capable of competitively inhibiting CSP1. 
 
Negative Charge and Enantiomericity of the First Glutamate Residue are Important for the 
Activity of CSP1 
Glutamate is polar and negatively charged. Substitution of glutamate with alanine (nonpolar, 
neutral) at the first position generates a strong competitive inhibitor of CSP1 (Figure 13). This 
observation suggests that the negative charge of glutamate is important for the activity of CSP1, 
but dispensable for the binding to ComD1. To determine the importance of negative charge on 
glutamate to the activity of CSP1, we examined five additional synthetic analogs (Fig. 14A), by 
substituting the glutamate with glutamine (CSP1-E1Q, polar, neutral), leucine (CSP1-E1L, 
non-polar, neutral), aspartic acid (CSP1-E1D, polar, negatively-charged), and arginine 
(CSP1-E1R, polar, positively-charged), and an enantiomeric analog using the D-glutamate 
(CSP1-D-E1, polar, negatively-charged) (Fig. 14), for their ability to competitively inhibit CSP1. All 
five new analogs were attenuated in their ability to induce the expression of comX (Fig. 14B). 
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Importantly, the analog CSP1-E1D, in which the glutamate residue is substituted with another 
polar and negatively-charged amino acid aspartate, retains 35.6% of the wild-type CSP1 activity 
to induce the expression of comX (Fig. 14A), strongly suggesting that negative charge of the 
glutamate residue is important for the activity of CSP1. Concurring with this hypothesis, we 
showed that CSP1-E1R (polar, positive-charged arginine) was most attenuated, with the levels 
of comX induction and genetic transformation reduced to 4.6% and 0% (800 ng/ml), respectively 
(Fig. 14A–B). In addition, CSP1-E1L and CSP1-E1Q were also able to induce comX expression 
and genetic transformation, but to lesser degrees than CSP1-E1D. Finally, substitution of 
L-glutamate in the first position of CSP1 with its enantiomeric isomer D-glutamate also impaired 
its ability to induce comX expression and genetic transformation (Fig. 14A–B). Collectively, these 
results suggest that negative charge and structural conformation in the N-terminus of CSP1 are 
important for its activity. 
 
Differential Amino Acid Substitutions of Glutamate at the First Position Generate New 
Inhibitors of CSP1 
Next, we examined whether these CSP1 analogs with substitution at the glutamate residue 
could competitively inhibit the induction of comX and genetic transformation. All analogs 
inhibited comX induction and ComX-dependent genetic transformation to similar levels (Fig. 
15A–B). The lack of distinction between the ability of CSP1-E1A and CSP1-E1R versus 
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CSP1-E1D was surprising, probably caused by high amounts of analogs (100 ng/ml) that were 
used for these assays. To overcome the aforementioned difficulty, we examined CSP1 inhibition 
using lower concentrations of these analogs (Fig. 16). Analogs CSP1-E1R, CSP1-D-E1 and 
CSP1-E1Q had low ability to induce genetic transformation (Fig. 16A). Interestingly, at low 
concentrations, CSP1-E1Q and CSP1-E1D were found to be most effective at inhibiting 
CSP1-mediated transformation (Fig. 16B). Surprisingly, CSP1-E1R, which had the lowest ability 
to induce comX and genetic transformation (Figs. 16A), was least effective in inhibiting genetic 
transformation at low peptide concentrations (Fig. 16B). Conversely, CSP1-E1D, which retained 
one of the highest activities to induce comX expression and genetic transformation (Fig. 16A), 
was the most effective competitive inhibitor at low peptide concentrations (Fig. 16B). Finally, 
CSP1-E1Q, which was highly attenuated in its ability to induce comX expression and genetic 
transformation (Fig. 16A), was as effective as CSP1-E1D at competitively inhibiting CSP1 at low 
peptide concentrations (Fig. 16B). 
 
Discussion 
The competence regulon regulates genetic transformation (Claverys et al., 2009, Johnsborg 
and Havarstein, 2009) and virulence in Streptococcus pneumoniae (Lau et al., 2001). In this 
study, we used saturated alanine scanning to identify synthetic analogs of CSP1 that could 
competitively inhibit genetic transformation of an antibiotic resistance gene. Substitutions of the 
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1st (CSP1-E1A), 3rd (CSP1-R3A), 7th (CSP1-F7A), 8th (CSP1-F8A) and 11th (CSP1-F11A) amino 
acid residues with alanine generate synthetic analogs with impaired ability to induce the 
competence regulon. However, only substitutions of the glutamate residue at the first position 
generate analogs that competitively inhibit CSP1. These results suggest that the glutamate 
residue is important for the ability of CSP1 to induce ComD, but is dispensable for binding to the 
histidine kinase receptor. 
The chemical properties of individual amino acid residues, including charges, acidity, polarity 
and hydrophobicity may influence the activity of a peptide. Glutamate is negatively charged. The 
importance of negative charge is demonstrated by the analog CSP1-E1D, which has the 
glutamate in the first position substituted with negatively charged aspartate, preserves significant 
amounts of ability to induce competence regulon. This suggests that CSP1-E1D retains 
significant amount of binding to ComD1, and is thus, more efficient in preventing the binding of 
CSP1 to ComD1. This argument is supported by the observation that CSP1-E1R, which the 
glutamate has been substituted with positively-charged arginine (CSP1-E1R), is least effective in 
inhibiting CSP1. Another highly effective inhibitory analog is CSP1-E1Q. Glutamine is neutrally 
charged, yet structurally most similar to glutamate. Structural similarity and lesser charge 
difference between glutamate-glutamine versus glutamate-arginine may have contributed to the 
different competitiveness between CSP1-E1Q versus CSP1-E1R. Because of its low ability to 
induce competence and genetic transformation, yet strong ability to competitively inhibit CSP1, 
we predict that CSP1-E1Q is the best inhibitor analog. Finally, the L-glutamate conformation is 
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also important because enantiomeric substitution with D-glutamate severely reduces the activity 
of CSP1. 
The use of inhibitory analogs of CSP1 may have an application in reducing horizontal transfer 
of antibiotic resistance genes. For example, competence in genetic transformation is induced by 
CSP1 and other peptide pheromones in streptococcal species by two major systems (Pestova et 
al., 1996). These systems differ in their methods of inducing the expression of ComX. 
Streptococcal species in Anginosus and Mitis groups use the ComCDE system to 
induce comX expression. Thus, CSP analogs that inhibit ComD to suppress competence may be 
applicable in these streptococcal species. The second system, ComRS, is utilized by 
streptococcal species in Pyogenic, Salvarius and Bovis groups (Mashburn-Warren et al., 2010). 
In this system, the precursor of the competence peptide ComS is cleaved by an extracellular 
protease, and the processed peptide re-enters the cytoplasm through peptide permease to 
activate the cytoplasmic transcriptional regulator ComR to initiate the expression of comX. It will 
be interesting to explore if analogs of ComS could inhibit competence in the relevant 
streptococcal species. 
In recent decades, incidence of Streptococcus pneumoniae resistance to β-lactams, 
macrolides, and other classes of antibiotics has escalated dramatically (Klugman and Lonks, 
2005, Jacobs, 2008, Croucher et al., 2009, Coker et al., 2010, Linares et al., 2010, Lynch and 
Zhanel, 2010, Jones et al., 2010). While conjugative elements appear to be more important for the 
spread of antibiotic resistance genes (Croucher et al., 2009, Pozzi et al., 1996, Whatmore et al., 
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1999), horizontal gene transfer of penicillin binding protein genes has occurred in clinical isolates 
of Streptococcus pneumoniae (Morrison and Lee, 2000). Importantly, it has been shown that 
under in vitro conditions, antibiotic stress stimulates horizontal gene transfer in bacteria, 
including Streptococcus pneumoniae (Dorer et al., 2010, Maiques et al., 2006). For example, 
β-lactams induce the SOS response and horizontal transfer of virulence factors 
in Staphylococcus aureus (Maiques et al., 2006). Similarly, DNA damaging antibiotics trigger 
genetic exchange in Helicobacter pylori (Dorer et al., 2010). In this case, a coupling agent that 
inhibits horizontal gene transfer reduces the risk of generating antibiotic resistant pathogens 
during antibiotic treatment. In Streptococcus pneumoniae, antibiotic stress has been reported to 
induce the competence regulon and increase genetic transformation (Prudhomme et al., 2006). 
These authors also reported that induction of competence by antibiotic stress does not occur in 
a comA mutant that lacks the ABC transporter needed to export CSP, suggesting that this 
process is CSP-dependent. Collectively, these studies suggest that under certain clinical 
conditions, Streptococcus pneumoniae actively exploits the opportunity of antibiotic stress to 
acquire exogenous genes. Thus, antibiotic resistance mediated by the competence regulon may 
be under reported and worth more detailed investigations. 
In conclusion, our data show that CSP analogs can effectively attenuate genetic 
transformation in Streptococcus pneumoniae. This strategy may be applicable to reduce the 
incidence of horizontal gene transfer and acquisition of antibiotic resistance genes.  
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Figure 11. Amino acid sequences of CSP1 and its alanine substitution analogs. 
Analogs were synthesized based on the sequence of CSP1 by alanine substitutions. 
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Figure 12. Analyses of the ability of CSP1 analogs to induce comX expression and genetic 
transformation. 
Pneumococcal cells were incubated with CSP1 or with each analog at a final concentration of 100 
ng/ml. The ability of each peptide to induce the competence regulon was measured by induction 
of the comX expression using the ß-galactosidase assays in D39pcomX::lacZ cells (A) or by 
genetic transformation using the rpsL gene in D39 cells (B). Transformants were selected on THB 
agar containing 100 µg/ml streptomycin. Experiments were performed in triplicates and repeated 
three times. The means ± SD of one typical experiment are shown. 
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Figure 13. CSP1-E1A is uniquely able to inhibit the expression of comX and genetic 
transformation. 
(A) CSP-E1A competitively inhibits CSP1-mediated induction of comX in a dose dependent 
manner. D39pcomX::lacZ cells were exposed to 100 ng/ml of CSP1 alone or simultaneously with 
increasing concentrations of each CSP1 analog. The activity of the comX gene promoter was 
measured by β-galactosidase activity. (B) CSP-E1A competitively inhibits CSP1-mediated 
genetic transformation. Genetic transformation was performed using 30 µg/ml of the D39 genomic 
DNA containing the rpsL gene. Transformants were selected on THB agar containing 100 µg/ml 
streptomycin. Experiments were performed in triplicates and repeated three times. The means ± 
SD of one typical experiment are shown. 
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Figure 14. The negative charge and enantiomericity of glutamate residue in the first position is 
important for the activity of CSP1. 
(A) Amino acid substitutions of the first glutamate residue in CSP1. (B) Induction 
of comX expression by CSP1 analogs. D39pcomX::lacZ were incubated with CSP1 or with each 
glutamate substituted analog at a final concentration of 100 ng/ml. The ability of each peptide to 
induce the competence regulon was measured by induction of the comX by ß-galactosidase 
assays. (C) Genetic transformation of D39 cells in the presence of indicated concentrations of 
CSP1 and its analogs using the rpsL gene. Transformants were selected on THB agar containing 
100 µg/ml streptomycin. Experiments in B and C were performed in triplicates and repeated three 
times. The means ± SD of one typical experiment are shown. 
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Figure 15. Dose dependent inhibition of comX expression and genetic transformation by CSP1 
analogs with substitution at glutamate residue in the first position. 
(A) CSP1 analogs with substitution at the first glutamate acid competitively inhibit CSP1-mediated 
induction of comX. D39pcomX::lacZ cells were exposed to 100 ng/ml of CSP1 alone or 
simultaneously with increasing concentrations of CSP1 analogs. The activity of the comX gene 
promoter was measured by β-galactosidase activity. Experiments were performed in triplicates 
and repeated three times. The means ± SD of one typical experiment are shown. (B) CSP1 
analogs with substitution at the first glutamate acid competitively inhibit the ability of CSP1 to 
induce genetic transformation. Genetic transformation was performed using the rpsL gene. 
Transformants were selected on THB agar containing 100 µg/ml streptomycin. Experiments were 
performed in triplicates and repeated three times. The means ± SD of one typical experiment are 
shown. 
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Figure 16. Competitive inhibition of CSP1 by low concentrations of analogs with 
substitutions of glutamate residue in the first position. 
(A) Induction of genetic transformation by each analog using the genomic DNA containing 
the rpsL gene. Transformants were selected on THB agar containing 100 µg/ml streptomycin. 
Experiments were performed in triplicates and repeated three times. The means ± SD of one 
typical experiment are shown. (B) Competitive inhibition of genetic transformation by low 
concentrations of CSP1 analogs. Genetic transformation was performed using the genomic DNA 
containing the rpsL gene. Transformants were selected on THB agar containing 100 µg/ml 
streptomycin. Experiments were performed in triplicates and repeated three times. The means ± 
SD of one typical experiment are shown. 
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CHAPTER 4: COMPETENCE-INDEPENDENT ACTIVITY OF PNEUMOCOCCAL 
ENDA MEDIATES DEGRADATION OF EXTRACELLULAR DNA AND NETS AND IS 
IMPORTANT FOR VIRULENCE 
 
Abstract 
Membrane surface localized endonuclease EndA of the pulmonary pathogen Streptococcus 
pneumoniae (pneumococcus) is required for both genetic transformation and virulence. 
Pneumococcus expresses EndA during growth. However, it has been reported that EndA has no 
access to external DNA when pneumococcal cells are not competent for genetic transformation, 
and thus, unable to degrade extracellular DNA. Here, by using both biochemical and genetic 
methods, we demonstrate the existence of EndA-mediated nucleolytic activity independent of the 
competence state of pneumococcal cells. Pneumococcal mutants that are genetically deficient in 
competence development and genetic transformation have extracellular nuclease activity 
comparable to their parental wild type, including their ability to degrade neutrophil extracellular 
traps (NETs). The autolysis deficient ∆lytA mutant and its isogenic choline-treated parental 
wild-type strain D39 degrade extracellular DNA readily, suggesting that partial cell autolysis is 
not required for DNA degradation. We show that EndA molecules are secreted into the culture 
medium during the growth of pneumococcal cells, and contribute substantially to 
competence-independent nucleolytic activity. The competence-independent activity of EndA is 
responsible for the rapid degradation of DNA and NETs, and is required for the full virulence of 
Streptococcus pneumoniae during lung infection.  
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Introduction 
 EndA is reported to be a membrane-localized pneumococcal endonuclease (Rosenthal and 
Lacks, 1980). It was first implicated to play a role in genetic transformation by Kohoutova 
(Kohoutova, 1961), and subsequently confirmed by Lacks and colleagues (Lacks and Greenberg, 
1973, Lacks et al., 1974, Lacks et al., 1975). During genetic transformation, EndA degrades one 
strand of double stranded DNA (dsDNA) and converts it into single stranded DNA (ssDNA) for 
uptake and recombination (Lacks, 1962). Acid soluble DNA fragments or nucleotides generated 
during DNA degradation are released into the culture medium (Lacks et al., 1974), and are only 
detectable during competence development (Chen and Morrison, 1987). These observations 
were further confirmed by Berge and colleagues (Berge et al., 2002). They showed that the 
∆comD mutant, which lacks the histidine kinase receptor required for the induction of the 
competence regulon and genetic transformation, is both unable to develop competence and 
degrade DNA. In addition, the comEA and cglABCDEFG operons, which encode the apparatus 
for DNA binding and uptake, are required for EndA-mediated DNA degradation. These authors 
proposed that DNA attaches to the apparatus in competent pneumococcal cells, allowing the 
membrane-localized EndA to gain access to the extracellular DNA. For pneumococcal cells not 
under the competent state, EndA is unable to gain access to donor DNA, and is incapable of 
degrading extracellular DNA.  
 Demonstration of EndA’s role in pneumococcal virulence is comparatively recent. An 
EndA-deficient mutant was identified in a signature-tagged mutagenesis screen in mouse lungs 
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(Hava and Camilli, 2002). Furthermore, EndA degrades neutrophil extracellular traps (NETs) 
(Beiter et al., 2006). Composed of both DNA and antibacterial proteins, NETs are released by 
activated neutrophils to capture and kill bacterial cells (Brinkmann et al., 2004). Thus, it is 
conceivable that rapid degradation of NETs by EndA releases captured pneumococcal cells and 
facilitates their dissemination.  
 In this study, we present experimental evidence that majority of the nucleolytic activities of 
EndA are independent of competence development, and the “competence-independent activity” 
of EndA contributes to lung infection. In addition, EndA is secreted during pneumococcal growth. 
 
Materials And Methods 
Synthetic CSP1, bacterial strains and growth conditions 
 CSP1 (≥ 95% purity) was synthesized by Elim Biopharm. S. pneumoniae strains are listed on 
Table S1. Wild-type strain D39 (Avery et al., 1979) was a gift from Dr. David Briles (University of 
Alabama-Birmingham). R6 is a capsule-deficient mutant derived from D39 (Avery et al., 1944) 
whereas 0100993 is a highly encapsulated serotype III clinical isolate (Lau et al., 2001). Mutant 
strains ∆comD, ∆comA, ∆cglABCDEFG, ∆lytA, and ∆endA were generated by nonpolar deletions 
in D39 using the Janus cassette as previously described (Sung et al., 2001). Strain JC0923, 
which carries both an insertion of the lacZ gene under the control of the comX promoter and a 
nonpolar deletion in the comA gene, was generated by transforming ∆comA with the genomic 
DNA from D39pcbpD::lacZ (Sung and Morrison, 2005, Zhu and Lau, 2011). Bacteria were 
streaked from frozen stocks onto THB (Todd Hewitt Broth) agar containing 5% defibrinated horse 
82 
 
blood at 37°C with 5% CO2. Fresh colonies were grown in THB or CTM (complete transformation 
medium) (Pestova and Morrison, 1998) to desired density. 
 
DNA degradation assay  
 Pneumococcal cells were grown in THB to early log phase around 108 CFU/ml (1 ml). The 
OD 600nm at this bacterial concentration for D39, R6 and 0100993 were 0.15, 0.1 and 0.4, 
respectively. The differing OD600nm at 108 CFU/ml between strains D39 and 0100993 is due to 
the presence of different capsules. Pneumococcal cells were washed three times with PBS and 
resuspended in 1ml of fresh THB and added to column purified PCR products of the 
streptomycin resistance rpsL gene (30 µg). At indicated time points, a 100 µl aliquot of the 
bacteria-DNA mixture was withdrawn and immediately centrifuged at 12000 rpm for 2 min. 
DNA-containing supernatants were stored in -80°C to prevent further degradation. The integrity 
of DNA was visualized by agarose gel electrophoresis. For degradation of DNA in the CTM 
medium, pneumococcal strains were grown in THB to 108 CFU/ml (1 ml), washed three times 
with PBS and resuspended in 1ml of CTM. In addition, we also grew pneumococcal strains in 
CTM to 108 CFU/ml (1 ml), washed, and resuspended in 1ml of THB. Degradation of DNA was 
performed as above. As controls, DNA degradation was inhibited using the nuclear inhibitor 
aurintricarboxylic acid (ATA) (15 µg/ml). For the dsDNA integrity assay, supernatant that 
contained donor DNA was stained with ethidium bromide (0.5 µg/ml). The fluorescence was 
measured using a fluorometer at indicated wavelengths (excitation: 300nm; emission: 600nm). 
To assay DNA degradation on agar plates, pneumococcal strains were streaked on THB agar 
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incorporated with 166 µg/ml salmon sperm DNA. After 12 hr, DNA plates were flooded with 5 ml 
of 1N HCl as previously described (Jeffries et al., 1957). DNA degradation appeared as 
transparent zones of clearance.  
 
Degradation of [α32P]-dATP-labelled DNA. 
 P-32 labeled donor DNA was amplified by PCR using 1x PCR master mix (Thermoscientific) 
and D39 chromosomal DNA (100µl reaction size). PCR was carried out with the rpsL primers in 
the presence 100 μCi [α32P]-dATP (Amersham; specific activity 111x106 kBq mmol−1) for 40 
cycles with the following settings: 30 seconds at 94°C, 30 seconds at 54°C, 60 seconds at 72°C, 
followed by a 10 min extension step. P-32 labeled PCR products were purified by QIAquick PCR 
Purification Kit (Qiagen). P-32 labeled DNA (5 μCi) was exposed to 108 CFU/ml ∆comA cells (in 1 
ml) with or without CSP1 stimulation. The ∆endA cells (108 CFU/ml) and THB were used as 
controls. To determine the extent of DNA degradation, an aliquot of 100 μl was withdrawn from 
each group at indicated time points after incubation. The samples were centrifuged at 12000 rpm 
for 1 min to remove bacterial cells. Large intact P-32 labeled DNA fragments within the 
supernatant were removed by QIAquick PCR Purification columns. The filtrates (20 µl), which 
contained the radioactive nucleotides and small DNA fragments (< 100 bp), were spotted on filter 
paper, dried, and exposed in a phosphoimager exposure cassette for 8 hr and scanned with the 
FujiFilm FLA-3000 PhosphorImager. Phosphoimager signals were quantified by Image J. For 
quantitative determination of released nucleotides/small DNA fragments, the filtrates (20 µl), 
which contained the radioactive nucleotides and small DNA fragments (< 100 bp), were mixed 
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thoroughly with 5ml of Cytoscint* Scintillation Cocktail (Thermoscientific). Radioactivity was 
quantified by using a Tri-Carb® 2100TR Liquid Scintillation Counter (Perkin Elmer).  
 
Analysis of the EndA secretion  
 Pneumococcal strains TIGR4, 0100993, and D39 and its derivatives comD and lytA, were 
cultured in THB to ~ 108 CFU/ml. One ml of culture was withdrawn and subjected to centrifugation. 
Bacterial cells were then washed three times with PBS to remove cultural medium and 
resuspended into 1 ml of fresh THB. Resuspended bacterial strains were allowed to grow in the 
37oC incubator supplemented with 5% CO2. At 0, 30, 60 and 90 min, supernatant samples of each 
bacterial culture were collected. Pneumococcal cells were removed using the 0.25 µm filters. 20 
µl of bacterial cells or supernatant was boiled with 5 µl of 5x SDS loading buffer (0.25% 
Bromophenol blue, 0.5 M dithiothreitol, 50% Glycerol, 10% SDS, 0.25 M Tris-Cl, pH 6.8) for 5 min, 
and subjected to SDS-PAGE in an acrylamide gel incorporated with 15 µg/ml of salmon sperm 
DNA. Following electrophoresis, the gel was washed with pure water to remove SDS, allowing 
renaturation of proteins. After 12 hr of incubation in 2 mM MgCl2 solution at 37oC, the gel was 
stained with 10 µg/ml of ethidium bromide to visualize bands of DNA clearance caused by 
pneumococcal nuclease. A band of clearance at 25 kDa indicates the presence of EndA 
nucleolytic activities.  
 To further compare the amount of EndA secreted by pneumococcus growing in THB versus in 
CTM, washed D39 cells (108 CFU/ml) were resuspended into 1 ml of fresh THB or CTM, 
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respectively, allowed to grow in the 37oC incubator supplemented with 5% CO2 for 2 hr. One ml of 
cell-free supernatant from D39 cells growing in THB were diluted 10, 100 and 1000 folds. 
Nuclease activity of different diluents was compared against cell-free supernatant from D39 cells 
grown in CTM. Each supernatant sample was incubated with hot PCR product at 37oC for 1 hr. 
The release of nucleotides/small DNA fragments was quantified by using the Tri-Carb® 2100TR 
Liquid Scintillation Counter (Perkin Elmer). 
 
Genetic transformation assay  
 Pneumococcal JC0923 cells were grown to OD 600nm 0.15 in THB (pH 6.8), washed and 
resuspended in fresh THB (pH 8.3) (Lau et al., 2001), or CTM, and stimulated with 400 ng/ml 
CSP1. Donor DNA was added to the final concentration of 30 µg/ml. Donor DNA was generated 
by amplifying a mutated rpsL gene and its flanking regions from a streptomycin resistant strain 
CP1296 (Table S1), using the following primers: rpsL upper 
5’-GGGCTAGTAGAAGTAGTTGG-3’; rpsL lower: 5’-CGGAAGTGTGCGAATGCACG-3’ (PCR 
product size: 1633 bp).  The transformation mix was then incubated at 37°C with 5% CO2 for 2 
hr. Transformants were selected on THB agar supplemented with 100 µg/ml streptomycin after 
serial dilutions. 
 
Activation assay of comX and promoter 
 JC0923 cells were grown in THB (pH 6.8) until OD 600nm of 0.15, washed and resuspended 
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in fresh THB (pH 8.3) or CTM. CSP1 (400 ng/ml) was added to the bacterial culture and 
incubated at 37°C for 30 min. -galactosidase activity was measured according to previously 
published protocols (Johnsborg et al., 2006) and expressed as Miller units. 
 
Neutrophil NETs degradation assay  
 Human neutrophils (Innovative Research) grown in RPMI medium were exposed to 10 mM 
H2O2 in 37oC for 20 min to induce the formation of NETs (Liu et al., 2012). Activated neutrophils 
were incubated for 60 min with RPMI, 108 cells of D39, ∆comCDE, ∆cglABCDEFG, or ∆endA, 
respectively. Neutrophils were fixed with 4% paraformaldehyde and stained with DAPI to 
visualize NETs degradation by using a fluorescence microscope (Zeiss LSM 700). 
 
Ethics statement 
 The animal study was carried out in strict accordance with the recommendations in the Guide 
for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was 
approved by the Institutional Animal Care and Use Committee (IACUC) at the University of 
Illinois at Urbana-Champaign (Protocol Number: 12230). 
 
Mouse acute pneumonia infection  
 CD1 mice (6-week old, n = 10) (Charles River) were housed in positively-ventilated 
microisolator cages with automatic recirculating water, located in a room with laminar, high 
efficiency particle accumulation–filtered air. The animals received autoclaved food, water, and 
87 
 
bedding. Mice were anesthetized with isoflurane and intranasally administered 106 CFU of D39, 
∆cglABCDEFG, or ∆endA cells. The infected mice were monitored for 48 hr before the lungs 
were harvested for bacterial enumeration. Moribund animals that displayed rough hair coat, 
hunched posture, distended abdomen, lethargy or inability to eat or drink were euthanized. 
Animal studies were carried out in strict accordance to the protocol (#12230) approved by the 
IACUC at the University of Illinois at Urbana-Champaign. 
 
Statistical analyses  
 Statistical analyses of in vitro experiments were performed using the Student's t-test and 
one-way analyses of variance (ANOVA). Statistical significance of bacterial burden in mouse 
lungs was compared using the GraphPad Prism statistical software package. A significant 
difference was considered to be p < 0.05. 
 
RESULTS 
Degradation of extracellular DNA by EndA does not require components of the 
competence regulon 
 We compared the ability of the wild-type pneumococcal strain D39 and its isogenic 
endonuclease-deficient ∆endA mutant to degrade extracellular DNA. DNA was rapidly degraded 
by D39 (Fig. 17A). After 60 min of incubation with D39 cells, no clear DNA band was visible. In 
contrast, the DNA exposed to ∆endA remained intact for the entire duration of 90 min, similar to 
the DNA exposed to THB (Fig. 17A). These results were confirmed by degradation of salmon 
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sperm DNA incorporated into agar plates (Fig. 17B). Transparent halos surrounded D39 colonies, 
indicating DNA was degraded. In contrast, no halos were visible on the ∆endA plates. The 
nuclease inhibitor aurintricarboxylic acid (ATA) (15 µg/ml) (Hallick et al., 1977) inhibited EndA 
activities, with no significant amounts of DNA degradation detected during the 90 min incubation 
(Fig. 17A). ATA also inhibited the degradation of salmon sperm DNA (Fig. 17B). Collectively, 
these results indicate that EndA is the principle endonuclease that rapidly degrades extracellular 
DNA in pneumococcus. 
 To determine the relationship between competence development and nucleolytic activity of 
EndA, we compared the DNA degradation ability of D39 versus its isogenic mutants ∆comCDE 
and ∆cglABCDEFG. The ∆comCDE mutant is deleted in the operon encoding the 17 amino acid 
peptide pheromone competence stimulating peptide 1 (CSP1), the histidine kinase receptor 
ComD, and the response regulator ComE, respectively, which together, regulates the 
competence regulon (Pestova et al., 1996). As such, this mutant is unable to enter the competent 
state (Pestova et al., 1996). The ∆cglABCDEFG is deficient in the DNA uptake apparatus 
required for initial DNA recruitment and binding (Berge et al., 2002). Both ∆comCDE and 
∆cglABCDEFG mutants degraded extracellular DNA as efficiently as D39 (Fig. 17A-B). 
Collectively, these results suggest the existence of EndA activity that is independent of the 
competence development in pneumococcus.  
 
DNA degradation by EndA is not due to pneumococcal autolysis  
 Autolysis of pneumococcus during growth is primarily mediated by the autolysin LytA 
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(Mellroth et al., 2012b), and may release EndA from cell membrane or cytoplasm into the 
environment. However, the ∆lytA mutant degraded extracellular DNA as efficiently as D39 (Fig. 
17A-B). In addition, D39 cells treated with 2% choline chloride — which inhibit the autolytic 
activities of all pneumococcal lytic proteins LytA, LytB, LytC and CbpD (Garcia et al., 1999, 
Briese and Hakenbeck, 1985, Mellroth et al., 2012a, Steinmoen et al., 2002, Moscoso et al., 
2006) — degraded extracellular DNA as efficiently as untreated D39 cells (Fig. 17A-B). These 
results indicate that pneumococcal autolysis does not contribute significantly to the 
competence-independent EndA activity. 
 
Induction of competence contributes minimally to the overall amount of DNA degradation 
by pneumococcus  
 To determine if the extracellular DNA degradation by EndA was dependent on the 
development of competence, we examined the induction of competence by using the 
pneumococcal strain JC0923 (Table S1) in the presence or absence of CSP1. JC0923 cells carry 
a lacZ reporter gene under control of the comX promoter and a deletion of the comA gene. 
ComX is a competence specific sigma factor that positively regulates the transcription of genes 
for DNA uptake and recombination (Luo et al., 2003, Lee and Morrison, 1999). ComA is an ABC 
transporter that exports CSP1 (Alloing et al., 1998). Therefore, JC0923 serves as an ideal test 
strain to monitor comX expression and genetic transformation, which could only be triggered by 
exogenously supplied CSP1. We compared the transformation efficiency of JC0923 in THB and 
in CTM, a medium that allows high transformation efficiency (Pestova and Morrison, 1998). As 
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shown in Fig. 18A and 18B, the expression of comX promoter driven LacZ is comparable in both 
media, suggesting that the induction of competence by CSP1 in THB was successful. 
Nevertheless, transformation efficiency in the CTM is ~ 3 times higher than in the THB. JC0923 
cells grown in THB were able to degrade the rpsL DNA with equal efficiency in the presence or 
absence of exogenously supplied CSP1 (Fig. 18C). DNA staining with ethidium bromide over the 
time course of the experiment showed that the kinetics of DNA degradation was indistinguishable 
between the JC0923 cells with or without CSP1 treatment (Fig. 18D). Collectively, these results 
suggest that the contribution of competence induction to the overall DNA degradation by 
pneumococcus is negligible. 
 
Competence-independent EndA nucleolytic activity is conserved in different 
pneumococcal strains and is culture medium dependent 
 To determine if the competence-independent activity of EndA is a wide spread phenomenon, 
we tested the pneumococcal strains R6, 0100993, and TIGR4 as well as their isogenic ∆comD 
mutants for their ability to degrade extracellular DNA. D39 was used as positive control for DNA 
degradation. Pneumococcal strains were grew in THB, washed and resuspended in THB or CTM 
medium and examined for DNA degradation. As shown in Fig. 19A, R6, 0100993 and TIGR4 
possess different levels of nucleolytic activities. In contrast, their isogenic ∆endA mutants are 
unable to degrade DNA. Importantly, the ∆comD mutants degrade DNA as efficiently as their 
respective parental strains R6, 0100993 and TIGR4, confirming that the competence system is 
not important for EndA-mediated DNA degradation. In addition, D39 and its unencapsulated 
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derivative R6, as well as 0100993 and its capsule-deficient ∆cap3A mutant, show similar amount 
of DNA degradation activities. These results suggest capsule does not influence EndA activity in 
these strains. However, the nucleolytic activity appears to be influenced by pneumococcal 
growth. D39 grew at slower rate in the CTM (Fig. 19B). Similarly, TIGR4 and 0100993 also grew 
slower in CTM (data not shown). Degradation of extracellular DNA was severely impaired when 
D39 was grown in CTM (Fig. 19A). Because pneumococcal strains were cultured in THB before 
been resuspended in the nutritionally poorer CTM for DNA degradation, there is a possibility that 
the impaired DNA degradation in CTM was due to the inability of pneumococcus to adjust to 
poorer growth conditions. To rule our this possibility, pneumococcal strains were also cultured in 
CTM to achieve 108 CFU/ml, washed and resuspended in THB or CTM medium and examined 
for DNA degradation. Again, D39, R6, TIGR4, 0100993 and their competence-deficient comD 
derivatives degraded DNA efficiently in THB, but not in CTM (Fig. 20). These results suggest that 
EndA-mediated degradation of extracellular DNA is partially dependent on the nutritional 
condition of growth medium. Collectively, the aforementioned results suggest that 
competence-independent nucleolytic activity of EndA is conserved in different pneumococcal 
strains. Furthermore, EndA degrades DNA with equal efficiency in the presence or absence of 
capsule. However, a richer medium such as THB allows better bacterial growth and higher 
nucleolytic activities.  
 
Competence-dependent EndA activity mediates rapid release of small DNA fragments 
right after CSP1 stimulation 
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 Contrary to previous reports (Chen and Morrison, 1987, Berge et al., 2002), our results 
indicate that DNA degradation by EndA is not dependent on the development of pneumococcal 
competence. To determine if the discrepancy is caused by different methods of measuring 
nuclease activity, we examined DNA degradation mediated by competent and non-competent 
pneumococcal cells by measuring the EndA-mediated release of small DNA fragments and 
nucleotides, as previously published (Berge et al., 2002, Chen and Morrison, 1987). Degradation 
of P-32-labeled hot DNA was compared among ∆comA cells with or without CSP1 stimulation, 
∆endA cells or THB control. As expected, substantial release of small DNA fragments and 
nucleotides was only observed in the ∆comA and ∆comA+CSP1 groups (Fig. 21A-B), indicating 
that EndA was responsible for DNA degradation. However, the initial rate of DNA degradation 
differed significantly. After 30 min of incubation, the amount of small DNA fragments and 
nucleotides released by CSP1-stimulated competent ∆comA cells was 3.9 fold higher than 
untreated ∆comA, as determined by densitometry analysis. In contrast, the amount of small DNA 
fragments and nucleotides released by the ∆comA group at this time point was only slightly higher 
than THB group (Fig. 21A-B), similar to previous reports (Chen and Morrison, 1987, Berge et al., 
2002). However, by 90 and 150 min post CSP1 exposure, the amount of small DNA fragments 
and nucleotides released by the ∆comA+CSP1 became indistinguishable than the ∆comA (Fig. 
21A-B). Because densitometry method only measures DNA degradation in a semi-quantitative 
manner, we repeated the experiments in Figure 21 using pneumococcal cells grown in THB and 
in CTM, and quantified the release of small DNA fragments and nucleotides by using a 
scintillation counter. As shown in Figure 22, after 30 min of incubation, nucleotides/small DNA 
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fragments released by ∆comA grown in CTM supplemented with CSP1 (21 cpm), is much higher 
than ∆comA grown in CTM without CSP1 (0.73 cpm). Similarly, at this time interval, 
nucleotides/small DNA fragments released by ∆comA grown in THB with CSP1 (41.23 cpm), is 
significantly higher than ∆comA grown in THB without CSP1 (20.2 cpm). This indicates that the 
competence-induced DNA degradation is apparent at 30 min after CSP1 stimulation. After 90, 
150 and 210 min of incubation, competence induced DNA degradation is no longer obvious. At 
these time intervals, nucleotides/small DNA fragments released by ∆comA grown in THB alone 
increase dramatically, and is statistically indistinguishable from ∆comA grown in THB 
supplemented with CSP1. In contrast, after 90, 150 and 210 min of incubation, small DNA 
fragments/nucleotide released by ∆comA grown in CTM was very low (Figure 22). These 
observations suggest that competence independent nuclease activity is low when ∆comA was 
cultured in CTM. Collectively, these results suggest the existence of both competence-dependent 
and competence-independent EndA nucleolytic activities. Competence-dependent EndA 
mediates rapid release of small DNA fragments right after CSP1 stimulation while 
competence-independent EndA activity mediates gradual release of small DNA fragments after 
the peak of competence for genetic transformation. Overall, the competence-dependent EndA 
activity is relatively weak and transient, and its contribution to DNA degradation is negligible under 
our experimental conditions.  
 
Secreted form of EndA contributes substantially to the “competence-independent” 
activity of EndA  
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 It has been purported that membrane-localized EndA, presumably recruited by the 
pseudopilus and other competence apparatus, can only gain access and degrade DNA when 
pneumococcal cells enter competent state (8). However, our experimental data suggest that the 
competence-independent activity of EndA is responsible for majority of DNA degradation. We 
hypothesized that pneumococcal cells secrete EndA into the culture medium during growth and 
contribute to the competence-independent degradation of the extracellular DNA. A small portion 
of the EndA molecules may have been recruited by the pseudopilus when pneumococcal cells are 
competent for genetic transformation. To determine whether EndA is secreted, cell-free 
supernatants of D39 and its isogenic, ΔcomD and ΔlytA mutants were collected overtime and 
assessed for their ability to degrade DNA. As shown in Fig. 23A, the nucleolytic activities increase 
in a time-dependent manner in the cell-free supernatants of D39, ΔcomD and ΔlytA grown in the 
THB. In addition, cell-free supernatants from ΔcomD and ΔlytA mutants degraded DNA to the 
same extent as D39, suggesting that competence development and cell lysis do not contribute 
significantly to the accumulation of secreted EndA.  
 To further confirm EndA is secreted into the culture medium, bacterial cells and cell-free 
supernatant were collected from D39 and its isogenic mutants ΔcomD, ΔlytA, and ΔendA and 
subjected to SDS-PAGE in a acrylamide gel incorporated with 15 µg/ml of salmon sperm DNA 
(Lacks et al., 1975). The gel was then washed with pure water to remove SDS and allow proteins 
to renature, and examined for DNA degradation after staining with ethidium bromide. As shown in 
Fig. 23B, EndA activities were detected in both bacterial lysate as well as cell-free supernatants 
from D39, ΔcomD and ΔlytA. In contrast, no nucleolytic band was visible in the ΔendA. These 
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results strongly suggest that EndA is secreted in a process independent of competence 
development or partial cell lysis.  
 
EndA secretion is conserved in different pneumococcal strains and is culture medium 
dependent  
 Next, we compared the EndA secretion by various pneumococcal strains cultured in THB 
versus in CTM. D39, TIGR4 and 0100993 cultured in THB secreted much higher amounts of 
EndA when compared to these strains cultured in CTM (Figure 24A). To quantitatively compare 
the amount of EndA secretion by pneumococcus growing in THB versus in CTM, 1 ml of cell-free 
supernatant from D39 grown in THB were diluted 10 folds, 100 folds and 1000 folds. Nuclease 
activities of different diluents were compared against the nuclease activity of undiluted cell-free 
supernatant from D39 grown in CTM. Each supernatant samples were exposed to hot PCR 
product and incubated at 37C for 1 hr. The release of nucleotides/small DNA fragments was 
quantified by a scintillation counter. As shown in Fig. 24B, cell-free supernatant of D39 cultured in 
THB produced a nuclease activity of 348 cpm, decreasing to 40.6 cpm, 3.8 cpm and 0.21 cpm in 
10 fold, 100 fold and 1000-fold THB diluents, respectively. In contrast, the nuclease activity of 
undiluted cell-free supernatant of D39 cultured in CTM is 4.2 cpm, which is approximates the 
100-fold diluent of the THB supernatant. These results suggest that D39 cells growing in THB 
release about 100 times more EndA than D39 cells growing in CTM. These observations could 
partially explain weak nucleolytic activities when pneumococcal strains were cultured in CTM 
(Figs. 20-21). 
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Degradation of NETs by EndA is independent of competence and is inhibited by ATA 
 EndA has been previously shown to degrade NETs, a host defense mechanism elaborated by 
neutrophils (Brinkmann et al., 2004). We examined whether the EndA-mediated degradation of 
NETs in pneumococcus is dependent on the induction of the competence regulon. As expected, 
NETs were intact in RPMI culture medium or ∆endA treated neutrophils (Fig. 25A). In contrast, 
D39, ∆comCDE and ∆cglABCDEFG readily digested NETs (Fig. 25A). In addition, degradation of 
NETs by D39 cells was inhibited by 15 µg/ml ATA (Fig. 25A). Collectively, these results suggest 
that the degradation of NETs by EndA is independent of competence development.  
 
EndA but not CglABCDEFG is required for lung infection  
 The DNA uptake apparatus of pneumococcus encoded by the cglABCDEFG operon was 
previously reported to be required for DNA degradation during competence (Berge et al., 2002). 
To determine whether competent dependent-EndA-mediated DNA degradation is important for 
virulence, we compared the bacterial burden of D39, ∆endA and ∆cglABCDEFG using an acute 
pneumonia model of infection. The number of ∆endA bacteria was approximately 2 logs lower 
than that of the D39 in mouse lungs (n = 10). In contrast, the number of ∆cglABCDEFG bacteria 
was not significantly different from that of the D39 (Fig. 25B). This result suggests that the 
competence-independent activity of EndA is more important to the pneumococcal virulence than 
the EndA activities expressed when pneumococcus is competent for genetic transformation. 
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DISCUSSION 
 According to previous studies, nucleolytic activity of EndA was only detectable in 
pneumococcal cells competent for genetic transformation (Berge et al., 2002, Chen and 
Morrison, 1987). Nucleolytic activity of EndA was also used as an indicator of competent state 
(Chen and Morrison, 1987). Here, we demonstrate the existence of competence-independent 
EndA activities that is responsible for the majority of the degradation of extracellular DNA and 
NETs, and is important for virulence. Several lines of experimental evidence support these 
conclusions: (i) the overall nucleolytic activity of competence-deficient mutants is comparable to 
their parental wild-type D39; (ii) addition of exogenous CSP1 that induces competence 
development contributes minimally to the overall rate of DNA degradation; (iii) partial cell 
autolysis, which may release EndA into DNA-rich environments, is not required for the nucleolytic 
activity; and (iv) secreted form of EndA contributes substantially to competence-independent 
nucleolytic activity of pneumococcus. 
 The aforementioned observations raise an intriguing question: why is it that in some studies 
(Berge et al., 2002, Chen and Morrison, 1987) the nucleolytic activity of EndA is only detectable 
during the competent state while we could detect nuclease activity in both competent and 
non-competent cells? We attribute part of these discrepancies to different strains used for the 
experiment. For example, the serotype III clinical isolate 0100993 has weaker nuclease activity 
than that of D39, R6 or TIGR4. This suggests that different pneumococcal strains express and/or 
secrete EndA at different levels. Another factor that determines EndA activities is the growth 
medium. We found that nucleolytic activity of EndA is severely reduced in the CTM, which is a 
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nutritionally poorer medium when compared to the THB. CTM is a preferred medium used in 
many genetic transformation studies, likely because it allows the integrity of donor DNA to be 
preserved for a longer period of time. Based on this, we concluded that previous observation of 
competence-dependent EndA activity (Chen and Morrison, 1987, Berge et al., 2002) does not 
conflict with our observation of competence-independent EndA activity. Competence-dependent 
EndA activity is transient but detectable for a short period of time right after CSP1 stimulation. In 
contrast, competence-independent EndA activity predominates after longer incubation in a richer 
medium like THB. 
 EndA has been reported to be a transmembrane protein (Lacks et al., 1975). The thickness of 
D39 cell wall is estimated to be 23 nm (Tran et al., 2011). However, according to the 3D modeling 
of protein structure using the VMD software program, estimated size of the EndA catalytic domain 
is approximately 4.5 nm (data not shown). It has been suggested that EndA could only gain 
access to extracellular DNA through the cglABCDEFG operon encoded pseudopilus uptake 
apparatus (Berge et al., 2002). However, our results show that pneumococcal cells deficient in the 
Cgl proteins rapidly degrade extracellular DNA. A previous study has attributed the DNA 
degradation in non-competent pneumococcal cells to the release of EndA molecules into the 
medium by autolysis or other mechanisms (Moscoso and Claverys, 2004). However, our finding 
shows that the autolysis deficient ∆lytA mutant degrades DNA as rapidly as the parental wild-type 
D39. Furthermore, inclusion of choline chloride, which completely abolishes the function of all the 
autolysins including LytA, LytB, LytC and CbpD, neither delays nor attenuates DNA degradation. 
Collectively, these data refute the argument that rapid DNA degradation is caused by the release 
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of EndA mediated by partial autolysis during pneumococcal growth. Rather, we provide strong 
evidence that EndA is secreted during normal growth of pneumococcus, which contributes 
substantially to the competence-independent DNA degradation.  
 In conclusion, we have shown that the main nucleolytic activity of pneumococcal EndA is 
independent of the competence development in THB. Competence-independent activity of EndA 
is responsible for rapid degradation of extracellular DNA, NETs, and is required for the virulence 
of S. pneumoniae during lung infection. Therefore, drugs that inhibit EndA, including ATA, could 
potentially be used to attenuate pneumococcal-mediated degradation of NETs and spread of 
infection, and reduce horizontal gene transfer. Also, because EndA is secreted and accessible by 
antibodies, it may serve as an attractive vaccine target. 
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Figure 17. Extracellular DNA degradation by pneumococcus EndA is independent of the 
competence regulon and cell autolysis. (A) The rpsL PCR products (30 µg/ml) were exposed 
to the wild-type D39 and isogenic mutants for the indicated time intervals, or in the presence or 
absence of ATA or 2% choline chloride. The integrity of DNA was visualized by agarose gel 
electrophoresis. (B) Competence-deficient pneumococcal mutants degrade salmon sperm DNA 
efficiently. Pneumococcal cells were streaked onto the THB agar supplemented with salmon 
sperm DNA in the presence or absence of ATA or choline chloride. After 24 hr, DNA degradation 
was visualized by flooding the plates with HCl. Three independent experiments were performed 
for both A and B with similar results. The data from one typical experiment are shown. 
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Figure 18. Induction of competence with CSP1 does not appreciably increase 
EndA-mediated DNA degradation. (A-B) Induction of both comX expression (A) and genetic 
transformation (B) in the JC0923 cells grown in THB or CTM with or without exposure to 400 
ng/ml CSP1. Genetic transformation was performed with the addition of 30 ug/ml rpsL PCR 
products. Experiments were performed in triplicates and repeated three times. The means ± SD 
of one typical experiment are shown. (C) Integrity of the rpsL DNA exposed to THB-grown 
JC0923 cells in the presence or absence of CSP1. (D) Measurement of dsDNA integrity (from C) 
with ethidium bromide (excitation: 300nm; emission: 600nm). Experiments were performed in 
triplicates and repeated three times. The means ± SD of one typical experiment are shown. 
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Figure 19. EndA-mediated competence-independent DNA degradation is conserved in 
multiple pneumococcal strains and is growth medium-dependent. (A) Pneumococcal strains 
D39, R6, 0100993, Tigr4 and their isogenic derivatives were cultured in THB to 108/ml 
concentration, washed and resuspended in fresh THB or CTM. The rpsL PCR products (30 µg/ml) 
were exposed to the pneumococcal strains for the indicated time intervals. The integrity of DNA 
was visualized by agarose gel electrophoresis. The experiments were repeated independently 
three times. The results from one typical experiment are shown. (B) Growth kinetics of D39 in 
THB versus CTM. The experiments were performed independently in triplicates and repeated 
three times. The means ± SD of one representative experiment are shown. 
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Figure 20. Pneumococcal strains cultured in CTM have impaired ability to degrade DNA. 
Pneumococcal strains D39, R6, 0100993, Tigr4 and their isogenic derivatives were grown in CTM 
to 108/ml concentration, washed and resuspended in fresh THB or CTM. The rpsL PCR products 
(30 µg/ml) were exposed to the pneumococcal cells for the indicated time intervals. The integrity 
of DNA was visualized by agarose gel electrophoresis. The experiments were repeated 
independently three times. The results from one typical experiment are shown. 
 
 
 
 
 
 
 
 
 
 
 
104 
 
 
Figure 21. Nucleolytic activity of EndA during competence induction by CSP1. 
PCR-amplified P-32 labeled donor DNA was exposed to ∆comA cells in the presence or absence 
of 400 ng/ml CSP1. The ∆endA cells and THB were used as controls. Experiments were 
performed in triplicates. (A) Scanned image of small hot DNA fragments (< 100 bp) and 
nucleotides spotted on filter paper and exposed to a phosphoimager cassette. (B) Quantification 
of dots (n = 3) in A. *p < 0.05 when comparing the densitometry number of comA supplemented 
with CSP1 against comA alone at 30 min and 90 min post CSP1 exposure. 
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Figure 22. Quantitative detection of nucleotides and small DNA fragments released by 
pneumococcus with or without CSP1 stimulation in THB or CTM. ∆comA cells resuspended 
in fresh THB or CTM in the presence or absence of 400 ng/ml CSP1 were exposed to 
PCR-amplified P-32 labeled donor DNA. The amount of nucleotides/small DNA fragments 
release at 0, 30, 90, 150 and 210 min after incubation were quantified by radiometric detection 
and expressed as counts per minute (cpm). The experiments were independently performed 
three times, in triplicates. The means ± SD of one representative experiment are shown.  
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Figure 23. Competence-independent DNA degradation is caused by EndA secreted by 
pneumococcus into the culture medium. (A) The rpsL PCR products (30 µg/ml) were exposed 
to cell-free supernatants from D39 and its isogenic ∆comD and ∆lytA mutants collected during 
growth at the indicated time intervals. The integrity of DNA was visualized by agarose gel 
electrophoresis. (B) Bacterial cell lysates and cell-free supernatants from D39, ∆comD and ∆lytA 
in THB were subjected to SDS-PAGE in a gel incorporated with 15 μ/ml of salmon sperm DNA. 
After renaturation, the gel was stained with ethidium bromide to visualize bands of DNA clearance 
by EndA. The experiments were performed independently three times. The results from one 
typical experiment are shown. 
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Figure 24. Pneumococcal strains grown in the CTM secrete lower amounts of EndA when 
compared to the same bacterial strains grown in the THB. EndA activity in the culture 
supernatant of D39 was determined and compared between pneumococcus growing in THB and 
CTM by in-gel digestion assay (A), and by quantitative DNA degradation assay in D39 culture 
supernatant serially diluted with fresh THB (B). The experiments were performed independently in 
triplicates and repeated three times. The means ± SD of one representative experiment are 
shown. 
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Figure 25. The competence-independent activity of EndA is important for virulence. (A) 
Degradation of NETs by EndA is independent of the development of competence. Neutrophils 
were activated to produce NETs before exposure to RPMI medium, wild-type D39 or mutant 
strains deficient in genetic transformation ∆endA, ∆comCDE, ∆cglABCDEFG, or D39 + 15 µg/ml 
ATA. The samples were stained with DAPI, and imaged under a fluorescence microscope. (B) 
Competence-dependent degradation of DNA by EndA is not important for lung infection. CD-1 
mice (n = 10) were intranasally infected with 106 of D39, ∆endA or ∆cglABCDEFG. Mouse lungs 
were harvested 48 hr post-infection for bacterial enumeration. * p < 0.05 by GraphPad Prism 
statistical method when comparing bacterial load of ∆endA against D39 or ∆cglABCDEFG.   
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CHAPTER 5 GENETIC ANALYSIS OF STREPTOCOCCUS PNEUMONIAE 
COMPETENCE REGULON REVEALS GENES IMPORTANT FOR BACTERIAL 
FITNESS DURING HOST INFECTIONS  
 
Abstract 
The competence regulon of the Gram-positive pathogen Streptococcus pneumoniae 
(pneumococcus) is crucial for genetic transformation. Previously, we and others have shown that 
ComD, a master regulator of competence development, is also an important virulence 
determinant. This suggests that competence for genetic transformation may influence bacterial 
fitness during host infection. One of the key events during the competence development in S. 
pneumoniae is the induction of ComX, an alternative sigma factor. ComX initiates the 
transcription of ~ 80 “late” competence genes. Among these, only 16 late genes are important for 
genetic transformation. We hypothesized that the expression of the late genes that are 
dispensable for competence is beneficial to the overall fitness of S. pneumoniae during infection. 
In this study, we performed systematic gene deletion and examined the contribution of 
ComX-regulated late competence genes to pneumococcal fitness during mouse models of 
bacteremia and acute pneumonia. We identified 14 ComX-regulated late genes that are 
important for at least one model of mouse infection. Among these, all the genes required for 
allolysis are important for infection. In addition, dprA, a gene that encodes a protein controlling 
pneumococcal cells exiting from the competence state, contributes substantially to fitness during 
infections. Significantly, deletion of some late competence genes attenuate pneumococcal 
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fitness to the same level in both wild-type background and ComX-null background, suggesting 
that the constitutive baseline expression of these genes is important for bacterial fitness. In 
contrast, some of the other mutants are attenuated only in the wild-type genetic background but 
not in the ComX-null background, indicating that specific expression of these genes during 
competence contributes to bacterial fitness. This study significantly expands the current 
knowledge about the relationship between competence development and virulence in S. 
pneumoniae. 
 
Introduction 
 Streptococcus pneumoniae (pneumococcus) is an important cause of human infections, 
including pneumonia, otitis media, meningitis and sepsis. Although vaccination and antibiotic 
treatment are widely used, the effort to eradicate pneumococcal disease has been hampered by 
increasing prevalence of antibiotic resistance and the limited protective spectrum of currently 
licensed vaccines (Mitchell et al., 1997, Tomasz, 1999). Several large-scale signature-tagged 
mutagenesis (STM) screens have been conducted to search for new virulence factors that may 
serve as novel drug or vaccine targets (Polissi et al., 1998, Hava and Camilli, 2002, Lau et al., 
2001). Intriguingly, two of the STM screens identified components of the competence regulon 
ComB and ComD, to be important for infection (Lau et al., 2001, Hava and Camilli, 2002). ComB 
is an accessory protein to the ComA ABC transporter required for the export of competence 
stimulating peptide (CSP) (Hui and Morrison, 1991, Hui et al., 1995). ComD is a 
membrane-associated receptor histidine kinase, which together with ComE response regulator, 
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form a two component regulatory system that controls the expression of genes within 
competence regulon required for genetic transformation (Pestova et al., 1996).  
 The development of competence for genetic transformation in pneumococcus resembles a 
quorum-sensing-like mechanism (Claverys and Havarstein, 2002, Steinmoen et al., 2002). 
During growth, pneumococcus secretes and accumulates the CSP peptide pheromone in the 
environment. When a threshold concentration is exceeded, CSP interacts with and activates 
ComD. Activated-ComD phosphorylates ComE, which in turn positively regulates the 
transcription of 24 “early” competence genes, including the gene that encodes the alternative 
sigma factor, ComX (Luo et al., 2003, Luo and Morrison, 2003, Piotrowski et al., 2009). ComX 
binds to the “combox” sequence in the promoter and associates with RNA polymerase, initiating 
the transcription of over 80 “late” competence genes (Peterson et al., 2004). Among these, only 
16 genes have been established as essential for genetic transformation (Peterson et al., 2004). 
We hypothesized that the expression of the remaining 64 ComX-regulated genes might be 
beneficial for the overall fitness of pneumococcus during host infection. In this study, we 
performed both systematic genetic deletion and epistasis genetic analyses to examine the 
contribution of ComX-regulated genes to the overall fitness of pneumococcus during mouse 
models of bacteremia and acute pneumonia infection.  
 
Results and Discussion 
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ComX-deficient mutant is attenuated in mouse models of acute pneumonia and 
bacteremia infection 
 ComX is the alternative sigma factor specifically expressed in the competent pneumococcus 
cells to initiate the expression of many essential effectors for DNA uptake, processing and 
integration, as well as some other genes of unknown functions (Lee and Morrison, 1999, Luo et 
al., 2003). ComX is encoded by two identical and redundant genes — comX1 and comX2 (Lee 
and Morrison, 1999). To determine if ComX played a role in survival and fitness during host 
infection, we analyzed ∆comX1 (strain AD0014), ∆comX2 (strain AD1818) and ∆comX1∆comX2 
(strain FS1975) in direct competitive infection with the parental wild-type D39 in mouse models of 
acute pneumonia and bacteremia. Deletion of either comX1 or comX2 alone did not alter the 
competitiveness during lung and blood infection (Figure 26A, 26B). However, the 
∆comX1∆comX2 double mutant was only 23 and 20% as competitive as D39 during infection in of 
lungs and blood, respectively. The ∆comX1∆comX2 mutant is also attenuated in single infection 
by 1.29 and 1.34 logs in lung and blood, respectively (see Figure 28 below).  
 
ComX-regulated genes are important for survival and fitness during acute pneumonia and 
bacteremia infections 
 The attenuation of virulence in the ∆comX1∆comX2 mutant prompted us to examine the 
contribution of ComX-regulated genes to infection. We constructed 35 deletion mutants to allow 
full coverage of all the nonessential “late” genes within the 19 operons that carry a combox, and 
tested these mutants for competition against the wild-type D39 in mouse model of bacteremia. Of 
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these, 13 genes are important in the bacteremia and/or acute pneumonia models of mouse 
infection (Figure 27, Table 5).  
 Because competitive infection may not reveal the true levels of attenuation, we examined the 
virulence of five mutants in both the acute pneumonia and bacteremia models of single 
infections. Four of the five mutants, ∆comX1∆comX2 (FS1975), ∆recA (AD1739), ∆spd_0981 
(AD0981), and spd_0031 (AD0031) were attenuated in the lung infection (Figure 28A). All five 
mutants, including ∆radC (AD0975), were attenuated In the bacteremia model of infection (Figure 
28B). These results suggest that in vivo competition assays are good indicators of virulence 
attenuation for single infections. ComX, RecA, SPD_0981 and SPD_0031 are important for 
infection in both lung and blood. In contrast, under our experimental conditions, RadC only plays 
a role during bacteremia but not pneumonia. 
 
Functional annotation of ComX-regulated genes important for virulence  
 Various mutants are tentatively grouped based on their known or predicted functions. 
Detailed characterization of individual mutants are briefly discussed below: 
 
Stress responses 
radA 
 The ∆radA mutant (strain AD0029) is only 41% and 32% as competitive as D39 in the 
bacteremia and acute pneumonia models of infection, respectively (Table 5, Figure 27). These 
results concur with two previous STM screens that identified radA as important for survival within 
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host (Polissi et al., 1998, Hava and Camilli, 2002). Bioinformatic analysis indicates that RadA is a 
RecA-like NTPase that possesses an ATP binding site, a walker A motif and a walker B motif. 
RadA is important for genetic recombination and transformation in Escherichia coli and Bacillus 
subtilis (Beam et al., 2002, Carrasco et al., 2002). Its role in pneumococcal genetic 
transformation remains controversial. Burghout et al have shown that RadA is required for 
transformation (Burghout et al., 2007). In contrast, Peterson et al showed that it is dispensable 
for transformation (Peterson et al., 2004). Nevertheless, ∆radA is more susceptible to mutagen 
MMS than its parental wild-type (Burghout et al., 2007), suggesting RadA plays a role in DNA 
repair.  
 
recA 
 The ∆recA mutant (strain AD1739) is only 0.4% and 0.3% as competitive as D39 (Table 5), 
and is attenuated by 2.4 and 4.7 logs in the acute pneumonia and bacteremia models of 
competitive and single infections, respectively (Figure 28A, 28B). The recA gene (Figure 29A) 
encodes a pneumococcal DNA recombination protein essential for genetic transformation (Martin 
et al., 1992b, Martin et al., 1995). During pneumococcal genetic transformation, RecA protects 
the single stranded DNA (ssDNA) (Berge et al., 2003) and plays an important role in searching 
for homologous sequences to allow DNA recombination (Kowalczykowski and Eggleston, 1994, 
Steffen and Bryant, 2000). 
 ∆recA grows slower than D39 (Figure 29B). In addition, ∆recA is about four times more 
sensitive to hydrogen peroxide (H2O2) than D39 (Figure 29C). Pneumococcal pyruvate oxidase 
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SpxB is responsible for the production of endogenous H2O2 (Regev-Yochay et al., 2007, 
Spellerberg et al., 1996). ∆spxB produces 100-fold less H2O2 than D39 (Spellerberg et al., 1996). 
Deletion of the spxB gene in the ∆recA mutant background partially restored the growth defect of 
∆recA (Figure 29B), suggesting that RecA protects pneumococcus against endogenous 
H2O2-mediated DNA damage.  
 Interestingly, careful bioinformatic analysis reveals that two promoters (p1 and p2) regulate 
the expression of recA. p1 overlaps the combox before the start of the cinA gene. p1 is also 
called the “cinbox”, and is only active during the competence stage (Pearce et al., 1995). 
Activation of p1 is required for the optimal recombination proficiency during genetic 
transformation (Mortier-Barriere et al., 1998). The p2 promoter is located between the cinA and 
recA genes. p2 is constitutive and is required for the baseline expression of the recA gene 
(Pearce et al., 1995). Deletion of p1 neither influenced the in vitro growth nor altered the H2O2 
sensitivity of the mutant (Figure 29C). In contrast, deletion of p2 generated a mutant with a 
growth defect (Figure 29B) and increased susceptibility to H2O2, phenotypes that are very similar 
to recA mutant (Figure 29C). These results suggest that p2 regulates the growth and stress 
response to H2O2, and that both processes are independent of the induction of competence for 
genetic transformation. 
 
spd_1778 
 The ∆spd_1778 mutant (strain AD1778) is only 1.2% and 15% as competitive as D39 in 
mouse models of bacteremia and acute pneumonia infection, respectively (Table 5). Spd_1778 is 
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a member of the bacterial RmuC family of DNA recombination proteins. For example, RmuC of E. 
coli limits the rate of DNA inversions at short inverted repeats (Slupska et al., 2000), suggesting a 
potential role of the protein in DNA recombination. Furthermore, RmuC is a component of the E. 
coli LexA regulon, which controls bacterial response to DNA damage (Van Dyk et al., 2001). van 
Opijnen and Camilli have reported that the RmuC (SP_1981 in pneumococcal strain TIGR4) is 
involved in the resistance against DNA gyrase inhibitor Norfloxacin and the DNA damaging agent 
Methyl methanesulfonat (MMS) (van Opijnen and Camilli, 2012). These reports further suggest a 
role for Spd_1778 in protecting pneumococcus against DNA damage.  
 
spd_0031 
 ∆spd_0031 (strain AD0031) is only 8% and 5% as competitive as D39 in mouse models of 
bacteremia and acute pneumonia (Table 5). It is also 1.75 log and 1.64 log more attenuated 
during bacteremia and acute pneumonia single infections (Figure 28). spd_0031 encodes a 
protein that belongs to the PrsW family of peptidases. In Clostridium difﬁcile, PrsW cleaves the 
RsiT anti-sigma factor to allow an increasing expression of the sigma factors CsfT and CsfU. In 
turn, CsfT and CsfU positively regulate resistance to antimicrobial peptides that damage the cell 
membrane and to other agents that cause cell envelope stress (Ho and Ellermeier, 2011). The 
∆prsW mutant of C. difﬁcile is 30-fold less virulent than the wild-type (Ho and Ellermeier, 2011). 
Similarly, PrsW of B. subtilis degrades anti-sigma factor RsiW, and senses antimicrobial peptides 
and cell envelope stress (Ellermeier and Losick, 2006).  
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Transporter 
spd_1828 
 The ∆spd_1828 mutant (strain AD1828) is only 1.3% as competitive as D39 in a mouse 
model of bacteremia infection, but nearly as competitive as the wild-type strain in the acute 
pneumonia infection (Table 5). spd_1828 was first identified by Bartilson and colleagues to be 
the CSP-inducible gene CPIP788 (Bartilson et al., 2001). Similar to our results, these authors 
found that ∆CPIP788 was significantly attenuated during blood infection but was as virulent as 
the wild-type in the lungs (Bartilson et al., 2001). Bioinformatic analysis indicates that Spd_1828 
is a 43 aa protein harboring an ABC ATPase domain with similarity to the iron (III) dicitrate 
transport ATP-binding protein FecE in Neisseria polysaccharea and N. meningitides (Figure 30). 
However, Spd_1828 of D39 and other pneumococcal isolates are much shorter (43 aa – 64 aa) 
when compared to homologs from other Streptococcal species and from other bacteria, including 
the Neisseria spp (217 aa – 278 aa). This suggests that there may have been a mis-annotation of 
Spd-1828 in D39 and other pneumococcal isolates (Figure 30). Alternatively, Spd_1828 of 
pneumococcus has undergone a species-specific truncation during evolution.  
 
Cellular metabolism 
spd_0030  
 The ∆spd_0030 mutant (strain AD0030) is only 1.4% and 13% as competitive as D39 in the 
mouse models of bacteremia and acute pneumonia, respectively (Table 5). spd_0030 encodes a 
pneumococcal carbonic anhydrase (PCA), an enzyme that catalyzes the reversible hydration of 
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carbon dioxide (CO2 + H2O ---- HCO3- + H+) (Hewett-Emmett and Tashian, 1996, Smith and Ferry, 
2000, Smith et al., 1999, Lindskog, 1997). There are three distinct families — , , and -CAs — 
which show no significant sequence identity or structural similarity (Hewett-Emmett and Tashian, 
1996). Genome analysis revealed that PCA belongs to the -class, and is highly conserved 
among various pneumococcal isolates (Smith and Ferry, 2000). CO2 is important for the growth 
of S. pneumoniae (Kempner and Schlayer, 1942), likely because it needs CO2 or HCO3- during 
the biosynthesis of nucleic acids, amino acids, and fatty acids (Aguilera et al., 2005). Under 
CO2-rich conditions, pneumococcus may obtain CO2 through diffusion. Under CO2-poor 
conditions, CO2 fixation becomes important. Burghout and co-workers have shown that PCA is 
required for pneumococcal growth under CO2-poor conditions (Burghout et al., 2010). The 
growth defects of the PCA-deficient mutants under low CO2 conditions could be restored by 
addition of unsaturated fatty acids, suggesting that PCA-mediated CO2 fixation is at least 
associated with HCO3--dependent de novo biosynthesis of unsaturated fatty acids (Burghout et 
al., 2010). Similar to previous observations (Hewett-Emmett and Tashian, 1996), our results also 
show that ∆spd_0030 is unable to grow at 37°C in the absence of 5﹪ CO2 (Figure 31). Finally, 
consistent with our mouse infection results, PCA-mediated CO2 fixation pathways have been 
shown to be important for invasion of the human brain microvascular endothelial cells and uptake 
by the murine J774 macrophage cells (Burghout et al., 2010).  
 
cinA 
 The ∆cinA mutant (strain AD1740) is not attenuated in the mouse model of bacteremia, but 
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slightly less competitive than D39 (CI 0.64) during lung infection (Table 5). CinA has been shown 
to be important for lung infection in a STM screen (Hava and Camilli, 2002). cinA is the first gene 
in the cinA-recA-dinF-lytA operon. Bioinformatic analysis suggests that CinA has a molybdopterin 
binding domain with similarity to proteins involved in the biosynthesis of molybdopterin cofactor. 
 The combox in the promoter region of the cinA-recA-dinF-lytA operon (Figure 29A) is also 
called the cinbox. The ∆cinbox mutant (strain AD1740-1) is more attenuated than ∆cinA in the 
acute pneumonia model of infection (Table 5). In addition, ∆cinbox is less competitive than D39 
in the bacteremia infection (Table 5), suggesting that increased expression of cinA, recA, dinF 
and lytA during competence may be important for virulence. Because ∆dinF is not attenuated in 
both models of mouse infection (data not shown), it is likely that the ability to upregulate the 
expression of cinA, recA and lytA during competence contributes to pneumococcal fitness in 
vivo.  
 
spd_0981 
 The ∆spd_0891 mutant (strain AD0891) is only 15% and 24% as competitive as D39 in 
mouse models of bacteremia and acute pneumonia infection (Table 5). It is also attenuated by 
2.18 log and 1.43 log during single infection of blood and lung (Figure 28). Spd_0981 encodes a 
protein with a CYTH-like superfamily domain. Enzymes belonging to this superfamily hydrolyze 
triphosphate-containing substrates, require metal cations as cofactors, and have a unique active 
site located at the center of an eight-stranded antiparallel beta-barrel tunnel (the triphosphate 
tunnel). The name CYTH originated from the gene designation for bacterial class IV adenylyl 
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cyclases (CyaB) (Smith et al., 2006) and from thiamine triphosphatase (Kohn et al., 2012). This 
domain superfamily also contains RNA triphosphatases (Gong et al., 2006). Enzymes with this 
domain are believed to be involved in nucleotide or organic phosphate metabolism (Iyer and 
Aravind, 2002).  
 
Genes that participate in allolysis during competence 
 Allolysis is an unique physiological phenomenon that occurs in the pneumococcal cells 
competent for genetic transformation. This process involves the lysis of a subpopulation of 
pneumococcal cells, resulting in the release of cell wall components, DNA, as well as virulence 
factors, including pneumolysin (Guiral et al., 2005). During competence, ComX positively 
regulates the expression of four allolytic genes: lytA, cbpD, cibA and cibB (Guiral et al., 2005). 
LytA is a major pneumococcal autolysin important for virulence (Berry et al., 1989a). lytA is the 
fourth gene in the cinA operon (Figure 29A). The expression of lytA gene is driven by a 
constitutive promoter and a competence specific promoter upstream of cinA (p1). During the 
competence stage, the expression of lytA increases about 4-fold (Peterson et al., 2004). CbpD is 
a cell wall hydrolase specifically expressed in the pneumococcus competent for genetic 
transformation (Peterson et al., 2004, Kausmally et al., 2005). It is required for partial cell lysis 
and DNA release during competence (Kausmally et al., 2005). A ∆cbpD mutant was identified as 
attenuated in lung infection during a STM screen (Hava and Camilli, 2002). cibA and cibB are 
two genes in the same operon that encode two double-glycine bacteriocins essential for the 
competence-mediated allolysis (Guiral et al., 2005). Our results show that ∆cbpD (strain 
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AD2028-1), ∆cibAB (strain AD0133), and ∆lytA (strain AD1737) are all less competitive than D39 
in mouse models of bacteremia and acute pneumonia (Table 5). Both ∆cbpD and ∆cibAB are 
moderately but significantly attenuated in the single acute pneumonia infection (Figure 32). 
Similar to previous report (Orihuela et al., 2004), ∆lytA is severely attenuated during single lung 
infection (Figure 32). Collectively, these results suggest that CbpD, LytA and CibAB are important 
for virulence and host fitness during both acute pneumonia and bacteremia. 
 We performed genetic epistasis analyses to determine the hierarchical order of cbpD, cibAB 
and lytA, during single acute pneumonia infection. The results indicate that the ∆cbpD∆cibAB 
mutant (strain CD1880) is not more attenuated than ∆cbpD or ∆cibAB alone (Figure 32). 
∆cbpD∆lytA (strain GW1941) and ∆cibAB∆lytA (strain AF1928) are more attenuated than ∆lytA. 
∆cbpD∆cibAB∆lytA (strain FG1928) doesn’t seem to be more attenuated than ∆cbpD∆lytA or 
∆cibAB∆lytA (Figure 32). These results suggest that LytA functions in an independent pathway 
but acts synergistically/additively with CbpD or CibAB to cause host infections. In contrast, CbpD 
and CibAB may function within the same pathway, as the loss-of-function in both proteins does 
not confer additional attenuation than individual protein alone. 
 
Competence regulation 
dprA 
 The ∆dprA mutant (strain AD1122) is only 7% and 1% as competitive as D39 in bacteremia 
and acute pneumonia models of infection (Table 5, Figure 26). DprA is a dual functional 
competence protein essential for genetic transformation. During transformation, DprA binds to 
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ssDNA and delivers it to RecA for recombination (Mortier-Barriere et al., 2007). In addition, Berge 
and colleagues reported that DprA is required for the protection of ssDNA during competence. In 
the absence of DprA, the incoming ssDNA is degraded rapidly and could not be processed for 
recombination (Berge et al., 2003). Interestingly, two recent studies have reported that DprA is 
also required for turning off the competence development (Mirouze et al., 2013, Weng et al., 
2013). DprA binds to ComE and prevents the binding of the transcriptional activator to its 
promoter. ∆dprA has difficulty exiting from the competence state and has a growth defect when 
stimulated with the CSP.   
 If the inability of ∆dprA to exit the competence state contributes to its attenuation during 
infection, we hypothesized that ∆dprA would not be attenuated in a pneumococcal strain 
deficient in competence induction. Because both ∆comX1∆comX2 and ∆comDE are not 
transformable, we tested ∆dprA in the ∆comB background instead. Because of its inability to 
export CSP, ∆comB (strain AD0050) is not able to develop competence by itself. However, it is 
still transformable when induced with exogenously supplied CSP. As shown in Figure 33, 
∆dprA∆comB (strain LP1861) is as competitive as ∆comB in a mouse model of bacteremia 
infection, suggesting that the induction of competence is responsible for the attenuation of the 
∆dprA mutant. In the absence of competence induction, ∆dprA∆comB is not attenuated. Because 
mutations in other genes for DNA uptake and integration such as ssbB and coiA do not reduce 
the competitiveness of the mutants (Figure 33), it is likely that DNA uptake and integration is not 
important for infection. Rather, DprA contributes to bacterial fitness during infection by regulating 
physiological exit from the competence state, rather than by processing DNA. Collectively, 
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genetic analysis of the dprA locus suggests that the existence of competence-induced virulence 
versus basal expression-dependent virulence in pneumococcus. 
 
Gene of unknown function 
radC 
 The ∆radC mutant (strain AD0975) is 10% as competitive as D39 in bacteremia model of 
infection. No significant attenuation could be observed in acute pneumonia model of infection 
(Table 5). The CIs are reflected in the single infection, where ∆radC is attenuated by 1.55 log in 
the bacteremia, but only by 0.75 log in the acute pneumonia (Figure 28). The radC gene was 
originally named after the E. coli radC102 mutant (Felzenszwalb et al., 1984). This mutant has a 
moderate increase in sensitivity to radiation and X-ray, suggesting that RadC plays a role in DNA 
repair (Felzenszwalb et al., 1984). However the relevant mutation was subsequently shown to be 
in the recG gene. Thus, the original radC mutation was in fact an allele of recG (Lombardo and 
Rosenberg, 2000). The function of pneumococcal RadC remains to be determined. Claverys and 
co-workers have shown that pneumococcal RadC plays no role in the repair of DNA lesions, in 
recombination during genetic transformation, in gene conversion, nor in mismatch repair 
(Attaiech et al., 2008). Computational bioinformatic analysis suggests that RadC belongs to the 
JAB superfamily of metalloproteins that might function as a nuclease. 
 
Genetic loci with the unconventional “com boxes” 
When pneumococcus enters the state of competence, ComX binds to the “combox” resides 
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within the promoter and initiates the transcription of late competence genes within each operon 
(Peterson et al., 2004). However, we found three operons that harbor “unconventional 
comboxes” (Figure 34A). These “comboxes” are located inside the gene upstream of these late 
competence gene loci. The combox of the dut operon resides within a scRNA gene. Interestingly, 
there is also a small overlapping region between the dut and scRNA genes (Figure 34A). The 
combox of the spd_0981 operon is located inside spd_0982, a gene upstream of spd_0981 but 
with opposite orientation (Figure 34A). Finally, spd_1779, spd_1778 and cbf1 belong to the same 
operon, with the combox resides within the coding region of spd_1779. These observations raise 
an intriguing question: Are these unconventional comboxes relics of evolution? Thus, it seems 
the expression of genes in the operons with unconventional comboxes is not entirely dependent 
on ComX-mediated competence development since their comboxes are located within other 
genes and may be under the influence of promoters that regulate these other genes. 
 
Deletion of the dut gene serendipitously identified a small RNA gene required for optimal 
growth, genetic transformation and infection  
 dut (spd_0027) is the first gene of a late competence operon with “unconventional combox” 
(Figure 34A). Replacement of the entire dut gene with kanamycin resistance marker rendered 
the mutant (AD0027) with moderate growth defects in the Todd Hewitt broth (THB), abolished 
genetic transformation, and severely attenuated competitiveness during bacteremia model of 
infection (Figure 34B-34E). Careful bioinformatic analyses revealed that the 5’end of the dut 
gene partially overlaps with a small RNA gene, scRNA. Thus, deletion of the entire dut gene in 
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AD0027 also compromised the integrity of the scRNA gene. To clarify which gene is responsible 
for optimal growth, genetic transformation and virulence, we constructed a dut mutant without 
influencing the integrity of scRNA (AD0027-1, Figure 34B) and a scRNA deletion mutant without 
influencing the integrity of dut (AD0026, Figure 34B). As shown in Figure 9B, strain AD0027-1 did 
not exhibit phenotypic defects in growth, virulence, or genetic transformation (Figure 34C-34E). 
In contrast, strain AD0026 is attenuated in growth, virulence, and genetic transformation (Figure 
34C-34E). Collectively, these results suggest that scRNA rather than dut is required for optimal 
growth, genetic transformation, and virulence of pneumococcus.  
 
Competence dependent and independent manifestation of virulence among the late genes 
within the competence regulon 
Among the 14 deletion mutants, we had noticed that some strains were more attenuated than 
∆comX1∆comX2. For example, both ∆spd_1778 and ∆spd_0030 are more attenuated than the 
∆comX1∆comX2 during competition with D39 (Table 5). In addition, deletion analysis of dprA 
locus in the ∆comB genetic background suggests that the existence of competence-induced 
virulence versus basal expression-dependent virulence in pneumococcus. These reasons 
compelled us to examine if additional mutants could be examined for the existence of 
competence-induced virulence versus basal expression-dependent virulence in pneumococcus. 
We compared the competitiveness of 6 mutants (∆radC, ∆spd_0981, ∆spd_0031, ∆cbpD, ∆cibAB, 
and ∆cinbox) derived from D39 versus the same 6 mutants derived from the ∆comX1∆comX2 
mutant background, using a mouse model of bacteremia. Among these mutants, ∆radC, 
126 
 
∆spd_0031 and ∆spd_0981 were attenuated in both D39 as well as in the ∆comX1∆comX2 
backgrounds (Fig. 35A-35C) during bacteremia infection. These results suggest that the loss of 
virulence in these mutants is not dependent on the induction of competence by ComX. Rather, 
the baseline expression of these genes is important for bacterial fitness during mouse infection. 
In contrast, ∆cbpD, ∆cibAB or ∆cinbox were attenuated in D39 background but not in the 
∆comX1∆comX2 background, suggesting that the attenuation of these three mutants was ComX 
dependent (Fig. 35D-35F). Thus, increased expression of CbpD, CibAB and initiation of 
transcription of genes downstream of cinbox during competence induction are important for 
bacterial fitness during infection. These results, together with those of the ∆dprA (Figure 33), 
suggest that the existence of competence-induced virulence, which can be uncoupled from the 
basal expression-dependent virulence in pneumococcus. 
 
Conclusion Remarks 
In this study, we conducted a systematic deletion analysis on ComX-regulated “late” 
competence genes. We demonstrated that ComX and 14 ComX-regulated genes contribute to 
bacterial fitness during acute pneumonia and bacteremia infection in mice. We confirmed that 
genes that mediate allolysis, including lytA and cbpD are required for pneumococcal infection. In 
addition, deletion of some late competence genes attenuate bacterial fitness in the wild-type 
background but not in the ComX-null background, indicating specific expression of these genes 
during competence contributes to bacterial fitness. In contrast, deletion of some other late 
competence genes attenuate pneumococcal fitness to the same level in both wild type 
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background and ComX-null background, indicating their constitutive baseline expression is 
important for bacterial fitness. Finally, we showed that DprA, a regulator required for turning off 
competence development, is critical for pneumococcal fitness during infection. Collectively, our 
results suggest that the competence regulon needs to be tightly regulated to optimize 
pneumococcal fitness and survival during host infection.   
 
Materials and Methods 
Bacterial strains and growth conditions 
 S. pneumoniae D39 (Avery et al., 1979) is a generous gift from Dr. David Briles (University of 
Alabama-Birmingham). Deletion mutants derived from D39, and various primers used to 
construct the mutants are detailed in the Supplementary Materials. Bacteria were streaked from 
frozen stocks onto the THB agar containing 5% defibrinated horse blood and incubated at 37°C 
with 5% CO2. Fresh colonies were grown in THB to desired density. 
 
Construction of gene replacement mutants 
 Pneumococcal genes were deleted using the Janus cassette according to the previous 
published methods (Sung et al., 2001, Ramos-Montanez et al., 2008). Briefly, ~ 500 bp of DNA 
fragments flanking the gene targeted for deletion were amplified by PCR, and were ligated to the 
two ends of kanamycin and/or erythromycin resistance cassettes by overlapping PCR. Following 
gel purification, the PCR-amplified ligated products were transformed into appropriate recipient 
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strains. Transformants were selected on THB agar supplemented with 200 g/ml of kanamycin 
or 0.3 g/ml of erythromycin.  
 
Ethics statement 
 The animal study was carried out in strict accordance with the recommendations in the Guide 
for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was 
approved by the Institutional Animal Care and Use Committee (IACUC) at the University of 
Illinois at Urbana-Champaign (Protocol Number: 12230). 
 
Mouse models of single acute pneumonia and bacteremia infection 
 CD1 mice (6-week old) (Charles River) were housed in positively-ventilated microisolator 
cages with automatic recirculating water, located in a room with laminar, high efficiency particle 
accumulation–filtered air. The animals received autoclaved food, water, and bedding. For the 
mouse model of acute pneumonia, animals were anesthetized with isoflurane and intranasally 
administered 106 CFU pneumococcal cells. After 48 hr, lungs were removed from the euthanized 
animals, homogenized and enumerated for bacterial burden. For the bacteremia model, CD1 
mice were inoculated intraperitoneally with 104 CFU of pneumococcal cells. After 24 hr, 
pneumococcal burden in the spleens were enumerated.  Moribund animals that displayed rough 
hair coat, hunched posture, distended abdomen, lethargy or inability to eat or drink were 
euthanized immediately.  
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In vivo and in vitro competitive assays 
 In vivo competition assays were performed as previously described (Mei et al., 1997). Briefly, 
CD 1 mice were inoculated with a bacterial cell suspension containing a 1:1 mixture of parental 
strain (e.g., D39) and its and mutant derivative, using the bacterial concentration described above 
for single infections. At designated times, mouse lungs or spleens were harvested, homogenized 
and plated onto THB agar plates with and without antibiotics. The competitive index (CI) is defined 
as the output ratio of mutant to wild-type bacteria divided by the input ratio of mutant to wild-type 
bacteria. A mutant with a CI of 0.7 or lower was tentatively defined as attenuated, as we have 
previously described (Lau et al., 2001).  
 For in vitro growth competitions, both parental strain and its deletion mutant were allowed to 
grow in THB to OD 600nm of 0.1. One ml of both cultures were mixed thoroughly, and then diluted 
100-fold in fresh THB. Five ml of the diluted mixture was then allowed to grow for 6 hr, serially 
diluted and plated onto THB agar with or without antibiotics for CFU determination. 
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Figure 26. Analyses of ∆comX, ∆comX2 and ∆comX1∆comX2 in competitive infections 
against parental wild-type D39.  (A) CD 1 mice (n = 5) were intranasally challenged with 1:1 
mixture of D39 and each mutant strain (5 x 106 CFU/strain). After 48 hr, lungs were harvested, 
homogenized, serially diluted and plated onto THB agar plates with and without kanamycin to 
determine the competitive indexes (CI). (B) CD 1 mice (n=5) were intraperitoneally challenged 
with a bacterial cell suspension containing a 1:1 mixture of wild type and each mutant strain (1 x 
104 CFU/strain). Bacterial burdens were determined in the spleens 24 hr after infection. Each dot 
indicates the competitive index from one mouse. Bar shows the mean CI. 
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Figure 27. ComX-regulated pneumococcal late competence gene loci important for host 
infection. Nineteen operons that cover the 54 late competence genes were deleted by using the 
Janus cassette, and tested for their ability to compete against D39 in mouse model of bacteremia 
and pneumonia (see Table 1). Of these, deletion of 9 operons generated mutants with reduced 
virulence. Subsequently, each gene within these 9 operons was deleted, and tested for 
virulence. Of these, 14 genes were identified to be are important for infection in bacteremia 
and/or acute pneumonia models of mouse infection. Red boxes: Genes required for genetic 
transformation. Shaded boxes: Genes required for infections. “C” = combox in the promoter of 
each gene locus. Boxes with dotted lines: essential genes that are not included during the 
deletion process. spd_0974 and spd_0976 are transcribed as antisense RNA during 
competence. 
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Figure 28. Virulence of five deletion mutants by single acute pneumonia and bacteremia 
infections. (A) CD-1 mice (n = 10) were intranasally infected with 5x106 of D39, ∆comX1∆comX2 
(FS1975), ∆recA (AD1739), ∆spd_0981 (AD0981), ∆radC (AD0975), or spd_0031 (AD0031). 
Mouse lungs were harvested 48 hr post-infection for bacterial enumeration. (B) (A) CD-1 mice (n 
= 7) were intraperitoneally infected with 104 of D39, ∆comX1∆comX2, ∆recA, ∆spd_0981, ∆radC, 
or spd_0031. Mouse spleens were harvested 24 hr post-infection for bacterial enumeration. *p ≤ 
0.05 when compare the log10 CFU of individual mutants against D39. 
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Figure 29. Contribution of recA and two of its promoters to growth and resistance to 
oxidative stress. (A) The organization of the cinA-recA-dinF-lytA operon. p1 has a combox 
(cinbox), which is active during competence. p2 is a constitutive promoter of recA. (B) The 
growth curve of strains D39 versus AD1739 (∆recA), AD1740-1 (∆cinbox), AD1739-1 (∆p2) and 
∆recA∆spxB. ∆cinbox has a deletion of p1, the cinbox-containing promoter. The experiments 
were performed in triplicates for three times. The mean + standard deviation from one typical 
experiments are shown. (C) The sensitivity of D39 versus various mutants to H2O2. 1 x 103 CFU 
of each strain were seeded into 1 ml of THB supplemented indicated concentrations of H2O2. 
Pneumococcal strains were then incubated over night at 37°C with 5% CO2. “-” indicates no 
growth. “+” indicates positive growth. The experiments were repeated three times with similar 
results. The results from a representative experiments are shown. 
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Figure 30. Spd_1828 is truncated in pneumococcus. Protein alignment of Spd_1828 against 
various homologs from other pneumococcal strains, and other Streptococcus and Neisseria 
species. DNA alignments were performed using DNASTAR software program. 
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Figure 31. ∆spd_0030 has growth defect in the absence of CO2. D39 and AD0030 
(∆spd_0030) were allowed to grow to OD600 of 0.1 and then subjected to 10 fold serial dilutions. 
Each diluent (20 µl) was spotted onto the THB agar. The plates were incubated at 37°C overnight 
with or without 5% CO2 and photographed. The experiments were repeated three times 
independently with similar results. The results from one of the experiments are shown. 
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Figure 32. Allolysis genes are important for acute pneumonia infection by pneumococcus. 
CD-1 mice (n = 7) were intranasally infected with 106 of D39, ∆cbpD (AD2028-1), ∆cibAB 
(AD0133), ∆lytA (AD1737-1), ∆cbpD∆cibAB (CD1880), ∆cbpD∆lytA (GW1941), ∆cibAB∆lytA 
(AF1928), or ∆cbpD∆cibAB∆lytA (FG1928). Mouse lungs were harvested 48 hr post-infection for 
bacterial enumeration. 
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Figure 33. Analysis of ∆dprA (AD1122) in vitro competitiveness in wild type background 
and in comB null background, as well as ∆cflA (AD2035) and ∆ssbB (AD1711) in 
competitive infections with parental wild type D39. CD 1 mice (n = 5) were intraperitoneally 
challenged with a bacterial cell suspension containing a 1:1 mixture of indicated two strains (both 
have a CFU of 104). 24 hours after injection, spleens were isolated, homogenized and plated onto 
THB agar plates with and without antibiotics for CI determination. Each point indicates the 
competitive index from an individual mouse. Bar shows the mean CI.  
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Figure 34. scRNA controls both virulence and genetic transformation in pneumococcus. 
(A) Three late gene loci with “unconventional combox”. Vertical black bars represent the 
locations of comboxes. Arrows indicate the direction of transcription. (B-E) Deletion of a scRNA 
impairs virulence and genetic transformation. (B) Wild-type and various deletion constructs of the 
scRNA and the dut genes. (C) Growth kinetics of indicated strains in THB. (D) Competitive fitness 
of various dut and scRNA mutants during mouse model of bacteremia infection. (E) 
Transformation efficiency of dut and scRNA mutants. 
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Figure 35. In vivo competition assays differentiate the importance of basal expression and 
competence induction in genes required for bacteremia infection. Competition assays were 
conducted to compare the competitiveness of late competence gene mutants against the 
parental strain D39 or KM1983 (∆comX1∆comX2). (A) D39 vs. ∆cbpD, KM1983 
(∆comX1∆comX2) vs. KF1940 (∆cbpD∆comX1∆comX2);  (B) D39 vs. ∆cinbox, KM1983 
(∆comX1∆comX2) vs. GG1602 (∆cinbox∆comX1∆comX2); (C) D39 vs. ∆cinAB, KM1983 
(∆comX1∆comX2) vs. EB1890 (∆cibAB∆comX1∆comX2);  (D) D39 vs. ∆radC, KM1983 
(∆comX1∆comX2) vs. GM1856 (∆radC∆comX1∆comX2); (E) D39 vs. ∆spd_0031, KM1983 
(∆comX1∆comX2) vs. RH1665 (∆spd_0031∆comX1∆comX2); and (F) D39 vs. ∆spd_0981, 
KM1983 (∆comX1∆comX2) vs. EJ1796 (∆spd_0981∆comX1∆comX2). 
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Table 5 Attenuated late competence gene knockout mutants identified in this 
study. (Both serial numbers and genotype designations are given to strains made 
in this work. Genotype designations are used in the text and figures for reader’s 
convenience) 
Strain Deleted 
gene/region 
Function Bacteremia 
CI 
Pneumonia 
CI 
Growth 
competition 
CI 
REFERENCE STRAINS 
D39  / 1 1 1 
FS1975 
(∆comX1∆comX2) 
  0.23 0.2 0.97 
STRESS RESPONSES 
AD0029 (∆radA) radA DNA repair 0.41 0.32 1.13 
AD1739 (∆recA) recA DNA recombination and 
repair 
0.004 0.003 0.2 
AD1778 
(∆spd_1778) 
spd_1778 RmuC family protein, DNA 
repair 
0.012 0.15 0.96 
AD0031 
(∆spd_0031) 
spd_0031 PrsW protease family 0.08 0.05 0.97 
TRANSPORTER 
AD1828 
(∆spd_1828) 
spd_1828 ABC transporter 0.013 0.66 0.96 
CELLULAR METABOLISM 
AD0030 
(∆spd_0030) 
spd_0030 Carbonic anhydrase 0.014 0.13 0.89 
AD1740 (∆cinA) cinA Biosynthesis of 
molybdopterin, putative 
0.78 0.64 1.02 
AD1740-1 
(∆cinbox) 
cinbox Promoter of cinA operon 0.41 0.32 1.08 
AD0981 
(∆spd_0981) 
spd_0981 Hypothetical protein 0.15 0.24 0.98 
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Table 5 (cont.) 
 
Strains Deleted 
gene/region 
Function Bacteremia 
CI 
Pneumonia 
CI 
Growth 
competition 
CI 
ALLOLYSIS 
AD1737 (∆lytA) lytA Autolysin 0.53 0.16 1.13 
AD2028 (∆cbpD) cbpD Lysozyme 0.43 0.35 0.92 
AD0132 
(∆spd_0132-0133) 
spd_0132-01
33 
Bacteriocins 0.5 0.37 1.18 
COMPETENCE REGULATION AND DNA PROCESSING 
AD1122 (∆dprA) dprA DNA processing protein 0.07 0.01 0.77 
UNKNOWN 
AD0975 (∆radC) radC Unknown 0.1 0.78 1.02 
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CHAPTER 6: GENERAL CONCLUSION AND DISCUSSION 
At the beginning of my graduate studies, I proposed two research aims: (i) to explore the 
possibility of inhibiting competence development in pneumococcus; (ii) to explore the 
relationship between pneumococcal competence and virulence. For the first aim, I have 
identified CSP1-E1A, a CSP1 analog that inhibits competence development in a dose dependent 
manner. For the second aim, I have demonstrated that ComX, the competence specific sigma 
factor, and 13 of its regulated genes are important for infection. Two additional findings were also 
obtained. Firstly, I discovered pneumococcal nuclease EndA has two distinct kinds of activities, 
namely, “competence dependent activity” and “competence independent activity”. Secondly, I 
showed that a small RNA gene that overlaps with the late competence gene dut is required for 
optimal growth, virulence and genetic transformation of pneumococcus.  
Competence development in S. pneumoniae is initiated by the interaction between CSP 
and ComD. I hypothesized that inhibitors capable of disrupting the CSP-ComD interaction could 
effectively inhibit competence development. I conducted a saturated alanine scanning 
mutagenesis on CSP1, aiming to find an analog that competitively outcompetes CSP1 and 
reduces competence development. I showed that CSP1-E1A, an analog of CSP1, which was 
generated by substituting the glutamate in the first position into alanine, is able to reduce 
competence in a dose dependent manner. CSP1-E1A competitively inhibits the acquisition of an 
antibiotic resistance gene and capsule gene important for virulence during pneumococcal 
bacteremia. In addition, CSP-E1A delays the death of mice during pneumococcal pneumonia. 
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However, the abovementioned findings do not necessarily mean CSP1-E1A and other inhibitory 
analogs could be directly used to treat pneumococcal infections in humans. First of all, the 
stability of linear peptide such as CSP1 analogs in human lung and serum, is unknown. Secondly, 
using large amount of peptides of bacterial origin also raises safety concerns in humans. Future 
efforts need to explore alternative ways to inhibit competence regulon. A vaccine that targets 
CSPs is a potential option. CSPs are secreted peptide. It is accessible to antibodies in the 
environment. According to our unpublished result, CSP covalently conjugated to keyhole limpet 
hemocyanin is very effective in inducing neutralizing antibody against CSP in rabbit. If CSP 
antibody is effective in inhibiting pneumococcal competence development during infection, CSP 
could be considered to be included as one component of future pneumococcal vaccines.  
When I started thinking about the connections between competence and virulence in 
pneumococcus, I came across a paper describing the contribution of pneumococcus 
endonuclease EndA to virulence (Beiter et al., 2006). The authors show that EndA is required 
and sufficient for the degradation of NETs and infection. Prior to this publication, the major role of 
EndA was believed to be degrading one strand of donor DNA during competence for genetic 
transformation (Berge et al., 2002). Because EndA is a membrane protein, it is unable to access 
extracellular DNA without the help of DNA uptake apparatus (Berge et al., 2002). This suggests 
that, in theory, EndA could only gain access to DNA only during competence state. This 
prompted me to examine if EndA-mediated DNA degradation by competent pneumococcus 
could explain the connection between competence and virulence. My results, however, 
disproved this hypothesis. Instead, I showed that EndA has two distinct forms of activity: (i) the 
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“competence dependent” and (ii) the “competence independent”. The “competence-dependent 
EndA activity” is mediated by pneumococcal cell membrane associated EndA molecules. It could 
only be detected during competence state and is required for genetic transformation. The 
“competence-independent EndA activity” is mediated by secreted form of EndA. Importantly, I 
showed that “competence-independent EndA activity” is required for degrading NETs, as well as 
infection, while “competence-dependent EndA activity” is not. These results lead me to conclude 
that competence-induced DNA degradation could not explain the connections between 
competence and virulence. During the course of EndA studies, I also showed that the 
“competence-independent EndA activity” is culture medium-dependent. Further study showed 
that pneumococcal cells growing in THB release more EndA molecules into the medium than 
pneumococcal cells growing in CTM. CTM is widely used during pneumococcus transformation 
experiments. Because the “competence-independent EndA” degrades donor DNA randomly and 
reduces transformation efficiency, it is conceivable that higher transformation efficiency could be 
achieved in CTM where donor DNA could survive for longer period of time. Because the secreted 
form of EndA is responsible for its “competence-independent activity”, it will be intriguing to study 
how and why EndA, a typical membrane protein, is released into the environment. One 
possibility is that when pneumococcus is growing in rich medium such as THB, the expression 
level of EndA is so high that it exceeds the capacity of pneumococcal membrane to hold proteins. 
In contrast, for pneumococcal cells grown in the CTM, because the expression level of EndA is 
low, majority of the endonuclease molecules are associated with cell membrane. Under this 
condition, relatively smaller amount of EndA could be released. If this is true, future efforts should 
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also be made to study the regulation of EndA expression by nutritional factors.  
If competence-mediated DNA degradation is not the missing link between competence and 
virulence, other possibilities should be explored. ComX expression triggers many key events 
during competence, including DNA uptake and integration, allolysis and competence shutoff. I 
examined whether ComX plays any role in virulence. There are two identical copies of comX 
genes in the pneumococcal genome, namely, comX1 and comX2. I showed that deletion of 
comX1 or comX2 alone did alter the fitness of mutants during infection. However, deletion of both 
comX1 and comX2 genes rendered the mutant less virulent in both acute pneumonia and sepsis 
models of infection. These results suggest ComX is required for the fitness of pneumococcus 
during infection, and prompted me to study if ComX-regulated genes play any role in infection. 
During competence state, ComX initiates or up-regulates the expression of about 80 “late” 
competence genes. By performing deletion analyses, and in vivo competition assay and single 
infections, I identified 13 ComX regulated genes that are important for infection. Among them, 
cbpD, cibAB and lytA, the three genes required for allolysis are all important for infection, 
suggesting partial cell lysis during competence contributes to pneumococcal fitness during 
infection. ∆cbpD and ∆cibAB are both moderately attenuated for infection. Knocking out both 
cbpD and cibAB does not further attenuate the virulence, suggesting CbpD and CibAB may 
function within the same pathway. Similar to previous report (Orihuela et al., 2004), ∆lytA is 
severely attenuated during single lung infection (Figure 32). ∆cbpD∆lytA and ∆cibAB∆lytA are 
more attenuated than ∆lytA. ∆cbpD∆cibAB∆lytA doesn’t seem to be more attenuated than 
∆cbpD∆lytA or ∆cibAB∆lytA (Figure 32). These results suggest that LytA functions in an 
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independent pathway but acts additively with CbpD or CibAB to cause host infections.  
Another gene important for virulence is DprA. During transformation, DprA binds to ssDNA 
and delivers it to RecA for recombination (Mortier-Barriere et al., 2007). DprA is also required for 
competence shutoff (Mirouze et al., 2013, Weng et al., 2013). DprA deficient strain has difficulty 
exiting from the competence state and has growth defect when stimulated with the CSP. Further 
study suggested that DprA contributes to bacterial fitness during infection by regulating 
physiological exit from the competence state, rather than by processing DNA. This result 
suggests that the competence system of pneumococcus needs to be tightly regulated for optimal 
fitness during infection, and that prolonged period of competence induction is detrimental to the 
bacteria. It would be interesting to unravel what causes ∆dprA’s conditional growth defect during 
both in vitro growth in the presence of CSP and attenuation of virulence during infection. 
Because the expression of DprA is dependent on ComX, deletion of both comX1 and comX2 
should abolish the expression of DprA. However, the phenotypes of ∆comX1∆comX2 and ∆dprA 
are different in the following two aspects. First, ∆dprA has growth defect when stimulated with 
CSP, while ∆comX1∆comX2 has no growth defect. Second, ∆dprA is much more attenuated than 
∆comX1∆comX2 during infection. It is possible that unregulated overexpression of some of the 
late competence genes (e.g., allolysis genes) in ∆dprA mutant in the presence of CSP is 
responsible for its unique phenotype in vitro and in vivo.  
Among the attenuated late competence gene deletion mutants, I had noticed that some 
strains were more attenuated than ∆comX1∆comX2. For example, ∆spd_0981, ∆spd_1778 and 
∆spd_0030 are more attenuated than the ∆comX1∆comX2 during competition with D39 (Table 5). 
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This prompt me to study if the attenuation of these mutants could be used to explain the 
attenuation of ∆comX1∆comX2. Further study indicates the contribution of these genes to 
virulence is not dependent on ComX expression. Knocking out these gene decreases the fitness 
of mutants in both wild type background and comX null background. This result indicates the 
expression of these genes is not entirely dependent on competence. Although the expression 
level of these genes could be enhanced by ComX during competence, it seems the baseline 
expression of these genes is more important for infection. Question still remains on why 
pneumococcus enhances the expression of these genes during competence. Genes such as the 
∆spd_0981, ∆spd_1778 and ∆spd_0030 are dispensable for genetic transformation. Also, the 
enhanced expression of these genes during competence does not seems to benefit 
pneumococcus during infection. It is possible that the contribution of enhanced expression of an 
individual gene during competence is small, but the cumulatively, these “small benefits” may 
make a big contribution to pneumococcal fitness in the host. It would be interesting to delete all 
the combox before genes like ∆spd_0981, ∆spd_1778 and ∆spd_0030 and see if the induction of 
these genes plays any role in competence and virulence. 
One serendipitous discovery was obtained when making the dut gene knockout mutant. dut 
(spd_0027) is the first gene of a late competence operon with “unconventional combox” (Figure 
35A). Replacement of the entire dut gene with kanamycin resistance marker rendered the mutant 
(AD0027) with moderate growth defects in the Todd Hewitt broth (THB), abolished genetic 
transformation, and severely attenuated competitiveness during bacteremia model of infection 
(Figure 34B-34E). Careful bioinformatic analyses revealed that the 5’end of the dut gene partially 
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overlaps with a small RNA gene, scRNA. Thus, deletion of the entire dut gene in AD0027 also 
compromised the integrity of the scRNA gene. Further study suggested that scRNA rather than 
dut is required for optimal growth, genetic transformation, and virulence of pneumococcus. 
scRNA is one component of signal recognition particle which is required for the inserting some of 
the membrane proteins. It would be interesting to explore which proteins are missing from the 
cell membrane of scRNA deficient mutant and which of them are required for optimal growth, 
virulence or genetic transformation. My unpublished preliminary data showed that comX and 
cbpD could still be induced by CSP in scRNA deficient strain, suggesting genetic transformation 
is blocked in the final step, the DNA uptake. It is likely that due to the deficiency of inserting 
certain membrane proteins, DNA uptake apparatus cannot be assembled in scRNA mutant.  
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SUPPLEMENTARY INFORMATION  
 
Strain ID (strain serial number and phenotype designation), antibiotic resistance markers, and 
source are listed in Table S1. For the strains constructed in this work, primers used and 
schematic drawing of strain constructions could be found according to the page numbers.  
 
Antibiotic marker abbreviations: Kan: Kanamycin; Erm: Erythromycin; Cm: Chloramphenicol; Spc: 
Spectinomycin.  
 
Table S1. S. pneumoniae strains used in this study. (Both serial numbers and genotype 
designations are given to strains made in this work. Genotype designations are used in 
the text and figures for reader’s convenience) 
Strains Genotype Source 
D39 Wild-type (Avery et al., 1979) 
R6 A capsule-deficient derivative of D39 (Avery et al., 1944) 
TIGR4 Wild-type (Tettelin et al., 2001) 
0100993 Serotype 3 clinical isolate (Lau et al., 2001) 
CPM3 
R6 with a promoterless lacZ reporter 
gene fused behind the comX promoter 
(Lee and Morrison, 
1999) 
CP1296 
R6 strain with a modified rpsL gene that 
confers resistance to streptomycin 
(Sung et al., 2001) 
AD0014 (∆comX1) D39, but ∆comX1::Kan; KanR Page 154   
AD0026 (∆scRNA) D39, but scRNA::Kan; KanR Page 155 
AD0027 (∆dut) D39, but ∆dut::Kan; KanR Page 156 
AD0027-1 (∆dut) D39, but ∆dut::Kan; KanR Page 157 
AD0028 (∆spd_0028) D39, but ∆spd_0028::Kan; KanR Page 158 
AD0029 (∆radA) D39, but ∆radA::Kan; KanR Page 159 
AD0030 (∆spd_0030) D39, but ∆spd_0030::Kan; KanR Page 160 
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Table S1. (cont.) 
Strains Genotype Source 
AD0031 (∆spd_0031) D39, but ∆spd_0031::Kan; KanR Page 161 
AD0032 (∆spd_0032) D39, but ∆spd_0032::Kan; KanR Page 162 
AD0035 (∆spd_0035-0037) D39, but ∆spd_0035-0037::Kan; KanR Page 163 
AD0049 (∆comA) D39, but ∆comA::Kan; KanR Page 164 
AD0050 (∆comB::pID701) D39, but ∆ comB::pID701; CmR Page 165 
AD0133 (∆cibAB) D39, but ∆cibAB::Kan; KanR Page 166 
AD0186 (∆ccs4) D39, but ∆ccs4::Kan; KanR Page 167 
AD0636 (∆spxB) D39, but ∆spxB:: Kan; KanR Page 168 
AD0688 (∆spd_0683) D39, but ∆spd_0683:: Kan; KanR Page 169 
AD0843 (∆celA-celB) D39, but ∆celA-celB:: Kan; KanR Page 170 
AD0845 (∆spd_0845-0846) D39, but ∆spd_0845-0846:: Kan; KanR Page 171 
AD0865 (∆coiA) D39, but ∆coiA:: Kan; KanR Page 172 
AD0866 (∆pepF-prsA) D39, but ∆pepF-prsA::Spc; SpcR Page 173 
AD0975 (∆radC) D39, but ∆radC:: Kan; KanR Page 174 
AD0980 (∆prs2) D39, but ∆prs2:: Kan; KanR Page 175 
AD0981 (∆spd_0981) D39, but ∆spd_0981:: Kan; KanR Page 176 
AD1122 (∆dprA) D39, but ∆dprA:: Kan; KanR Page 177 
AD1310 (∆spd_1310-1308) D39, but ∆spd_1310-1308:: Kan; KanR Page 178 
AD1593 (∆cclA) D39, but ∆cclA:: Kan; KanR Page 179 
AD1711 (∆ssbB) D39, but ∆ssbB:: Erm; ErmR Page 180 
AD1737 (∆lytA) D39, but ∆lytA:: Kan; KanR Page 181 
 
 
151 
 
Table S1. (cont.) 
Strains Genotype Source 
AD1737-1 (∆lytA) D39, but ∆lytA::Erm; ErmR Page 182 
AD1738 (∆dinF) D39, but ∆lytA:: Kan; KanR Page 183 
AD1739 (∆recA) D39, but ∆recA:: Kan; KanR Page 184 
AD1739-1 (∆p2) D39, but ∆recA promoter:: Kan; KanR Page 185 
AD1740 (∆cinA) D39, but ∆cinA:: Kan; KanR Page 186 
AD1740-1 (∆cinbox) D39, but ∆cinbox:: Kan; KanR Page 187 
AD1762 (∆endA) D39, but ∆endA:: Kan; KanR Page 188 
AD1777 (∆cbf1) D39, but ∆cbf1:: Kan; KanR Page 189 
AD1778 (∆spd_1778) D39, but ∆spd_1778:: Kan; KanR Page 190 
AD1818 (∆comX2) D39, but ∆comX2:: Kan; KanR Page 191 
AD1818-1 (∆comX2) D39, but ∆comX2::Erm; ErmR Page 192 
AD1828 (∆spd_1828) D39, but ∆spd_1828:: Kan; KanR Page 193 
AD1855 (∆spd_1855-1854) D39, but ∆spd_1855-1854:: Kan; KanR Page 194 
AD1863 (∆cglA-G) D39, but ∆cglA-G:: Kan; KanR Page 195 
AD2027 (∆spd2027-2024) D39, but ∆spd2027-2024:: Kan; KanR Page 196 
AD2028 (∆cbpD) D39, but ∆cbpD:: Kan; KanR Page 197 
AD2028-1 (∆cbpD::pEVP3) D39, but ∆cbpD::pEVP3; CmR Page 198 
AD2033 (∆raiA) D39, but ∆raiA:: Kan; KanR Page 199 
AD2035 (∆cflA-F) D39, but ∆cflA-cflF:: Kan; KanR Page 200 
AD2064 (∆comCDE) D39, but ∆comCDE:: Kan; KanR Page 201 
AF1928 (∆cibAB∆lytA) D39, but ∆cibAB::Kan, ∆lytA::Erm; KanR, ErmR Page 202 
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Table S1. (cont.) 
Strains Genotype Source 
AG1762 (∆endA) 0100993, but ∆endA:: Kan; KanR Page 188 
AG2236 (∆comD) 0100993, but ∆comD:: Kan; KanR Page 203 
AT1762 (endA) TIGR4, but ∆endA:: Kan; KanR Page 188 
AT2236 (TIGR4 comD) TIGR4, but ∆comD:: Kan; KanR Page 203 
AR1779 (∆endA) R6, but ∆endA:: Kan; KanR Page 188 
AR2042 (∆comD) R6, but ∆comD:: Kan; KanR Page 203 
CD1880 (∆cibAB∆cbpD) 
 
D39, but ∆cibAB::Kan, ∆cbpD::pEVP3; 
KanR, CmR 
Page 204 
EB1890 
(∆cibAB∆comX1∆comX2) 
D39, but ∆cibAB::Kan, ∆comX1::pEVP3, 
∆comX2::Erm; KanR, CmR, ErmR 
Page 205 
EJ1796 
(∆spd_0981∆comX1∆comX2) 
D39, but ∆spd_0981::Kan, 
∆comX1::pEVP3, ∆comX2::Erm; KanR, 
CmR, ErmR 
Page 206 
FG1928 (∆cibAB∆cbpD∆lytA) 
D39, but ∆cibAB::Kan, ∆cbpD::pEVP3, 
∆lytA::Erm; KanR, CmR, ErmR 
Page 207 
FS1975 (∆comX1∆comX2) 
D39, but ∆comX1::Kan, ∆comX2::Erm; 
KanR, ErmR 
Page 208 
GM1856 
(∆radC∆comX1∆comX2) 
D39, but ∆radC::Kan, ∆comX1::pEVP3, 
∆comX2::Erm; KanR, CmR, ErmR 
Page 209 
GG1602 
(∆cinbox∆comX1∆comX2) 
D39, but ∆cinbox::Kan, ∆comX1::pEVP3, 
∆comX2::Erm; KanR, CmR, ErmR 
Page 210 
GW1941 (∆cbpD∆lytA) 
D39, but ∆cbpD::pEVP3, ∆lytA::Erm; CmR, 
ErmR 
Page 211 
IN1643 (D39pcomX::lacZ) D39, but ∆comX1::pEVP3, CmR Page 212 
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Table S1. (cont.) 
Strains Genotype Source 
IN1643-2 
(TIGR4pcomX::lacZ) 
TIGR4, but ∆comX1::pEVP3, CmR Page 212 
JC0923   
D39, but ∆comA::Kan, ∆comX1::pEVP3;  
KanR, CmR 
Page 213 
KF1940 
(∆cbpD∆comX1∆comX2) 
D39, but ∆cbpD::Kan, ∆comX1::pEVP3, 
∆comX2::Erm; KanR, CmR, ErmR 
Page 214 
KM1983 (∆comX1∆comX2) 
D39, but ∆comX1::pEVP3, ∆comX2::Erm; 
CmR, ErmR 
Page 215 
LP1861 (∆dprA∆comB) D39, but ∆dprA::Kan, ∆comB::Cm; KanR, CmR Page 216 
RH1665 
(∆spd_0031∆comX1∆comX2) 
D39, but ∆spd_0031::Kan, ∆comX1::pEVP3, 
∆comX2::Erm; KanR, CmR, ErmR 
Page 217 
ST2012 (∆cap3A) D39, but ∆cap3A::Kan, KanR Page 218 
TY1805 (∆spxB∆recA) 
D39, but ∆spxB::Erm, ∆recA::Kan; ErmR, 
KanR 
Page 219 
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Strategy for constructing mutants 
Strain ID: AD0014 (∆comX1) 
Gene deleted: comX1 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
comx1-1 CACGTGCAATGGTTACAGAGTACGG 
comx1-2 ACATTATCCATTAAAAATCAAACCCACAGTCCCTTGGACTTCTTCATAC 
comx1-3  GTATGAAGAAGTCCAAGGGACTGTGGGTTTGATTTTTAATGGATAATGT 
comx1-4 CTCCTTAAACACAATGCGTAAGTCTTGGGCCCTAGGTACTAAAACAA 
comx1-5 TTGTTTTAGTACCTAGGGCCCAAGACTTACGCATTGTGTTTAAGGAG 
comx1-6 TTGCATGTATTAGGCACGCCGCCAG 
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Strain ID: AD0026 (∆scRNA) 
Gene deleted: scRNA 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
Dut1 GAG TGA GGA GAG CTG GCG CTT GCT G 
Dut2-2 ACATTATCCATTAAAAATCAAACCCTCCACTATTTATTATATCACATTC 
Dut3-2 GAATGTGATATAATAAATAGTGGAGGGTTTGATTTTTAATGGATAATGT 
Dut4-2  CAATTCAAAACCACGAATTTTCATAATCCATGGGCCCTAGGTACTAAAACAA 
Dut5-2 TTGTTTTAGTACCTAGGGCCCATGGATTATGAAAATTCGTGGTTTTGAATTG 
Dut6 TTG GCA CAA ACT GGC GCA TGA GCA T 
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Strain ID: AD0027 (∆dut) 
Gene deleted: dut 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
Dut1 GAG TGA GGA GAG CTG GCG CTT GCT G 
Dut2 ACATTATCCATTAAAAATCAAACCCAATTCAAAACCACGAATTTTCATAAT 
Dut3  ATTATGAAAATTCGTGGTTTTGAATTGGGTTTGATTTTTAATGGATAATGT 
Dut4  TCGAACGCCATCAGCTGCATCTCCATGGGCCCTAGG TACTAAAACAA 
Dut5 TTGTTTTAGTACCTAGGGCCCATGGAGATGCAGCTGATGGCG TTC GA 
Dut6 TTG GCA CAA ACT GGC GCA TGA GCA T 
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Strain ID: AD0027-1 (∆dut) 
Gene deleted: dut 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences  
Dut1 GAG TGA GGA GAG CTG GCG CTT GCT G  
Dut2-1 ACA TTA TCC ATT AAAAATCAAACCTGCGCTGTCTCACGCTTGGGCAATA  
Dut3-1  TATTGCCCAAGCGTGAGACAGCGCAGGTTTGATTTTTAATGG ATA ATGT  
Dut4  TCGAACGCCATCAGCTGCATCTCCATGGGCCCTAGG TACTAAAACAA  
Dut5 TTGTTTTAGTACCTAGGGCCCATGGAGATGCAGCTGATGGCG TTCGA  
Dut6 TTG GCA CAA ACT GGC GCA TGA GCA T  
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Strain ID: AD0028 (∆spd_0028) 
Gene deleted: spd_0028 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
SPD0028-1 GAGCGTCTTAACCATCGTGTAGAGG 
SPD0028-2 TTGTTTTAGTACCTAGGGCCCACCTCTACACGATGGTTAAGACGCTC 
SPD0028-3  GAGCGTCTTAACCATCGTGTAGAGGTGGGCCCTAGGTACTAAAACAA 
SPD0028-4  CTTTGCGATGACAAACCTCTTTCTAGGTTTGATTTTTAATGGATAATGT 
SPD0028-5 ACATTATCCATTAAAAATCAAACCTAGAAAGAGGTTTGTCATCGCAAAG 
SPD0028-6 GCCAACTGCATGAGTTCAGCGGTCA 
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Strain ID: AD0029 (∆radA) 
Gene deleted: radA 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
RadA1 TATGAGACAGCTACGGAAATGAAGT 
RadA2 TTGTTTTAGTACCTAGGGCCCAAGAGTTGATTTCCCAATCCCAGGAT 
RadA3  ATCCTGGGATTGGGAAATCAACTCTTGGGCCCTAGGTACTAAAACAA 
RadA4 CGTTGATGCGTTGCTCAATACGATTGGTTTGATTTTTAATGGATAATGT 
RadA5 ACATTATCCATTAAAAATCAAACCAATCGTATTGAGCAACGCATCAACG 
RadA6 CATTTGTTGCTGGGAAATAACTAGC 
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Strain ID: AD0030 (∆spd_0030) 
Gene deleted: spd_0030 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
0030-1 TGCCAAGCGTACTACGACAGGACTT 
0030-2 ACATTATCCATTAAAAATCAAACCGATTTAACTGCCCATGTAGGGCAAC 
0030-3  GTTGCCCTACATGGGCAGTTAAATCGGTTTGATTTTTAATGGATAATGT 
0030-4  GCACCAGAGATAATGACATCGTCTGCTGGGCCCTAGGTACTAAAACAA 
0030-5 TTGTTTTAGTACCTAGGGCCCAGCAGACGATGTCATTATCTCTGGTGC 
0030-6 AACAAGTGGCAATAATTTCAAGGGT 
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Strain ID: AD0031 (∆spd_0031) 
Gene deleted: spd_0031 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
0031-1 TGCCACTTAAACCCAAAACAAGAGT 
0031-2 ACATTATCCATTAAAAATCAAACCCCGTCCGTATAGTAGATGGTTTCAT 
0031-3  ATGAAACCATCTACTATACGGACGGGGTTTGATTTTTAATGGATAATGT 
0031-4  AGACCCTGTTTCTTGCCAACCTTCTCTGGGCCCTAGGTACTAAAACAA 
0031-5 TTGTTTTAGTACCTAGGGCCCAGAGAAGGTTGGCAAGAAACAGGGTCT 
0031-6 CAAGCAGATTGTCATTTACAGGCGA 
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Strain ID: AD0032 (∆spd_0032) 
Gene deleted: spd_0032 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
0032-1 TGCGGAATATGGACTAATGGGAGTT 
0032-2 ACATTATCCATTAAAAATCAAACCCCCTGTTTCTTGCCAACCTTCTGTC 
0032-3  GACAGAAGGTTGGCAAGAAACAGGGGGTTTGATTTTTAATGGATAATGT 
0032-4  CGCTTTTTGCACTATTTTTCAATCACTGGGCCCTAGGTACTAAAACAA 
0032-5 TTGTTTTAGTACCTAGGGCCCAGTGATTGAAAAATAGTGCAAAAAGCG 
0032-6 GCAGCATGCAAGTCGATGGTCAATA 
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Strain ID: AD0035 (∆spd_0035-0037) 
Gene deleted: spd_0035-0037 
Antibiotic resistance cassette: Kan 
D39 transformed with genomic DNA of CP1295 (Peterson et al., 2004) 
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Strain ID: AD0049 (∆comA) 
Gene deleted: comA 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
ComA-1 CAATTGGTTTCCGCACTCAGGGCAA 
ComA-2 ACATTATCCATTAAAAATCAAACCTCCCATCCATGGTCGTCTTAGCCAA 
ComA-3  TTGGCTAAGACGACCATGGATGGGAGGTTTGATTTTTAATGGATAATGT 
ComA-4  AACCACCTTCTCTGTCCGCTCAGCATGGGCCCTAGGTACTAAAACAA 
ComA-5 TTGTTTTAGTACCTAGGGCCCATGCTGAGCGGACAGAGAAGGTGGTT 
ComA-6 TTGACTGATGAGGTTGCCGATTTCG 
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Strain ID: AD0050 (∆comB::pID701) 
Gene inactivated: comB 
Antibiotic resistance cassette: Cm 
D39 transformed with genomic DNA of STM strain C12-4 (Lau et al., 2001). 
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Strain ID: AD0133 (∆cibAB) 
Gene deleted: cibAB 
Antibiotic resistance cassette: Kan 
D39 transformed with genomic DNA of CP1279 (Peterson et al., 2004) 
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Strain ID: AD0186 (∆ccs4) 
Gene deleted: ccs4 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
0186-1 AGA CCT ATT TTT CTT GTC TTT TAC G 
0186-2 ACATTATCCATTAAAAATCAAACGGGGCGCAAACCTTGACTTCCATAATAGTC 
0186-3  GACTATTATGGAAGTCAAGGTTTGCGCCCCGTTTGATTTTTAATGGATAATGT 
0186-4 TCCTCAGTTGCTGTATAGTGCAACG ACGTGGGCCCTAGGTACTAAAACAA 
0186-5 TTGTTTTAGTACCTAGGGCCCACGT CGTTGCACTATACAGCAACTGAGGA 
0186-6 TGA ATT TCG TAA ATC TTA ATT CCC T 
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Strain ID: AD0636 (∆spxB) 
Gene deleted: spxB 
Antibiotic resistance cassette: Erm 
The PCR amplicon is prepared from IU2181 (∆spxB::Pcerm) (Ramos-Montanez et al., 2008) with 
primers SR11 (cttctcaacacccactggctgaggc) and SR14 (catttattcctccatacacaccagagatg) and then 
transformed into D39. 
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Strain ID: AD0688 (∆spd_0683) 
Gene deleted: spd_0683 
Antibiotic resistance cassette: Kan 
D39 transformed with genomic DNA of CP1773 (Peterson et al., 2004) 
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Strain ID: AD0843 (∆celA-celB) 
Gene deleted: celA and celB 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
cel-1 TAGACCTGTAACTTTGGATGATGCG 
cel-2 TTGTTTTAGTACCTAGGGCCCTGATTTTCTCGATAATTGCTTCCAT 
cel-3  ATGGAAGCAATTATCGAGAAAATCAGGGCCCTAGGTACTAAAACAA 
cel-4  CCTTAACCCCATGTTGAGCCAGTAGTTTGATTTTTAATGGATAATGT 
cel-5 ACATTATCCATTAAAAATCAAACTACTGGCTCAACATGGGGTTAAGG 
cel-6 CTTTCTCCTTGCCCCACATCCAGCA 
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Strain ID: AD0845 (∆spd_0845-0846) 
Gene deleted: spd_0845-0846 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
0845-1 TGGGAAATTCTTGGATAAGCAATTT 
0845-2 TTGTTTTAGTACCTAGGGCCCAAAGCATACTGATGGTCGTGATAGTT 
0845-3 AACTATCACGACCATCAGTATGCTTTGGGCCCTAGGTACTAAAACAA 
0845-4 TCCTTTTTACGTGAACTTCCCCATCGGTTTGATTTTTAATGGATAATGT 
0845-5 ACATTATCCATTAAAAATCAAACCGATGGGGAAGTTCACGTAAAAAGGA 
0845-6 CGAACTTCTTTCACAGTAACAACGC 
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Strain ID: AD0865 (∆coiA) 
Gene deleted: coiA 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
coiA-1 GTTGGCCTTTACGATATCAATTCAG 
coiA-2 ACATTATCCATTAAAAATCAAACCTCCTTGACGCAAATGGAGCTGGCCT 
coiA-3 AGGCCAGCTCCATTTGCGTCAAGGAGGTTTGATTTTTAATGGATAATGT 
coiA-4  AAAAGTGCTGATAATAGCTAGTCAACTGGGCCCTAGGTACTAAAACAA 
coiA-5 TTGTTTTAGTACCTAGGGCCCAGTTGACTAGCTATTATCAGCACTTTT 
coiA-6 ATAAACCTGCAGCTTTGGTTGAGCT 
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Strain ID: AD0866 (∆pepF-prsA) 
Gene deleted: pepF, spd_0867 and prsA 
Antibiotic resistance cassette: Spc 
D39 transformed with genomic DNA of pepF, SPD_0867 and prsA knockout strain CP1335 
(Peterson et al., 2004) 
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Strain ID: AD0975 (∆radC) 
Gene deleted: radC 
Antibiotic resistance cassette: Kan 
D39 transformed with genomic DNA of radC knockout strain CP1338 (Peterson et al., 2004) 
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Strain ID: AD0980 (∆prs2) 
Gene deleted: prs2 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
prs2-1 GCA ACT AAA AGA TGC TGA GAA CTA T 
prs2-2 ACATTATCCATTAAAAATCAAACGGTTCCAAGTGGGACACCAACAGCTTG 
prs2-3 CAAGCTGTTGGTGTCCCACTTGGAACCGTTTGATTTTTAATGGATAATGT 
prs2-4  AAGATAGCTTTCTTACCTTCAACATACGTGGGCCCTAGGTACTAAA ACA A 
prs2-5 TTGTTTTAGTACCTAGGGCCCACGTATGTTGAAGGTAAGA AAGCTATCTT 
prs2-6 CAC CAG AAG TGA AAA AGA TAT GTT G 
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Strain ID: AD0981 (∆spd_0981) 
Gene deleted: spd_0981 
Antibiotic resistance cassette: Kan 
D39 transformed with genomic DNA of spd_1981 knockout strain CP1273 (Peterson et al., 2004) 
 
 
177 
 
 
Strain ID: AD1122 (∆dprA) 
Gene deleted: dprA 
Antibiotic resistance cassette: Kan 
D39 transformed with genomic DNA of dprA knockout strain CP1389 (Peterson et al., 2004) 
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Strain ID: AD1310 (∆spd_1310-1308) 
Gene deleted: spd_1310-1308 
Antibiotic resistance cassette: Kan 
D39 transformed with genomic DNA of CP1775 (Peterson et al., 2004) 
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Strain ID: AD1593 (∆cclA) 
Gene deleted: cclA 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
cclA-1 GTGCTTCAACCATTTGAACGATTTC 
cclA-2 ACATTATCCATTAAAAATCAAACCGAAAGGAAGCTAGAATGCTCCCGAC 
cclA-3  GTCGGGAGCATTCTAGCTTCCTTTCGGTTTGATTTTTAATGGATAATGT 
cclA-4  AGTAGCAAGTAAGAGGAAAGGCACGCTGGGCCCTAGGTACTAAAACAA 
cclA-5 TTGTTTTAGTACCTAGGGCCCAGCGTGCCTTTCCTCTTACTTGCTACT 
cclA-6 GAGAGGGTTGGCAAGCGTGTCAGCA 
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Strain ID: AD1711 (∆ssbB) 
Gene deleted: ssbB 
Antibiotic resistance cassette: Erm 
D39 transformed with genomic DNA of ssbB knockout strain CP1857 (Bhushan V. Desai, PhD 
thesis, University of Illinois at Chicago, 2005) 
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Strain ID: AD1737 (∆lytA) 
Gene deleted: lytA 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
lytA-1 TGGGCAGGATATAAGGGTGTTATCC 
lytA-2 ACATTATCCATTAAAAATCAAACCCATTTTTTACAATCCAGAACCAGAA 
lytA-3 TTCTGGTTCTGGATTGTAAAAAATGGGTTTGATTTTTAATGGATAATGT 
lytA-4 TTACTGTAATCAAGCCATCTGGCTCCTGGGCCCTAGGTACTAAAACAA 
lytA-5 TTGTTTTAGTACCTAGGGCCCAGGAGCCAGATGGCTTGATTACAGTAA 
lytA-6 TGGCAATCATGCTTTGATTCAAAGA 
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Strain ID: AD1737-1 (∆lytA) 
Gene deleted: lytA 
Antibiotic resistance cassette: Erm 
Primers used to construct this mutant: 
primers primer sequences 
LytA2-1 CTTCTTGGCTAGTTCGACAGATGGT 
LytA2-2 CAAATCAAACAAATTTTGGGCCCGGTAAATAGGACTGACAAGGTCTGCAT 
LytA2-3  ATGCAGACCTTGTCAGTCCTATTTACCGGGCCCAAAATTTGTTTGATTTG 
LytA2-4 GACCTAATAATATGCGCTGTTCTGAAGTCGGCAGCGACTCATAGAATTAT 
LytA2-5 ATAATTCTATGAGTCGCTGCCGACTTCAGAACAGCGCATATTATTAGGTC 
LytA2-6 GGCGCTTCACCATCAGCTCCCAACT 
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Strain ID: AD1738 (∆dinF) 
Gene deleted: dinF 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
dinF1 AGC AGT GAA TGA AGA AGT TCC GCT T 
dinF2 TTGTTTTAGTACCTAGGGCCCAAA AAA TAT TTG ATAGCA AGA TTGGA 
dinF3 TCCAATCTTGCTATCAAATATTTTTTGGGCCCTAGGTACTAA AAC AA 
dinF4  CACCCTTATATCCTGCCCAAGGAATGGTTTGATTTTTAATGGATAATGT 
dinF5 ACATTATCCATTAAAAATCAAACCATTCCTTGGGCAGGATATAAGGGTG 
dinF6 AAT CCG CTT CAT TCT GTA CGG TTG A 
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Strain ID: AD1739 (∆recA) 
Gene deleted: recA 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
REC1 GAA CTG AAA AGG CAA GGG AAA ACC A 
REC2 TTGTTTTAGTACCTAGGGCCCACCGCACGTTCACCCAAACGCATGAT 
REC3 ATCATGCGTTTGGGTGAACGTGCGGTGGGCCCTAGGTACTAAAACAA 
REC4 AAG CGG AACTTCTTCATTCACTGCTGGTTTGATTTTTAATGGATA ATGT 
REC5 ACATTATCCATTAAAAATCAAACCAGCAGTGAATGAAGAAGT TCCGCTT 
REC6 AAA AAT ATT TGA TAG CAA GAT TGG A 
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Strain ID: AD1739-1 (∆p2) 
Deleted: recA promoter 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
recA pro-1 GCCAGACTTTCGAAGGAATTTCTTT 
recA pro-2 TTGTTTTAGTACCTAGGGCCCAGATATCAAAAGTTAGTCACTTAATAA 
recA pro-3 TTATTAAGTGACTAACTTTTGATATCTGGGCCCTAGGTACTAAAACAA 
recA pro-4  ATTCTATTCTCCTACATTCTAATGAGGTTTGATTTTTAATGGATAATGT 
recA pro-5 ACATTATCCATTAAAAATCAAACCTCATTAGAATGTAGGAGAATAGAAT 
recA pro-6 TCATCATACGAGCCTGCAAACCAAC 
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Strain ID: AD1740 (∆cinA) 
Gene deleted: cinA 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
CinA-1 AAT GGT GCT AGC TTT ACT TTC TGT A 
CinA-2 TTGTTTTAGTACCTAGGGCCCAGGACAATCTCAGCTAGTTTTTCCGACA A 
CinA-3  TTGTCGGAAAAACTAGCTGAGATTGTCCTGGGCCCTAGGTACTAAAACA A 
CinA-4 AAAGCCTTGCGAACTAGGTTAAAGGGGTTTGATTTTTAATGGATAATGT 
Cina-5 ACATTATCCATTAAAAATCAAACCCCTTTAACCTAGTTCGCAAGGCTTT 
CinA-6 TTG ATA ATA TCC AAA TCG CTT GCA A 
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Strain ID: AD1740-1 (∆cinbox) 
Gene deleted: cinbox 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
cinbox1 CAAAAATTAGTGGATGCAGTAGGAG 
cinbox2 TTGTTTTAGTACCTAGGGCCCAGTTAATTATCTTCATCACCAACAGGT 
cinbox3 ACCTGTTGGTGATGAAGATAATTAACTGGGCCCTAGGTACTAAAACAA 
cinbox4 CAGCAATGATTTCTGCTTTCATGTTGTTTGATTTTTAATGGATAATGT 
cinbox5 ACATTATCCATTAAAAATCAAACAACATGAAAGCAGAAATCATTGCTG 
cinbox6 AACTCGGGAATACAGCTTGCTCCCT 
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Strain ID: AD1762/AG1762/AT1762/AR1779 (∆endA) 
Gene deleted: endA 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
EndA-1 ACTGGTGGTGATGTCTTGATTCGAG 
EndA-2 ACATTATCCATTAAAAATCAAACCTGCTTGATATAATAGCTCCCTGTAG 
EndA-3  CTACAGGGAGCTATTATATCAAGCAGGTTTGATTTTTAATGGATAATGT 
EndA-4  ATCCGAAGACTTGGCTTCAATCTGTTGGGCCCTAGGTACTAAAACAA 
EndA-5 TTGTTTTAGTACCTAGGGCCCAACAGATTGAAGCCAAGTCTTCGGAT 
EndA-6 GCAGCTAAAAGCCAAACAAAAGGAC 
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Strain ID: AD1777 (∆cbf1) 
Gene deleted: cbf1 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
cbf1 AACAAGTACATAGCACCACCTCGGA 
cbf2 ACATTATCCATTAAAAATCAAACGGTTGGGCATCCCAGAGCTTCCCAT 
cbf3  ATGGGAAGCTCTGGGATGCCCAACCGTTTGATTTTTAATGGATAATGT 
cbf4  CTC TCT GAA TTC ACG TGG GCC CTA GGT ACT AAA ACA A 
cbf5 CTC TCT GAA TTC GGT GGA TAA AGG AGA GAT GTC CAA T 
cbf6 GCCAGCCCCAGTCACTGTCTGGATA 
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Strain ID: AD1778 (∆spd_1778) 
Gene deleted: spd_1778 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
1778-1 TGGAATTGGCTCTCTTAACCATCTT 
1778-2 ACATTATCCATTAAAAATCAAAC CTGGTCTGACAAATGATCTGCCTGA 
1778-3 TCAGGCAGATCATTTGTCAGACCAG GTTTGATTTTTAATGGATAATGT 
1778-4 CTATGGTACGACGGTTTAATAATTCGGGCCCTAGGTACTAAAACAA 
1778-5 TTGTTTTAGTACCTAGGGCCCGAATTATTAAACCGTCGTACCATAG 
1778-6 CTAATAGCGTCTGCCAAACGCACCA 
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Strain ID: AD1818 (∆comX2) 
Gene deleted: comX2 
Antibiotic resistance cassette: Kan (Sung et al., 2001) 
Primers used to construct this mutant: 
primers primer sequences 
comx2p1 GCACAAACCTACAATATGTTGGATA 
comx2p2 ACATTATCCATTAAAAATCAAACCATTTTCCCCTTTCTAGATACAGTC 
comx2p3  GACTGTATCTAGAAAGGGGAAAATGGTTTGATTTTTAATGGATAATGT 
comx2p4  ATACTCTTTGACGCCCTCGAAATCTGGGCCCTAGGTACTAAAACAA 
comx2p5 TTGTTTTAGTACCTAGGGCCCAGATTTCGAGGGCGTCAAAGAGTAT 
comx2p6 TACTCACCCGTTCGCAACTCATCCA 
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Strain ID: AD1818-1 (∆comX2) 
Gene deleted: comX2 
Antibiotic resistance cassette: Erm (Ramos-Montanez et al., 2008) 
Primers used to construct this mutant: 
primers primer sequences 
comx2beta1 GCACAAACCTACAATATGTTGGATA 
comx2beta2 CAAATCAAACAAATTTTGGGCCCGGATTTTCCCCTTTCTAGATACAGTC 
comx2beta3  GACTGTATCTAGAAAGGGGAAAATCCGGGCCCAAAATTTGTTTGATTTG 
comx2beta4  ATACTCTTTGACGCCCTCGAAATCAGTCGGCAGCGACTCATAGAATTAT 
comx2beta5 ATAATTCTATGAGTCGCTGCCGACTGATTTCGAGGGCGTCAAAGAGTAT 
comx2beta6 TACTCACCCGTTCGCAACTCATCCA 
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Strain ID: AD1828 (∆spd_1828) 
Gene deleted: spd_1828 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
1828-1 AGCAACATTACTTGCAGCTCCTTCC 
1828-2 TTGTTTTAGTACCTAGGGCCCACAAATTGGGAGATTGAAATTCATTTC 
1828-3 GAAATGAATTTCAATCTCCCAATTTGTGGGCCCTAGGTACTAAAACAA 
1828-4 CAAATAGATCAGGATAGTCAAATCGGGTTTGATTTTTAATGGATAATGT 
1828-5 ACATTATCCATTAAAAATCAAACCCGATTTGACTATCCTGATCTATTTG 
1828-6 TGGTTCTCTCATTCAACTCTCACTT 
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Strain ID: AD1855 (∆spd_1855-1854) 
Gene deleted: spd_1855-1854 
Antibiotic resistance cassette: Kan 
D39 transformed with genomic DNA of CP1382 (Peterson et al., 2004) 
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Strain ID: AD1863 (∆cglA-G) 
Deleted genes: cglA-G 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
cgl-1 TATCGTGTTATAGAAATGTACGGAG 
cgl-2 TTGTTTTAGTACCTAGGGCCCCTGATAACGGCTGCAAACTTTTCAA 
cgl-3 TTGAAAAGTTTGCAGCCGTTATCAGGGGCCCTAGGTACTAAAACAA 
cgl-4 GATTCAACGCATTATAGTTGAATTGTTTGATTTTTAATGGATAATGT 
cgl-5 ACATTATCCATTAAAAATCAAACAATTCAACTATAATGCGTTGAATC 
cgl-6 ATCAAATCCATGATGATTAGCTTCT 
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Strain ID: AD2027 (∆spd2027-2024) 
Gene deleted: spd2027-2024 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
ABC1 GGGAGTCTGTGTACAGTCTGAGAGG 
ABC2 TTGTTTTAGTACCTAGGGCCCAAGAAA ACCTGCTAACTGCCAGATTG 
ABC3 CAATCTGGCAGTTAGCAGGTTTTCTTGGGCCCTAGGTACTAA AACAA 
ABC4 CTCCCTGACTGA ACTTCTAAAATCCGGTTTGATTTTTAATGGATA ATGT 
ABC5 ACATTATCCATTAAAAATCAAACCGGATTTTAGAAGTTCAGTCAGGGAG 
ABC6 CTC ATC TTC AGACCAATCTAGTTTA 
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Strain ID: AD2028 (∆cbpD) 
Gene deleted: cbpD 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
cbpD-1 TCGCGATGACTACTATGAACGTGGT 
cbpD-2 TTGTTTTAGTACCTAGGGCCCTTGTTCCTCTTGCTATAAACGGTAA 
cbpD-3 TTACCGTTTATAGCAAGAGGAACAAGGGCCCTAGGTACTAAAACAA 
cbpD-4 TCGTATTAATAGCTAAGGCGCCTGATTTGATTTTTAATGGATAATGT 
cbpD-5 ACATTATCCATTAAAAATCAAATCAGGCGCCTTAGCTATTAATACGA 
cbpD-6 CATTGGCAAAGACATTGTCTGCCTC 
 
 
198 
 
 
Strain ID: AD2028-1 (cbpD::pEVP3) 
Gene inactivated: cbpD 
Antibiotic resistance cassette: Cm 
D39 with PEVP3 inserted into cbpD (Zhu and Lau, 2011) 
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Strain ID: AD2033 (∆raiA) 
Gene deleted: raiA 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
YifA1 CAGGTTGAGGGCTTGGTAGAGGCAG 
YifA2 TTGTTTTAGTACCTAGGGCCCACTTTTAAGTTAATTCGGGCATCCAA 
YifA3 TTGGATGCCCGAATTAACTTAAAAGTGGGCCCTAGGTACTAAAACAA 
YifA4 TGATCTTCAACATCCACATAGATAAGGTTTGATTTTTAATGGATAATGT 
YifA5 ACATTATCCATTAAAAATCAAACCTTATCTATGTGGATGTTGAAGATCA 
YifA6 CAGGCATCTGTTCCAATAGAGCTGT 
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Strain ID: AD2035 (∆cflA-F) 
Gene deleted: cflA and cflF 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
cflAF-1 GTGCAGTGTGTTTGGCTAGTCCTCG 
cflAF-2 ACATTATCCATTAAAAATCAAACCGTAAGATTTCTGCTAACTGCTCCCC 
cflAF-3 GGGGAGCAGTTAGCAGAAATCTTACGGTTTGATTTTTAATGGATAATGT 
cflAF-4 AACACGATTTATAGTTGCTCCTGTACTGGGCCCTAGGTACTAAAACAA 
cflAF-5 TTGTTTTAGTACCTAGGGCCCAGTACAGGAGCAACTATAAATCGTGTT 
cflAF-6 ACTGGACAATATTTGAATCTTCCAC 
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Strain ID: AD2064 (∆comCDE) 
Gene deleted: comCDE 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
CDE-1 AAAATTAAAGTTGTAACAGTTGGGA 
CDE-2 TTGTTTTAGTACCTAGGGCCCAAGTCTTTTTCCTTCAAAGCTACAAA 
CDE-3  TTTGTAGCTTTGAAGGAAAAAGACTTGGGCCCTAGGTACTAAAACAA 
CDE-4  GTCAATCACTTTTGAGATTTTTTCTGGTTTGATTTTTAATGGATAATGT 
CDE-5 ACATTATCCATTAAAAATCAAACCAGAAAAAATCTCAAAAGTGATTGAC 
CDE-6 GTAGAAAAAGCCGGAATTAGTCGTT 
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Strain ID: AF1928 (∆cibAB∆lytA) 
Deleted genes: cibAB and lytA 
Antibiotic resistance cassette: Kan/Erm 
AD0133 transformed with genomic DNA of AD1737-1 
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Strain ID: AR2042/AG2236/AT2236 (∆comD) 
Gene deleted: comD 
Antibiotic resistance cassette: Kan 
Primers used to construct this mutant: 
primers primer sequences 
ComD-1 AATTGCTGACCGTGATTTCGTTATT 
ComD-2 ACATTATCCATTAAAAATCAAACCTTTCCCCTTATTTCATTACTTTTTT 
ComD-3  AAAAAAGTAATGAAATAAGGGGAAAGGTTTGATTTTTAATGGATAATGT 
ComD-4  GCCTTCCATCTCTGTTTCTAAAATATGGGCCCTAGGTACTAAAACAA 
ComD-5 TTGTTTTAGTACCTAGGGCCCATATTTTAGAAACAGAGATGGAAGGC 
ComD-6 CTTGTGAGGAGAATAAAATCGCTGA 
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Strain ID: CD1880 (∆cibAB∆cbpD) 
Deleted/inactivated genes: cibAB and cbpD 
Antibiotic resistance cassette: Kan/Cm 
AD0133 transformed with genomic DNA of AD2028-1 
 
 
205 
 
 
Strain ID: EB1890 (∆cibAB∆comX1∆comX2) 
Deleted/inactivated genes: cibAB, comX1 and comX2 
Antibiotic resistance cassette: Kan/Cm/Erm 
AD0133 transformed with genomic DNA of KM1983 
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Strain ID: EJ1796 (∆spd_0981∆comX1∆comX2) 
Deleted/inactivated genes: spd_0981, comX1 and comX2 
Antibiotic resistance cassette: Kan/Cm/Erm 
AD0981 transformed with genomic DNA of KM1983 
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Strain ID: FG1928 (∆cibAB∆cbpD∆lytA) 
Deleted/inactivated genes: cibAB, cbpD and lytA 
Antibiotic resistance cassette: Erm/Cm/Kan 
CD1880 transformed with genomic DNA of AD1737-1 
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Strain ID: FS1975 (∆comX1∆comX2) 
Deleted genes: comX1 and comX2 
Antibiotic resistance cassette: Kan/Erm 
AD0014 transformed with genomic DNA of AD1818-1 
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Strain ID: GM1856 (∆radC∆comX1∆comX2) 
Deleted/inactivated genes: radC, comX1 and comX2 
Antibiotic resistance cassette: Kan/Cm/Erm 
AD0975 transformed with genomic DNA of KM1983 
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Strain ID: GG1602 (∆cinbox∆comX1∆comX2) 
Deleted/inactivated genes: cinbox, comX1, comX2 
Antibiotic resistance: Kan, Cm, Erm 
AD1740-1 transformed with the genomic DNA of KM1983 
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Strain ID: GW1941 (∆cbpD∆lytA) 
Deleted/inactivated genes: cbpD and lytA 
Antibiotic resistance cassette: Kan/Cm 
AD1737 transformed with genomic DNA of AD2028-1 
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Strain ID: IN1643 (D39pcomX::lacZ) 
Gene deleted: comX1 
Antibiotic resistance cassette: Cm 
D39 transformed with the genomic DNA of CPM3 (Sung and Morrison, 2005) 
 
 
Strain ID: IN1643 (TIGR4pcomX::lacZ) 
Gene deleted: comX1 
Antibiotic resistance cassette: Cm 
TIGR4 transformed with the genomic DNA of CPM3 (Sung and Morrison, 2005) 
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Strain ID: JC0923 (D39pcomX::lacZ, ∆comA) 
Gene deleted: comX1, comA 
Antibiotic resistance cassette: Cm, Kan 
IN1643 transformed with the genomic DNA of AD0049 
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Strain ID: KF1940 (∆cbpD∆comX1∆comX2) 
Deleted/inactivated genes: cbpD, comX1 and comX2 
Antibiotic resistance cassette: Kan/Cm/Erm 
AD2028 transformed with genomic DNA of KM1983  
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Strain ID: KM1983 (∆comX1∆comX2) 
Gene deleted/inactivated: comX1 and comX2 
Antibiotic resistance cassette: Cm/Erm 
AD1818-1 transformed with genomic DNA of CPM3 (Sung and Morrison, 2005) 
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Strain ID: LP1861 (∆dprA∆comB) 
Gene disrupted: comB and dprA 
Antibiotic resistance cassette: Cm and Kan 
AD0050 transformed with genomic DNA of AD1122. 
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Strain ID: RH1665 (∆spd_0031∆comX1∆comX2) 
Deleted/inactivated genes: spd_0031, comX1 and comX2 
Antibiotic resistance cassette: Kan/Cm/Erm 
AD0031 transformed with genomic DNA of KM1983 
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Strain ID: ST2012 (∆cap3A) 
Gene deleted: cap3A 
Antibiotic resistance cassette: Kan (Sung et al., 2001) 
Primers used to construct this mutant: 
primers primer sequences 
cap3A-1 AAGAGGATAGATTGAAGTTCGAGAA 
cap3A-2 TTGTTTTAGTACCTAGGGCCCAGGCAATTTTCATTTTACTACAGTCC 
cap3A-3 GGACTGTAGTAAAATGAAAATTGCCTGGGCCCTAGGTACTAAAACAA 
cap3A-4  TTATTCTCTGCCAAATAAATCGCGTGGTTTGATTTTTAATGGATAATGT 
cap3A-5 ACATTATCCATTAAAAATCAAACCACGCGATTTATTTGGCAGAGAATAA 
cap3A-6 ATTGCTTTCATAGTTCCTTCTGCCC 
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Strain ID: TY1805 (∆spxB∆recA) 
Gene deleted: spxB, recA 
Antibiotic resistance cassette: Erm, Kan 
TY1805 transformed with the genomic DNA of AD1739 
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Strain ID: KM1983 (∆comX1∆comX2) 
Gene deleted/inactivated: comX1 and comX2 
Antibiotic resistance cassette: Cm/Erm 
AD1818-1 transformed with genomic DNA of CPM3 (Sung and Morrison, 2005) 
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